: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neoplasms of the CNS

Free Subscription

Articles published in J Neurooncol
Retrieve available abstracts of 1274 articles:
HTML format

Single Articles

July 2026

MITOBE Y, Kamimura S, Nakamura K, Kanemura Y, et al
Prognostic impact of RANO resect group classification post-chemoradiotherapy in IDH-wildtype glioblastoma.
J Neurooncol. 2026;179:23.
PubMed Abstract available

REYES JS, Hadjipanayis CG, Bernstein K, Speckter H, et al
Personalized prediction of local control after stereotactic radiosurgery for craniopharyngioma: a multicenter machine learning survival model.
J Neurooncol. 2026;179:22.
PubMed Abstract available

HSI AH, Wathoo C, Campbell E, Nassif M, et al
Social vulnerability and survival among patients with high-grade glioma treated at a tertiary cancer center.
J Neurooncol. 2026;179:21.
PubMed Abstract available

CHOJAK R, Drewes NB, Slychan K, Lukas RV, et al
Spatial patterns of progression in reported glioblastoma cohorts after upfront chemoradiation and salvage therapy: a systematic review and meta-analysis.
J Neurooncol. 2026;179:20.
PubMed Abstract available

LIU YF, Li XC, Zhang J, Niu JH, et al
Real-world outcomes of radiotherapy timing in infants with medulloblastoma by molecular subtype: a single-center retrospective cohort study.
J Neurooncol. 2026;179:19.
PubMed Abstract available

RAMIREZ-FERRER E, Noll K, Mayorga-Corvacho J, Sierra MA, et al
Beyond motor: clinical manifestations of right hemisphere gliomas - a systematic review.
J Neurooncol. 2026;179:15.
PubMed Abstract available

ZHU JW, Fernandes I, Lopes JB, Moravan V, et al
Clinicopathological factors associated with brain metastases development among breast cancer patients receiving neoadjuvant chemotherapy.
J Neurooncol. 2026;179:14.
PubMed Abstract available

SANDERSON E, Drummond K, Dowling A, Bennett I, et al
Salvage therapies for recurrent grade 4 IDH-wildtype glioma: a BRAIN Registry analysis of real-world treatment patterns.
J Neurooncol. 2026;179:13.
PubMed Abstract available

CARRIERE PP, Haisraely O, Aaroe A, Ahmed K, et al
Long-term outcomes in IDH-wildtype (IDH-wt) gliomas with historical WHO grade 2 and 3 histology.
J Neurooncol. 2026;179:12.
PubMed Abstract available

DREWES NB, Koutah L, Jain R, Carnduff J, et al
Extent of resection and survival in IDH-wildtype glioblastoma: interaction with MGMT status and chemoradiation.
J Neurooncol. 2026;179:10.
PubMed Abstract available

MUSTAFA MA, Hannan CJ, Amoo M, Sokan J, et al
Derivation of a data-driven follow-up protocol for resected skull base meningiomas: a Bayesian analysis.
J Neurooncol. 2026;179:11.
PubMed Abstract available

WOJTON-DZIEWONSKA D, Skora T, Aniol J, Popow-Gierba A, et al
Survival, late toxicity and ability to return to work after proton radiotherapy for low-grade gliomas.
J Neurooncol. 2026;179:9.
PubMed Abstract available

MARCHAL J, Ybert L, Ducloie M, Geffrelot J, et al
The threefold value of surgery in previously irradiated brain metastases.
J Neurooncol. 2026;179:8.
PubMed Abstract available

ZHU Y, Yu S, Du B, Yao N, et al
The persistent benefit of chemotherapy in elderly lung adenocarcinoma patients with brain metastases in the immunotherapy era.
J Neurooncol. 2026;179:7.
PubMed Abstract available

XING J, Feinaj A, Ritter Z, Clarke K, et al
Spatial distribution and prognostic significance of hemorrhagic imaging features in brain metastases from metastatic renal cell carcinoma.
J Neurooncol. 2026;179:5.
PubMed Abstract available

MAATTA J, Laajava J, Niemela M, Korja M, et al
Declining age-adjusted surgical incidence of intracranial meningiomas: a 19-year retrospective analysis from an academic hospital.
J Neurooncol. 2026;179:6.
PubMed Abstract available

KINGER S, Sedor G, Buss EJ, Giannaris E, et al
Frameless stereotactic radiosurgery in the management of brain metastases: long-term oncologic and toxicity outcomes.
J Neurooncol. 2026;179:4.
PubMed Abstract available

REYES JS, Niranjan A, Bouras A, Wei CZ, et al
Therapeutic hybrid intelligence with neural and knowledge-based expert reasoning for SRS (THINKERS): an AI model for meningioma.
J Neurooncol. 2026;179:2.
PubMed Abstract available

DAMODHARAN S, Calderon A, Abdelbaki MS
Intratumoral and intracranial hemorrhage associated with MAPK-pathway targeted therapy: a systematic review and mechanistic synthesis.
J Neurooncol. 2026;178:103.
PubMed Abstract available

REYES JS, Bouras A, Hadjipanayis CG, Lunsford LD, et al
Dual AI models for gamma knife radiosurgery in craniopharyngioma: prescription dose modeling and outcome risk prediction.
J Neurooncol. 2026;178:102.
PubMed Abstract available

TRIPPETT JS, Dono A, Shams SS, Gurav J, et al
Motor mapping to enable resections of peri-rolandic diffuse gliomas.
J Neurooncol. 2026;178:100.
PubMed Abstract available

REYES JS, Bouras A, Lunsford LD, Niranjan A, et al
Machine learning prediction of local control after Gamma Knife radiosurgery to post-resection cavities from brain metastases: a proof-of-concept study.
J Neurooncol. 2026;178:98.
PubMed Abstract available

MUHLHAUSEN L, Kocher M, Karadachi HH, Sure U, et al
Leptomeningeal disease (LMD) after resection of brain metastases: results of the multicenter SUBAROMA study.
J Neurooncol. 2026;178:99.
PubMed Abstract available

REYES JS, Niranjan A, Hadjipanayis CG
Therapeutic Hybrid Intelligence with Neural and Knowledge-based Expert Reasoning for SRS (THINKERS): an AI model for GBM.
J Neurooncol. 2026;178:97.
PubMed Abstract available

GRIN EA, Frome S, Turner J, Clymer J, et al
Incidence and predictors of hemorrhage in pediatric low-grade glioma.
J Neurooncol. 2026;178:96.
PubMed Abstract available

PALEVSKI D, Stiebel-Kalish H, Bialer OY
Visual outcomes of sight threatening radiation-induced meningiomas after low-dose head irradiation: tinea capitis as a paradigm.
J Neurooncol. 2026;178:95.
PubMed Abstract available

GROSSENBACHER B, Le Rhun E, Roth P, Kulcsar Z, et al
Intratumoral hemorrhage in patients with brain metastasis from systemic tumors: risk factors and prognostic assessment.
J Neurooncol. 2026;178:93.
PubMed Abstract available

ALTIERI R, Ugga L, Bianconi A, Caneva S, et al
Rethinking white matter-tumor interaction: a tractography based analysis of associations between fractional anisotropy and morphometry in the IFOF and arcuate fasciculus.
J Neurooncol. 2026;178:94.
PubMed Abstract available

GHAITH HS, Zaidan SK, McIntyre MK, Gerges Castro CE, et al
Divided care, diminished outcomes? The impact of care fragmentation on survival in glioblastoma.
J Neurooncol. 2026;178:92.
PubMed Abstract available

BASARAN AE, Fahsold L, Vychopen M, Barrantes-Freer A, et al
Serum lactate dehydrogenase is associated with the presence and extent of preoperative peritumoral edema in melanoma brain metastases.
J Neurooncol. 2026;178:90.
PubMed Abstract available

CHEN AY, Shah R, Shi W, Urman N, et al
Feasibility evaluation of tumor treating fields for brainstem gliomas.
J Neurooncol. 2026;178:91.
PubMed Abstract available

FARAJ CA, Young CC, Beckham TH, Weinberg JS, et al
Intraoperative technological advances and new frontiers in precision glioma surgery.
J Neurooncol. 2026;178:89.
PubMed Abstract available

SHARPE MA, Baskin AM, Teh BS, Butler EB, et al
Optimizing the Stupp protocol for treatment of glioblastoma: eliminating age bias, enhancing treatment timing, use of stereotactically-guided sequential boost, and dexamethasone dosing.
J Neurooncol. 2026;178:88.
PubMed Abstract available

ALMEIDA ND, Sinha S, Fang M, Cheruvu H, et al
Gamma knife radiosurgery for renal cell carcinoma brain metastases across systemic therapy eras: survival, intracranial failure, and lesion-level predictors.
J Neurooncol. 2026;178:87.
PubMed Abstract available

SHARMA A, Agrawal D, Natanasabapathi G, Saha S, et al
Real-time confocal imaging for evaluation of dose-dependent effects of gamma knife radiosurgery on U87 glioblastoma cell line.
J Neurooncol. 2026;178:86.
PubMed Abstract available

LIN J, Tang W, Li K, Chen Z, et al
Clinical, surgical, and molecular characteristics and outcomes of adult patients with diffuse midline glioma, H3 K27-altered, treated with surgical resection.
J Neurooncol. 2026;178:85.
PubMed Abstract available

June 2026

WU WY, Numan Hellquist B, Melin B, Bjorkblom B, et al
Intratumoral serotonin and antidepressants in glioblastoma patients: narrowing the uncertainties.
J Neurooncol. 2026;178:84.
PubMed Abstract available

SHAH R, Jain S, Haldar N, Holt LA, et al
Fractionated stereotactic radiotherapy (fSRT) for symptomatic WHO grade 1 cavernous sinus meningiomas: long-term local control, clinical response, and toxicity outcomes.
J Neurooncol. 2026;178:83.
PubMed Abstract available

GARCIA-MILAN V, Bauluz Olmedo L, Marcos S, Lau R, et al
A label-free nanoplasmonic biosensor for intraoperative discrimination of tumor margins in brain metastases surgery.
J Neurooncol. 2026;178:81.
PubMed Abstract available

HONG Y, Jiang R, Chen S, Lu D, et al
Survival outcomes and a prognostic nomogram in EGFR-mutant non-small cell lung cancer with leptomeningeal metastasis: a real-world cohort study.
J Neurooncol. 2026;178:80.
PubMed Abstract available

SAMPATH SG, Tang AJ, Chen AX, Viswanathan A, et al
Correction to: cGAS-STING agonists in preclinical glioblastoma animal models: a systematic review of tumor microenvironment modulation and survival outcomes.
J Neurooncol. 2026;178:79.
PubMed

DATTA A, Pandey A, Verma R, Jaiswal AK, et al
Integrated serum and tissue NMR metabolomics with correlation analysis reveals metabolic alterations in gliomas.
J Neurooncol. 2026;178:77.
PubMed Abstract available

VAN DE LANGERIJT ON, Ehret F, Niemierko A, Oh KS, et al
Long-term outcomes and late effects of surgery and radiotherapy in adult intracranial ependymoma patients.
J Neurooncol. 2026;178:78.
PubMed Abstract available

AKKARA Y, Wang PP, Hon JJ, Egrilmezer A, et al
Perioperative determinants of oncologic trajectory shaping recurrence and survival following resection of brain metastases.
J Neurooncol. 2026;178:76.
PubMed Abstract available

KAPITANCUKE M, Petroska D, Petrosiute A, Luciunaite A, et al
Expression patterns of carbonic anhydrase IX and immune response biomarkers in pediatric gliomas and glioneuronal tumors.
J Neurooncol. 2026;178:75.
PubMed Abstract available

BARBE-RICHAUD JB, Cebula H, Todeschi J, Santin MDN, et al
From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence.
J Neurooncol. 2026;178:73.
PubMed Abstract available

REYES JS, Snyder MH, Roguski M, Hadjipanayis CG, et al
AI for prognosis and treatment stratification in glioblastoma neurosurgery: a systematic review.
J Neurooncol. 2026;178:71.
PubMed Abstract available

NATHAN CL, Ghandour D, Cunningham EM, Lukas RV, et al
Epilepsy characteristics and outcomes in patients with pleomorphic xanthoastrocytomas.
J Neurooncol. 2026;178:72.
PubMed Abstract available

SHEEHAN D, Sheehan K, Shinya Y, Fadul CE, et al
Long-term survival with stereotactic radiosurgery and 100+ cycles of Keytruda in a patient with brain metastases from melanoma.
J Neurooncol. 2026;178:70.
PubMed

GUI C, Funt SA, Boe LA, Deshane A, et al
Stereotactic radiosurgery and multimodal integration approaches for germ cell tumor brain relapse.
J Neurooncol. 2026;178:68.
PubMed Abstract available

BOTEZATU IV, Kondratova VN, Stroganova AM, Prokopev IG, et al
Quantitative DNA melting analysis with hybridization probes (qDMA-HP) as a novel approach to assess MGMT promoter methylation in malignant glioma.
J Neurooncol. 2026;178:66.
PubMed Abstract available

TRAN K, Goodin DA, Stephenson T, Williams BJ, et al
Glioma region-specific metabolites associated with patient seizures.
J Neurooncol. 2026;178:64.
PubMed Abstract available

AHMED S, Waheed H, Durrani A, Syed A, et al
Diagnostic utility of liquid biopsies in pediatric brain tumors: a systematic review.
J Neurooncol. 2026;178:63.
PubMed Abstract available

CHEN JS, Bergsneider B, Haddad AF, Morshed RA, et al
Intraoperative functional brain mapping for glioma surgery: a comprehensive review of the University of California San Francisco mapping protocol.
J Neurooncol. 2026;178:62.
PubMed Abstract available

LESKINEN S, Inzerillo S, Coelho A, Shah HA, et al
Symptomatic radiation necrosis following intracranial brachytherapy: a systematic review and meta-analysis.
J Neurooncol. 2026;178:61.
PubMed Abstract available

ALLMENDINGER FJK, Deng M, Regnery S, Wessel L, et al
Long-term outcomes of adjuvant proton radiotherapy (PRT) for residual pituitary adenoma (PA) in adults - a retrospective, single institute experience.
J Neurooncol. 2026;178:60.
PubMed Abstract available

BASARAN AE, Braune M, Barrantes-Freer A, Muller WC, et al
FOXC1 as a molecular predictor of postoperative peritumoral edema resolution in meningiomas.
J Neurooncol. 2026;178:59.
PubMed Abstract available

LIU L, Huang S, Huang Y, Xu J, et al
Development and validation of a machine learning-based model for predicting delirium risk in postoperative brain tumor patients in the Intensive Care Unit.
J Neurooncol. 2026;178:57.
PubMed Abstract available

SEIFERT AM, Richter S, Sagerer A, Lemnian I, et al
Comparison between molecular and histological IDH-wild-type glioblastoma and extensive subgroup analysis of IDH-wild-type astrocytic tumors without genomic glioblastoma-defining alterations.
J Neurooncol. 2026;178:58.
PubMed Abstract available

MIZUTANI Y, Hori YS, Kattaa AH, Harary PM, et al
Laser interstitial thermal therapy (LITT) for brain metastases: a systematic review and pooled analysis of Efficacy/Safety and the role of combination treatments.
J Neurooncol. 2026;178:56.
PubMed Abstract available

PARKER M, Carmichael A, Lucas CG Jr, Schreck KC, et al
Survival after hypofractionated radiation versus standard radiation in glioblastoma by MGMT promoter methylation status and age: an analysis of the national cancer database.
J Neurooncol. 2026;178:55.
PubMed Abstract available

LANMAN TA, Gonzalez Castro LN, Perlow HK, Youssef G, et al
Contemporary practice patterns in IDH-mutant glioma management: a multidisciplinary multi-institutional survey.
J Neurooncol. 2026;178:54.
PubMed Abstract available

ZHANG Y, Wang H, Wang J, Sui Y, et al
Targeting VAMP5 suppresses PLK1-driven growth of gliomas with high NDRG4 expression.
J Neurooncol. 2026;178:50.
PubMed Abstract available

JIANG LQ, Wan CY, Kang J, Fu R, et al
Survival outcomes and molecular predictors in small cell lung cancer with brain metastases receiving immunotherapy.
J Neurooncol. 2026;178:51.
PubMed Abstract available

BEA SINTES M, Velilla-Alonso G, Herrero-San Martin A, Gallego Perez-Larraya J, et al
Risk factors and long-term outcomes in smart syndrome: a multicenter study.
J Neurooncol. 2026;178:53.
PubMed Abstract available

FARAJ CA, McCutcheon IE
Loss of pituitary hormone function after stereotactic radiosurgery for pituitary adenomas: mechanisms and management.
J Neurooncol. 2026;178:48.
PubMed Abstract available

BENITEZ-ROCHA RD, Cabrera-Galeana P, Reyes JA, Villasenor-Navarro Y, et al
Prognostic impact of concomitant leptomeningeal disease in breast cancer patients with brain metastases: a large single-center cohort study.
J Neurooncol. 2026;178:49.
PubMed Abstract available

ZHANG S, Sun Z, Jiang S, Meng L, et al
Invasion/metastasis-related differentially methylated genes predict prognosis in diffuse gliomas.
J Neurooncol. 2026;178:46.
PubMed Abstract available

KUMAR S, Benavides-Serrato A, Saunders JT, Nishimura RN, et al
PKA signaling modulates PRMT5/hnRNP A1-mediated IRES translation and dictates responses to mTOR inhibition in glioblastoma.
J Neurooncol. 2026;178:45.
PubMed Abstract available

HIMIC V, Johnson ML, Ratnaparkhi A, Mayrand RC, et al
Butterfly gliomas: to biopsy or to ablate - a longitudinal cohort study.
J Neurooncol. 2026;178:44.
PubMed Abstract available

WILLIAMS ST, Kingdon S, Rominiyi O, Lorimer C, et al
Report of treatment intensity and survival outcomes in older patients with glioblastoma diagnosed according to WHO CNS 5 classification.
J Neurooncol. 2026;178:41.
PubMed Abstract available

SUREN D, Nergiz D, Topsoy C, Unal SEP, et al
The role of tumor-associated macrophages in the progression and recurrence of meningiomas.
J Neurooncol. 2026;178:40.
PubMed Abstract available

SHIDOH-KAZUKI R, Fujikawa Y, Kawabata S, Tsujino K, et al
Correction: Boron neutron capture therapy prolongs survival in a rat model of multifocal brain metastases.
J Neurooncol. 2026;178:42.
PubMed

HIGASHINO M, Tanaka K, Ishihara T, Nagashima H, et al
Long-term clinical outcomes and recurrence factors in intracranial germinoma.
J Neurooncol. 2026;178:43.
PubMed Abstract available

TROY C, Laird DG, Brimley C, Pinto S, et al
Neoadjuvant chemotherapy for pineal region tumors.
J Neurooncol. 2026;178:37.
PubMed Abstract available

ZHANG L, Feng M, Yang Y, Qi Z, et al
A comparative study of Ommaya reservoir versus lumbar puncture for intrathecal chemotherapy in patients with leptomeningeal metastasis: a systematic review and meta-analysis.
J Neurooncol. 2026;178:38.
PubMed Abstract available

May 2026

WANG D, Liu X, Wang J, Zhang B, et al
Efficacy of chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic pontine glioma: a study based on single-center and SEER data.
J Neurooncol. 2026;178:36.
PubMed Abstract available

ROSUEL J, Duffau H
What is the actual role of intraoperative MRI on long-term onco-functional outcome of surgery for low-grade glioma? A systematic review.
J Neurooncol. 2026;178:35.
PubMed Abstract available

GARCIA-HIDALGO C, Garcia Kempf AM, Galdo Galian D, Consentino Hernandez JA, et al
Candidate MRI biomarkers for CD79B status in primary CNS lymphoma: an exploratory radiogenomic analysis of the UCSF-PCNSL cohort.
J Neurooncol. 2026;178:33.
PubMed Abstract available

PICHARDO-ROJAS PS, Garcia-Torrico F, Andrade-Arbaiza EA, Calderon Magdaleno LF, et al
Radiotherapeutic management of metastatic brain disease: a two-decade meta-analysis of tumor control and neurocognitive outcomes with SRS alone versus SRS plus WBRT.
J Neurooncol. 2026;178:32.
PubMed Abstract available

ZHOU W, Yu M, Cheng S, Zhu H, et al
Pituitary adenomas associated with hydrocephalus: clinical characteristics, risk stratification, and clinical management.
J Neurooncol. 2026;178:31.
PubMed Abstract available

LEON S, Maity A, Gluski J, Brown EDL, et al
Intramedullary or invasive characteristics of spinal melanocytomas: a PRISMA compliant systematic review and pooled case analysis.
J Neurooncol. 2026;178:30.
PubMed Abstract available

HICKMAN-CHOW DA, Luckett PH, Olufawo M, Dierker D, et al
Predicting progression-free survival in glioblastoma with neuroimaging and machine learning.
J Neurooncol. 2026;178:29.
PubMed Abstract available

BREHMER S, Sarria GR, Wurfel S, Sulejmani A, et al
Intraoperative radiotherapy after resection of newly diagnosed brain metastases in adult patients - results of a prospective phase II trial (INTRAMET).
J Neurooncol. 2026;178:28.
PubMed Abstract available

TUOHY K, Badani A, Franklin A, Zacharia B, et al
Predicting late radiation-associated neurocognitive and endocrine toxicity in patients with brain tumors.
J Neurooncol. 2026;178:26.
PubMed Abstract available

ZHANG J, Zhang J, Qiu W, Zhang J, et al
Retraction Note: MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma.
J Neurooncol. 2026;178:27.
PubMed

MALGULWAR PB, Nambirajan A, Pathak P, Faruq M, et al
Retraction Note: Study of beta-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.
J Neurooncol. 2026;178:22.
PubMed

TZENG CC, Chung MW, Huang YC, Chen KT, et al
Peripheral hematological landscapes as biomarkers for detecting postoperative progression in glioblastoma multiforme: a multivariable risk scoring approach.
J Neurooncol. 2026;178:24.
PubMed Abstract available

MAI YY, Liu ZM, Zhou H, Jiang K, et al
Role of tumor momentum in neurocognitive deficits among pediatric brainstem glioma prior to treatment: a pilot study.
J Neurooncol. 2026;178:23.
PubMed Abstract available

IZHAR M, Hori YS, Lam FC, Kalra N, et al
Clinical utility of liquid biopsy in distinguishing true progression from radiation necrosis and pseudoprogression in malignant brain tumor.
J Neurooncol. 2026;178:21.
PubMed Abstract available

GLYNN SE, D'Agostino R Jr, Lanier CM, R Choi A, et al
Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patients.
J Neurooncol. 2026;178:20.
PubMed Abstract available

HWANG S, Kim PH, Kim H, Kim D, et al
Therapeutic effects of selumetinib on diffuse neurofibroma and optic pathway glioma in neurofibromatosis type 1.
J Neurooncol. 2026;178:18.
PubMed Abstract available

JUNG IH, Yoo J, Choi S, Roh TH, et al
Survival analysis of adult midline-located gliomas and diffuse midline gliomas: beyond the H3K27 mutation paradigm.
J Neurooncol. 2026;178:17.
PubMed Abstract available

ARJUNA S, Pirhoushiaran M, Bueno A, Sanchez-Espitia A, et al
CSF ctDNA analysis guides molecular reclassification of diffuse glioma patients.
J Neurooncol. 2026;178:14.
PubMed Abstract available

WONG DKK, Pu JKS, Li LF, Hui VKH, et al
Health-related quality-of-life of WHO grade 4 astrocytoma patients receiving alternating electrical field therapy: a prospective real-world multi-centre study.
J Neurooncol. 2026;178:16.
PubMed Abstract available

PALIT SR, Shinya Y, Celda MP, Karsy M, et al
Risk factors for postoperative cerebrospinal fluid leak following endoscopic transsphenoidal surgery for craniopharyngioma: a multicenter cohort study with a contemporary surgeon practice survey.
J Neurooncol. 2026;178:13.
PubMed Abstract available

SKARIN N, Hallbeck M, Werlenius K, Rohan Z, et al
MGMT promoter methylation status for glioblastoma: defining the clinically relevant cut-off value for pyrosequencing.
J Neurooncol. 2026;178:12.
PubMed Abstract available

JIA JL, Alshamsan B, Andronic C, Fazzari F, et al
Treatment patterns and outcomes in high-risk WHO grade 2 diffuse glioma: a multicentre retrospective cohort study.
J Neurooncol. 2026;178:10.
PubMed Abstract available

ZEYEN T, Decker A, Krause I, Kroh F, et al
APTw CEST MRI in therapy-naive IDH-wildtype glioblastoma: insights into tumor heterogeneity and molecular subtypes.
J Neurooncol. 2026;178:9.
PubMed Abstract available

VENTURA E, Alanesi A, Achterling M, Fistouris P, et al
Impact of postoperative tumor volume and relative volume reduction to predict meningioma recurrence - a retrospective analysis.
J Neurooncol. 2026;178:7.
PubMed Abstract available

SHIDOH-KAZUKI R, Fujikawa Y, Kawabata S, Tsujino K, et al
Boron neutron capture therapy prolongs survival in a rat model of multifocal brain metastases.
J Neurooncol. 2026;178:8.
PubMed Abstract available

BINDAL K, Dono A, Tandon N, Esquenazi Y, et al
Laser interstitial thermal therapy versus stereotactic radiosurgery for first-time treatment of recurrent glioblastoma: a retrospective single-center study.
J Neurooncol. 2026;178:6.
PubMed Abstract available

WIERZBICKI M, Bowden SG, Robert SM, Wang SY, et al
Care pathways for asymptomatic brain metastases: comparison of healthcare utilization, costs, and outcomes in outpatient versus acute settings.
J Neurooncol. 2026;178:5.
PubMed Abstract available

IZHAR M, Hori YS, Kattaa AH, Harary PM, et al
Outcome of CyberKnife stereotactic radiosurgery for the brain metastases in patients with Li Fraumeni syndrome.
J Neurooncol. 2026;178:4.
PubMed Abstract available

LEVIN-CARRION Y, Bhasin J, Titkov K, Anne S, et al
Should checkpoint inhibitors be reserved for biomarker-selected pediatric brain tumors?
J Neurooncol. 2026;178:2.
PubMed Abstract available

PALUMBO C, De Schlichting E, Le Lann F, Leboucher A, et al
Timing of adjuvant chemoradiotherapy after resection and survival in glioblastoma: a single-centre cohort analysis.
J Neurooncol. 2026;177:150.
PubMed Abstract available

BECHT K, Lindsay ME, Soulos PR, Singh C, et al
Disparities in stereotactic radiosurgery receipt in patients with brain metastases from non-small cell lung cancer.
J Neurooncol. 2026;177:151.
PubMed Abstract available

HEBDA A, Wawrzyniak P, Heinze S, Mazgaj P, et al
Diagnostic accuracy of 1H-MRS in detecting the oncometabolite 2-hydroxyglutarate (2HG) in adult-type diffuse gliomas.
J Neurooncol. 2026;177:149.
PubMed Abstract available

MUSHTAQ N, Bashir F, Zahid S, Shafique MA, et al
Pediatric low-grade gliomas; a 12-year retrospective review from a tertiary care hospital in LMIC.
J Neurooncol. 2026;177:148.
PubMed Abstract available

HERSH DS, Asher AL, Bydon M, Delawan M, et al
Developing a core outcome set for the NeuroPoint Alliance Quality Outcomes Database Pediatric Tumor Surgery Registry: a modified Delphi study.
J Neurooncol. 2026;177:147.
PubMed Abstract available

ALBANO L, Losa M, Vitale GG, Reyes JS, et al
Stereotactic radiosurgery for pediatric craniopharyngiomas: a multicenter retrospective study.
J Neurooncol. 2026;177:146.
PubMed Abstract available

LAPTEVA K, Gavrjushin A, Veselkov A
Intraoperative tract mapping through the biopsy cannula during stereotactic biopsy of brainstem lesions: a prospective feasibility study.
J Neurooncol. 2026;177:145.
PubMed Abstract available

MOHL S, Tenhoeve SA, King S, Zhao Y, et al
The impact of distance in treating glioblastoma: a retrospective single-center study.
J Neurooncol. 2026;177:144.
PubMed Abstract available

SAMPATH SG, Tang AJ, Chen AX, Viswanathan A, et al
cGAS-STING agonists in preclinical glioblastoma animal models: a systematic review of tumor microenvironment modulation and survival outcomes.
J Neurooncol. 2026;177:142.
PubMed Abstract available

CHUCK C, Teshome A, Lin A, Sayeed S, et al
Correction to: Redefining the therapeutic landscape of glioblastomas and brain metastasis through cesium brachytherapy and low-kV intra-operative radiation therapy (IORT).
J Neurooncol. 2026;177:137.
PubMed

GOEL K, Qian Y, Pollom E
Cost-effectiveness analysis of upfront HA-WBRT vs. SRS for treatment of brain metastases due to SCLC.
J Neurooncol. 2026;177:139.
PubMed Abstract available

SARFRAZ Z, Ranjan T, Mustafayev FNA, Luzarraga J, et al
Treatment patterns and survival outcomes in neuroendocrine neoplasms presenting with brain metastases.
J Neurooncol. 2026;177:141.
PubMed

KLAUS FL, Maragkou T, Delbridge C, Eberhardt CG, et al
Subtype-specific prognostic impact of TNIK in medulloblastoma.
J Neurooncol. 2026;177:140.
PubMed Abstract available

LI M, Zhu J, Huang R, Yao X, et al
Virus-like particle vaccine targeting meningeal lymphatic vessels via intradural delivery activates anti-glioma immunity.
J Neurooncol. 2026;177:138.
PubMed

ANDRADE A, Mureb M, Karaman N, Liu C, et al
Evaluating the efficacy of G12C inhibitors in conjunction with Gamma Knife radiosurgery for KRAS-mutant non-small cell lung cancer brain metastases.
J Neurooncol. 2026;177:135.
PubMed

SHIREMAN JM, Xie E, Lebakken CS, Damodharan S, et al
Human neural organoid modeling of diffuse midline glioma captures the complexity of patient tumors.
J Neurooncol. 2026;177:136.
PubMed

MITTELMAN L, Sistiaga IL, Seenarine N, Syed SA, et al
Correction to: Connectome-guided resection of deep-seated brain tumors using tubular retractors: matched cohort outcomes and exploratory quantitative tractometry.
J Neurooncol. 2026;177:134.
PubMed

DEMIRCAN V, Senturk E, Tezcanli E, Erpolat P, et al
Outcomes of early versus late radiotherapy in grade 2 meningiomas: a National retrospective analysis from the TROD neuro-oncology group.
J Neurooncol. 2026;177:133.
PubMed Abstract available

April 2026

KHAZANCHI R, Govind S, Jain R, Vignolles-Jeong J, et al
Unsupervised clustering analysis reveals distinct postoperative cortisol trajectories following pituitary adenoma resection in Cushing's disease.
J Neurooncol. 2026;177:132.
PubMed Abstract available

GOODIN DA, Chen J, Williams BJ, Frieboes HB, et al
Glioblastoma region-specific metabolic signatures reflect patient survival duration.
J Neurooncol. 2026;177:130.
PubMed Abstract available

GOULENKO V, Sinha S, Gulzar B, Madhugiri VS, et al
Longitudinal remodeling of brain metastasis resection cavities after adjuvant gamma knife radiosurgery.
J Neurooncol. 2026;177:129.
PubMed Abstract available

MA Y, Zhou R, Ma Y, Mou C, et al
Application of multidimensional cognitive training in the early postoperative period for glioma patients with cognitive impairment.
J Neurooncol. 2026;177:128.
PubMed

FRIEDES C, Berger M, Linkowski L, Hollawell C, et al
Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study.
J Neurooncol. 2026;177:125.
PubMed Abstract available

MAURICAITE R, Calvez KL, Robinson SD, Camp S, et al
Variation in rates of post-operative oncological treatment for patients with glioblastoma in England: a comprehensive multi-year National cohort study from the GlioCova project.
J Neurooncol. 2026;177:126.
PubMed Abstract available

YOMO S, Yako T, Kitazawa K, Oda K, et al
Long-term safety and efficacy of staged stereotactic radiosurgery with Ommaya reservoir aspiration for large cystic brain metastases.
J Neurooncol. 2026;177:121.
PubMed

KOKETSU Y, Deguchi S, Ohka F, Aoki K, et al
Feasibility of perampanel monotherapy for seizure management during awake craniotomy for glioma.
J Neurooncol. 2026;177:122.
PubMed

GAGLIARDI F, De Domenico P, Roncelli F, Snider S, et al
Circulating Angiopoietin-1/Angiopoietin-2 ratio may reflect pre- and post-treatment vascular states in Glioblastoma and improve discrimination between tumor recurrence and radiation necrosis.
J Neurooncol. 2026;177:123.
PubMed

MASSIMINO M, Carrabba G, Vennarini S, Pecori E, et al
Surgery and radiotherapy strategies at first relapse of pediatric intracranial ependymoma: an Italian retrospective study integrating molecular subgrouping.
J Neurooncol. 2026;177:124.
PubMed Abstract available

RYAN D, Peters KB, Sengupta S, Feng W, et al
Statin use is associated with reduced stroke risk after cranial radiation in glioma patients with hyperlipidemia.
J Neurooncol. 2026;177:118.
PubMed Abstract available

KENNEDY JC, Price SJ, Manly T, Woodberry E, et al
Returning to work after treatment for a low-grade glioma: analysing return-to-work rates and exploring barriers experienced by patients.
J Neurooncol. 2026;177:117.
PubMed Abstract available

HIMIC V, Vargas-George S, Knott MV, Govindarajan V, et al
Non-diagnostic stereotactic intracranial biopsies: a 15-year institutional experience.
J Neurooncol. 2026;177:116.
PubMed Abstract available

GAN T, Li M, Zhang J, Yao Y, et al
Structural organization of neurosurgical care and its influence on long-term outcomes in glioma: evidence from a large single-center cohort in China.
J Neurooncol. 2026;177:115.
PubMed

CHAO Y, Wang Y, Liu X, Ma P, et al
Retraction Note: Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway.
J Neurooncol. 2026;177:114.
PubMed

MATSUDA R, Yamada K, Yokoyama S, Uemura K, et al
Awake mapping-guided salvage resection for local recurrence or radiation necrosis after stereotactic radiosurgery and radiotherapy for brain metastases.
J Neurooncol. 2026;177:113.
PubMed

MITTELMAN L, Sistiaga IL, Seenarine N, Syed SA, et al
Connectome-guided resection of deep-seated brain tumors using tubular retractors: matched cohort outcomes and exploratory quantitative tractometry.
J Neurooncol. 2026;177:109.
PubMed

ABU-ARJA MH, Rajabi Z, McGlynn MC, Ghebrelul RT, et al
Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors.
J Neurooncol. 2026;177:111.
PubMed Abstract available

GHOCHE MT, Gecici NN, Miki K, Yuan F, et al
Predictors of diagnostic yield and surgical safety in stereotactic brain biopsy.
J Neurooncol. 2026;177:112.
PubMed Abstract available

YANG M, Zhou D, Fan J, Qi X, et al
Low-grade neuroepithelial tumor with FGFR1::TACC1 fusion: a clinicopathologic analysis of seven cases.
J Neurooncol. 2026;177:110.
PubMed Abstract available

HOU Z, Liu X, Zhang C, Sun S, et al
Alterations in cerebral iron deposition in low-grade glioma-related epilepsy.
J Neurooncol. 2026;177:108.
PubMed

NAKANO H, Shiinoki T
Radiosensitivity index stability across glioma progression: a longitudinal bulk and single-cell analysis.
J Neurooncol. 2026;177:107.
PubMed

LIU X, Zeng M, Zhang J, Richard SA, et al
Microsurgical outcomes and prognostic analysis of cerebellar gliomas; pathology, molecular biomarkers, and novel clinical insights: a retrospective study.
J Neurooncol. 2026;177:106.
PubMed

KULAKAUSKIENE D, Kriauciunaite K, Balion Z, Stankevicius E, et al
Small and medium/large glioblastoma extracellular vesicles differentially regulate endothelial and mitochondrial function in blood-brain barrier and peripheral vasculature models.
J Neurooncol. 2026;177:103.
PubMed Abstract available

SALIM HA, Agosto S, Qudah HA, Learned K, et al
A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation.
J Neurooncol. 2026;177:105.
PubMed Abstract available

DUZKALIR AH, Yildirim DC, Askeroglu MO, Peker S, et al
Single-fraction Gamma Knife radiosurgery for pineal region meningiomas: a retrospective single-center cohort of 44 patients.
J Neurooncol. 2026;177:104.
PubMed Abstract available

SANTHUMAYOR BA, Domogauer JD, Bernstein K, Donahue B, et al
Evaluation of disparities in timely stereotactic radiosurgery for brain metastases in a safety net hospital system through a centralized workflow.
J Neurooncol. 2026;177:102.
PubMed

SAHU AP, Palsa K, Shenoy G, Slagle-Webb B, et al
Tumor-associated macrophages promote ferroptosis resistance in glioblastoma by stimulating iron-loaded extracellular vesicle release.
J Neurooncol. 2026;177:99.
PubMed Abstract available

XU Y, Zhao P, Yao Z, Shen T, et al
CRYM suppresses glioblastoma progression by inhibiting the TGFbeta1/Smad-EMT signaling pathway.
J Neurooncol. 2026;177:101.
PubMed

WANG Y, Chan WL, Li F, Cai J, et al
Neurobehavioral outcomes and associated risk factors in pediatric brain tumor survivors.
J Neurooncol. 2026;177:98.
PubMed Abstract available

D'ANTONIO F, Rossi S, Carai A, Colafati GS, et al
Pubertal development and hormonal modulation in pediatric low-grade gliomas: a retrospective cohort study.
J Neurooncol. 2026;177:96.
PubMed Abstract available

BOUFFET E, Ramaswamy V, Lafay-Cousin L
Radiation-sparing management of WNT medulloblastoma of early childhood with high dose chemotherapy: In response to Gupta et al.
J Neurooncol. 2026;177:95.
PubMed

KIM T, Kim SK, Chung CK, Park CK, et al
Long-term radiological progression after resection of dysembryoplastic neuroepithelial tumors: patterns and prognostic factors.
J Neurooncol. 2026;177:94.
PubMed Abstract available

GONZALEZ-AGUILAR A, Jimenez-Quintero A, Diaz-Alba A, Macias-Arriaga G, et al
Multiple presentations: a single pathology, primary central nervous system lymphoma (PCNSL). A multicenter study.
J Neurooncol. 2026;177:93.
PubMed Abstract available

BOUX F, Mercier A, Talba D, Giraud JY, et al
Magnetic resonance imaging-based biodistribution of theranostic AGuIX nanoparticles in the NANORAD 2 clinical trial for brain metastases.
J Neurooncol. 2026;177:91.
PubMed Abstract available

SAITO K, Kawauchi D, Ono Y, Ohno M, et al
Significance of shunt placement for secondary communicating hydrocephalus in patients with high-grade glioma.
J Neurooncol. 2026;177:92.
PubMed

SHIN CJ, Mahammedi A, Massoud TF
Intraventricular meningiomas show size-dependent increases in peak ASL-MRI perfusion reflecting vascular heterogeneity.
J Neurooncol. 2026;177:89.
PubMed

OWENS GC, Contreras EM, Kienzler JC, Treger J, et al
Therapeutic efficacy of dendritic cell vaccination in a novel syngeneic mouse model of diffuse hemispheric glioma, H3 G34-mutant.
J Neurooncol. 2026;177:88.
PubMed

GRIGORIAN J, Chandler KE, Miller K, Mehta A, et al
Young adults with primary brain tumors: predictors of referral to a fertility specialist for fertility preservation counseling and the impact on tumor treatment.
J Neurooncol. 2026;177:87.
PubMed

DUFAULT ME, Akhavan-Sigari A, Pachon-Londono MJ, Olson VA, et al
From barrier to bridge: a scoping review on the methods, clinical efficacy, and safety of blood-brain barrier disruption in treating high-grade glioma.
J Neurooncol. 2026;177:86.
PubMed

BALDINI C, Cassier PA, Delord JP, Simonelli M, et al
Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 study.
J Neurooncol. 2026;177:85.
PubMed

March 2026

FUKAMI S, Akimoto J, Nagai K, Nakajima N, et al
Photodynamic therapy using talaporfin sodium for grade 2/3 meningiomas: a preliminary study of safety, feasibility, and clinical outcomes.
J Neurooncol. 2026;177:84.
PubMed Abstract available

LESKINEN S, Coelho A, Mittelman L, Haile H, et al
Low-energy X-ray intraoperative radiotherapy for brain metastases: a systematic review of efficacy and safety.
J Neurooncol. 2026;177:81.
PubMed

RONCELLI F, Snider S, Boselli D, De Domenico P, et al
Correction to: Prognostic relevance and cytokine correlates of peripheral immune subpopulations in newly diagnosed glioblastoma.
J Neurooncol. 2026;177:78.
PubMed

SHRIVASTAVA S, Szewczyk C, Grelewicz Z, Schelt JV, et al
Cesium-131 brachytherapy for central nervous system salvage therapy.
J Neurooncol. 2026;177:80.
PubMed Abstract available

KIM Y, Seo Y, Kim J
Novel cilengitide derivatives suppress migration and invasion of temozolomide-resistant glioblastoma cells via MAPK/Akt pathway inhibition.
J Neurooncol. 2026;177:77.
PubMed

SANKAR BS, Johnson D, Boasiako PA, Vargas LO, et al
Cerebrospinal fluid ctDNA as a prognostic and disease-activity biomarker in leptomeningeal metastases: systematic review, meta-analysis, and implications for CSF-guided care.
J Neurooncol. 2026;177:75.
PubMed Abstract available

WANG X, Wen H, Xie Y, Xu T, et al
Salvage dacomitinib plus intraventricular pemetrexed for leptomeningeal metastasis after failure of third?generation EGFR?TKIs in EGFR?mutant NSCLC: an ambispective cohort study.
J Neurooncol. 2026;177:76.
PubMed Abstract available

REUTER J, Werfel T, Ruhle A, Wurschi G, et al
Regret concerning treatment decisions in patients with primary or secondary brain tumors - a cross-sectional exploratory bicentric analysis.
J Neurooncol. 2026;177:74.
PubMed Abstract available

IZHAR M, Kattaa AH, Hori YS, Lam FC, et al
Treatment outcomes of stereotactic radiosurgery for sarcoma brain metastases-systematic review.
J Neurooncol. 2026;177:70.
PubMed

MULLER S, Hendricks A, Uttinger K, Kostatin M, et al
Brain metastases from colorectal cancer - a retrospective dual center study.
J Neurooncol. 2026;177:71.
PubMed Abstract available

AYDIN HA, Keskin E, Kalayci M
Perioperative risk stratification after resection of brain metastases: internal development and validation of the dominant lesion surgery score in a 20-year single-center cohort.
J Neurooncol. 2026;177:69.
PubMed Abstract available

DELBRIDGE C, Hou HX, Hielscher T, Wiestler B, et al
Prognostic impact of radiotherapy timing in WHO grade 2 and 3 meningiomas utilizing an integrated molecular-morphologic classification.
J Neurooncol. 2026;177:67.
PubMed Abstract available

BANSON M, Lear G, Darko K, Moor RSF, et al
Leveraging biometric data for meaningful outcome assessments in the care of patients with brain tumors: a systematic review.
J Neurooncol. 2026;177:66.
PubMed

WEE CW, Park JW, Suh CO, Lim DH, et al
Improved tumor control with adjuvant radiotherapy in patients with central neurocytoma: a multicenter study.
J Neurooncol. 2026;177:68.
PubMed Abstract available

LIU J, Han Q, Wu W, Wang H, et al
[(18)F]FET-PET in dissecting low-grade oligodendrogliomas.
J Neurooncol. 2026;177:65.
PubMed Abstract available

NADEL JL, Gamboa NT, Botros D, Crabb BT, et al
Lower-grade glioma imaging volumes and survival: a single-institution analysis of 90 patients after resection using intraoperative MRI.
J Neurooncol. 2026;177:63.
PubMed Abstract available

OZONO I, Yamasaki F, Onishi S, Yonezawa U, et al
T2-FLAIR mismatch sign in nonenhancing astrocytoma, IDH-mutant: impact of tumor area on diagnostic sensitivity.
J Neurooncol. 2026;177:64.
PubMed Abstract available

SONG R, Dapash M, Jamshidi P, Gondi V, et al
Survival and function in elderly patients with GBM: the role of surgical resection with contemporary multimodal therapy.
J Neurooncol. 2026;177:62.
PubMed Abstract available

LU Y, Cao J, Liu X, Wang H, et al
The predictive value of serum neurofilament light chain combined with inflammatory biomarkers for post-surgical epilepsy after brain tumor resection: a retrospective diagnostic study.
J Neurooncol. 2026;177:61.
PubMed

CHEHADE R, Al-Humiqani A, Hanna L, Sahgal A, et al
Brain metastases among patients with gynecologic cancers: a single-centre retrospective study of patients treated with brain radiotherapy.
J Neurooncol. 2026;177:58.
PubMed

SARKAR MM, Gonsalves N, Davarzani A, Mitchell E, et al
Disrupting Akt-Wnt/beta-catenin signaling suppresses glioblastoma stem cell growth and tumor progression in immunocompetent mice.
J Neurooncol. 2026;177:56.
PubMed Abstract available

BINDAL S, Gonzalez B, Dono A, Riascos R, et al
Patterns of failure following stereotactic radiosurgery salvage for recurrent high-grade glioma.
J Neurooncol. 2026;177:55.
PubMed Abstract available

LIU J, Abikenari M, Annagiri S, Ha JH, et al
Endogenous immune recruitment in glioblastoma CAR T therapy: cytokine, myeloid, and chemokine circuitry.
J Neurooncol. 2026;177:50.
PubMed Abstract available

ELIA A, Roux A, Demasi M, Debacker C, et al
Neurocognitive functioning, seizure control, and return to work after awake surgery with or without adjuvant therapy in IDH-mutant grade 3 diffuse gliomas.
J Neurooncol. 2026;177:53.
PubMed

PULSIPHER AM, Khattar G, Gotway MB, Grill MF, et al
Pneumocystis jirovecii pneumonia in patients with CNS tumors receiving dexamethasone: clinical outcomes and prophylaxis gaps.
J Neurooncol. 2026;177:51.
PubMed Abstract available

PRINS TJ, Lai TJ, Li T, Fisher A, et al
MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy.
J Neurooncol. 2026;177:48.
PubMed

SARAF A, Ford J, Parsons M, Sherman J, et al
Longitudinal changes of neurocognitive function and ALPS-index in patients with brain tumors receiving brain irradiation.
J Neurooncol. 2026;177:47.
PubMed

ZENG W, Jedwood C, Chung R, Cote DJ, et al
Associations of surgical menopause and hormone replacement therapy with meningioma development.
J Neurooncol. 2026;177:49.
PubMed

ABU-ARJA MH, Stuckert A, Ghebrelul RT, Chintagumpala M, et al
Immunotherapy approaches for the treatment of relapsed or progressive medulloblastoma.
J Neurooncol. 2026;177:39.
PubMed

WANG Y, Xie K, Yang K, Luo A, et al
Socioeconomic disparities in IDH-wildtype glioblastoma survival: interactions between age and household income in a SEER cohort.
J Neurooncol. 2026;177:40.
PubMed Abstract available

ZHENG S, Lin L, Ren G, Lan H, et al
Correction to: Phosphoenolpyruvate carboxykinase 2 as a prognostic biomarker: expression and clinical significance in Group 3 and Group 4 medulloblastoma.
J Neurooncol. 2026;177:41.
PubMed

AMPIL F, Moncrief O, Sin A, Toms J, et al
Reduced dose single-fraction frame-based postoperative radiosurgery for large (> 10 cm(3)) brain metastases cavities: real world outcomes.
J Neurooncol. 2026;177:43.
PubMed

CIOFFI G, Waite K, Baranova A, Barnholtz-Sloan J, et al
Individualized prediction of survival after brain metastasis development in patients with breast cancer.
J Neurooncol. 2026;177:44.
PubMed

JUNGK C, Goepfert K, Gluszak M, Marhaba K, et al
Prognostic relevance of resection at first recurrence in isocitrate dehydrogenase mutant lower-grade glioma: results from a retrospective, single-center, volumetric analysis.
J Neurooncol. 2026;177:42.
PubMed Abstract available

AGARWAL V
The promise and potential of porphyrin metabolite activation using sonodynamic therapy for the treatment of glioblastoma.
J Neurooncol. 2026;177:45.
PubMed

BYTNAR JA, Robins KR, Theeler BJ, Shriver CD, et al
The relationship between asthma and glioma: a case-control study in a universal access healthcare system.
J Neurooncol. 2026;177:38.
PubMed Abstract available

GECICI NN, Stepniak A, Ozcinar KK, Habib A, et al
Malignant transformation in IDH-mutant gliomas: clinical drivers and survival outcomes in a histologically defined cohort.
J Neurooncol. 2026;177:37.
PubMed

PACK E, Cifarelli CP, Bhatia S, Lewis J, et al
Glioblastoma survival in rural America: a 10-year experience from a quaternary care center.
J Neurooncol. 2026;177:36.
PubMed Abstract available

KHATRI VM, Aboujaoude M, Karapetyan L, Tarhini AA, et al
Melanoma brain metastases outcomes following nivolumab and relatlimab after ipilimumab and nivolumab progression.
J Neurooncol. 2026;177:35.
PubMed

RONCELLI F, Snider S, Boselli D, De Domenico P, et al
Prognostic relevance and cytokine correlates of peripheral immune subpopulations in newly diagnosed glioblastoma.
J Neurooncol. 2026;177:34.
PubMed

GUPTA T, Dasgupta A, Chatterjee A
Craniospinal irradiation plus tumor-bed boost with standard adjuvant chemotherapy OR high-dose chemotherapy plus autologous stem cell transplant as a radiation-sparing approach in WNT medulloblastoma of early childhood: Fire OR Ice?
J Neurooncol. 2026;177:33.
PubMed

KOHANBASH G, Ryall S, Gary SE, Hoffman LM, et al
PTPN11-related Noonan syndrome predisposes to multifocal low-grade CNS tumors harboring FGFR1 variants.
J Neurooncol. 2026;177:31.
PubMed Abstract available

MAYEN T, Morelle M, Zouaoui S, Kallel M, et al
Adolescents and young adults with predominantly low grade primary central nervous system tumors: patient reported socioeconomic outcomes and health-related quality of life ten years after diagnosis.
J Neurooncol. 2026;177:32.
PubMed Abstract available

ROBLES C, Das A, Pai V, Laughlin S, et al
Imaging assessment of immunotherapy in pediatric brain tumors.
J Neurooncol. 2026;177:30.
PubMed

JEISING S, Reinken J, Rapp M, Sabel M, et al
Can we make it up? - second-look surgery due to post-operative residual tumour in patients diagnosed with diffuse glioma.
J Neurooncol. 2026;177:29.
PubMed Abstract available

ONDER T, Ates O
Biological aging enhances prognostic stratification beyond chronological age in breast cancer brain metastases.
J Neurooncol. 2026;177:28.
PubMed

YENIDOGAN I, Tabori U, Das A
Immune checkpoint inhibitors in pediatric central nervous system tumors: biology, clinical experience, and translational pathways to precision immunotherapy.
J Neurooncol. 2026;177:27.
PubMed Abstract available

FUKUDA S, Tamura K, Shimizu K, Orihara A, et al
Thalamic involvement in glioblastoma is associated with lower risk of seizures: a retrospective cohort study.
J Neurooncol. 2026;177:24.
PubMed

CHANG X, He Z, Wang H, Zhu H, et al
Real-world comparison of BTK inhibitors and lenalidomide as first-line maintenance in primary CNS lymphoma: a multi-center retrospective study.
J Neurooncol. 2026;177:26.
PubMed Abstract available

BEN-SHOSHAN A, Heymann S, Asprilla J, Kelmer P, et al
Upfront stereotactic radiosurgery for large posterior fossa metastases: a multicenter evaluation of clinical outcomes.
J Neurooncol. 2026;177:25.
PubMed Abstract available

February 2026

BLUMS K, Kalra LP, Nerntengian N, Zylyftari S, et al
Prospective evaluation of GFAP point-of-care testing for rapid diagnosis of glioblastoma.
J Neurooncol. 2026;177:22.
PubMed Abstract available

DUFFAU H
Traveling large distances for awake functional-based surgery of IDH-mutated grade 2 glioma: outcomes comparison between loco-regional versus international patients.
J Neurooncol. 2026;177:20.
PubMed

PICART T, Ducray F
Comment on: "Extent of resection and adjuvant treatment in adult cerebellar glioblastoma: systematic review and meta-analysis of survival outcomes".
J Neurooncol. 2026;177:21.
PubMed

ZHANG C, Yin C, Xie J, Hou Z, et al
Trends in global, regional and national burden of brain and CNS cancers, 1990-2021 and predictions to 2036: analysis based on the global burden of disease study 2021.
J Neurooncol. 2026;177:18.
PubMed Abstract available

ZHENG S, Lin L, Ren G, Lan H, et al
Phosphoenolpyruvate carboxykinase 2 as a prognostic biomarker: expression and clinical significance in Group 3 and Group 4 medulloblastoma.
J Neurooncol. 2026;177:16.
PubMed Abstract available

ELGEHINY A, Fan AE, Frost M, He J, et al
Clinical and translational progress in oncolytic virotherapy for pediatric CNS tumors.
J Neurooncol. 2026;177:17.
PubMed Abstract available

ALHALABI OT, Mironov K, Nabiev K, Kramer J, et al
Repeat resection for recurrent glioblastoma - does timing matter?
J Neurooncol. 2026;177:14.
PubMed Abstract available

MENDOZA MIRELES EE, Blakstad H, Server A, Leske H, et al
Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study.
J Neurooncol. 2026;177:15.
PubMed Abstract available

NATH B, Bobholz SA, Kim DC, Lowman AK, et al
Altered perivascular diffusivity in glioblastoma: integrating DTI-ALPS index with radio-pathomic and histopathologic correlates.
J Neurooncol. 2026;177:12.
PubMed Abstract available

RAUCH S, Wan Y, Halai A, Manly T, et al
Multidimensional cognitive reserve and cognitive outcomes in glioblastoma: a pre- and postoperative analysis.
J Neurooncol. 2026;177:11.
PubMed Abstract available

FALCAO V, Rego LHRM, Rodrigues PB, de Moraes FCA, et al
Hormone therapy and the risk of central nervous system tumors in women: a systematic review and meta-analysis.
J Neurooncol. 2026;177:13.
PubMed Abstract available

LEE JY, Koo JY, Kim NI, Kim SS, et al
HER2 heterogeneity between primary cancers and brain metastases: a retrospective analysis of 185 matched pairs across multiple cancer types.
J Neurooncol. 2026;177:10.
PubMed

MALHOTRA R, Moitra P, Chatterjee A, Kota PK, et al
Clinical and genetic predictors of temozolomide-induced severe myelotoxicity in adult diffuse glioma: a case-control study.
J Neurooncol. 2026;177:9.
PubMed

SHIMIZU T, Sato H, Sanada T, Saito M, et al
A voxel-based quantitative framework for analyzing the spatial redistribution and directionality of recurrence in glioblastoma.
J Neurooncol. 2026;177:8.
PubMed

WONG CE, Kuo YC, Chen PW, Lee PH, et al
Early withdrawal of systemic corticosteroid following malignant glioma craniotomy: a real-world population-based cohort study.
J Neurooncol. 2026;177:5.
PubMed

SATGUNASEELAN L, Xian E, Madani D, Gamage KK, et al
Impact of an evolving classification system on diffuse glioma repositories: experience from the Sydney brain tumour bank.
J Neurooncol. 2026;177:6.
PubMed Abstract available

GUHA A, Gawde J, Mahajan K, Bagal B, et al
Is looking at the tip of the iceberg sinking our ship? A longitudinal cohort study on the patterns of evolution on treatment of non-enhancing FLAIR lesions in primary CNS lymphoma.
J Neurooncol. 2026;177:7.
PubMed Abstract available

ILIKHAN A, Tasdemir S, Oral S, Kucuk A, et al
Evaluation of NETosis-related biomarkers in glioblastoma multiforme: PAD4 as a potent diagnostic predictor.
J Neurooncol. 2026;177:3.
PubMed

MENG W, Duan J, Guo C, Xu J, et al
Multiomics integration of serum proteome and autoantibody profiles reveals diagnostic and prognostic biomarkers in glioma.
J Neurooncol. 2026;177:2.
PubMed

WANG C, Xu H, Hu Y, Ma L, et al
Tumor treating fields for newly diagnosed glioblastoma: a retrospective analysis.
J Neurooncol. 2026;177:1.
PubMed Abstract available

MC CARTHY L, Andersen BM, Wen PY, Reardon DA, et al
Meta-analysis of treatment-emergent seizures in glioma vaccine trials.
J Neurooncol. 2026;176:212.
PubMed

YAMASHITA S, Kanamori M, Kubozono M, Shimoda Y, et al
Consolidation reduced-dose whole-brain radiation therapy with response-adapted boost in older patients with newly diagnosed primary central nervous system lymphoma.
J Neurooncol. 2026;176:211.
PubMed Abstract available

HOOKS RE, Yadav N, Mondia MWL, Mantziaris G, et al
Belzutifan-induced tumor regression in sporadic hemangioblastoma: a case report and literature review.
J Neurooncol. 2026;176:213.
PubMed Abstract available

DENIZ B, Arpaci MF, Pekmez H, Uzun GB, et al
Investigation of the effects of radiotherapy and chemotherapy on brain volume in cancer patients: brain tumor study.
J Neurooncol. 2026;176:210.
PubMed Abstract available

TOLL SA, Rechberger JS, Chow WD, Biswas S, et al
Update of NK cell therapy in pediatric brain tumors.
J Neurooncol. 2026;176:209.
PubMed

LOUGHAN AR, Braun SE, Lanoye A, Willis K, et al
Post-traumatic growth in patients and caregivers after a primary brain tumor diagnosis.
J Neurooncol. 2026;176:208.
PubMed Abstract available

BIYIKLI E, Aybal T, Aslan B, Gul D, et al
Prognostic role of delta radiomics in pediatric pontine diffuse midline gliomas.
J Neurooncol. 2026;176:206.
PubMed Abstract available

RAMSEY KA, Byrne L, Taylor OB, Soliman A, et al
High frequency and unique subtypes of meningioma in patients with BAP1 tumor predisposition syndrome.
J Neurooncol. 2026;176:207.
PubMed Abstract available

PURI S, Sloan L, Doucet M, Katulis L, et al
Radiation immunodynamics: association of baseline and longitudinal cytokine levels during radiotherapy in glioblastoma with survival.
J Neurooncol. 2026;176:204.
PubMed

JOHNSON KJ, Brown DS, Johnston KJ
SEER-Medicaid and SEER-Medicare data for neuro-oncology research.
J Neurooncol. 2026;176:205.
PubMed Abstract available

STEELE EM, Hall JT, Lui K, Darawsheh R, et al
Symptomatic radiation necrosis after concurrent targeted therapy and stereotactic radiosurgery for brain metastases: a bicentric retrospective analysis.
J Neurooncol. 2026;176:203.
PubMed

MORAES FY, Isen J, Perry J, Laperriere N, et al
Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.
J Neurooncol. 2026;176:200.
PubMed

MIRIAN C, Jensen LR, Hoffmann AG, Juratli TA, et al
Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients.
J Neurooncol. 2026;176:201.
PubMed Abstract available

JANKOVIC D, Thavarajasingam SG, Scurtu D, Baby MV, et al
Maximal resection improves survival in MGMT methylated very elderly glioblastoma patients.
J Neurooncol. 2026;176:202.
PubMed Abstract available

KITE T, Hanft S, Zeller S, Lee S, et al
Local control and leptomeningeal disease after resection and GammaTile brachytherapy for newly diagnosed brain metastases: results from a prospective registry.
J Neurooncol. 2026;176:199.
PubMed Abstract available

MEL'NIKOV MY, Shakhzadayev R, Baiturlin Z, Batyrkhanov D, et al
Frequency-specific resting state fMRI features in gliomas.
J Neurooncol. 2026;176:198.
PubMed

ROUX A, Elia A, Nadler C, Hudelist B, et al
Impact of Carmustine wafer implantation in epileptic seizures of newly diagnosed glioblastomas, IDH-wildtype in adults.
J Neurooncol. 2026;176:196.
PubMed Abstract available

KIDWELL RL, Trippett J, Aghi MK
Molecular biology of pituitary neuroendocrine tumors.
J Neurooncol. 2026;176:197.
PubMed Abstract available

HON JJ, Akbarzadeh Mostaghbal H, Akkara Y, Das JM, et al
Socioeconomic disparities in glioma outcomes: a grade-specific analysis.
J Neurooncol. 2026;176:195.
PubMed

BASARAN AE, Braune M, Barrantes-Freer A, Mueller WC, et al
FOXC1 expression and radiological predictors of peritumoral brain edema in meningiomas.
J Neurooncol. 2026;176:194.
PubMed Abstract available

OKUBO T, Nagoshi N, Iga T, Takeda K, et al
Clinical characteristics and surgical outcomes of intradural spinal metastases: a comparative analysis between intramedullary and extramedullary lesions.
J Neurooncol. 2026;176:193.
PubMed Abstract available

January 2026

QIU H, Huang Y, Zhou J, Jiang Z, et al
Construction and application of an ERAS-based nursing pathway for postoperative pain management in brain tumor patients.
J Neurooncol. 2026;176:192.
PubMed

KITE T, Mckenna A, Wegner RE, Herbst J, et al
Stereotactic radiosurgery for pineal gland metastases: results from the international radiosurgery research foundation.
J Neurooncol. 2026;176:188.
PubMed Abstract available

DIPASQUALE A, Giordano P, Bosio A, Wijnenga MMJ, et al
Reasons driving choice and clinical course of patients with CNS WHO grade 3 IDH mutant glioma receiving vorasidenib after surgery: a pilot experience.
J Neurooncol. 2026;176:186.
PubMed

GORWOOD W, Peciu-Florianu L, Strachowski O, Vannod-Michel Q, et al
The neuropsychological outcome of patients undergoing intraoperative MRI surgery for insular infiltrating gliomas.
J Neurooncol. 2026;176:187.
PubMed Abstract available

DIXIT KS, Kumthekar P, Lukas RV, Williams A, et al
A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combination.
J Neurooncol. 2026;176:185.
PubMed

LOPES TLM, Balsells MD, Cavalcante MA, de Queiroz AGD, et al
Awake surgery versus general anesthesia in the treatment of Diffuse Low-Grade Gliomas - and the role of supplementary intraoperative techniques: a systematic review and meta-analysis.
J Neurooncol. 2026;176:184.
PubMed

NOZZOLI F, Ortenzi V, Nucci E, Morelli I, et al
Prognostic significance of H3.K27me3 loss in CNS WHO grade 2 meningiomas: a multicentre clinicopathological study.
J Neurooncol. 2026;176:183.
PubMed

CHEN SH, Wang HN, Toh CH, Wei KC, et al
PET RANO 1.0 criteria improve prognostic stratification in high-grade gliomas using (11)C-methionine PET/MR.
J Neurooncol. 2026;176:180.
PubMed

CIOFFI G, Waite K, Baranova A, Barnholtz-Sloan JS, et al
Individualized prediction of brain metastasis risk in patients with breast cancer.
J Neurooncol. 2026;176:179.
PubMed

BEKELMAN NJ, Ghaith AK, Yang L, Momeni A, et al
Rates of recurrence and symptom improvement following resection of spinal meningiomas in the pediatric population: individual participant data meta-analysis.
J Neurooncol. 2026;176:178.
PubMed Abstract available

PATEL SH, Mayorov S, Kim W, Singh K, et al
Magnetic resonance imaging features differentiate histologic and molecular subtypes of glioblastoma IDH-Wild type CNS WHO grade 4.
J Neurooncol. 2026;176:177.
PubMed Abstract available

BHANDARKAR S, Palermo M, Wu C, Myneni S, et al
Profiling T-cell activity and exclusion in pediatric medulloblastoma highlights immunotherapy-responsive subgroups.
J Neurooncol. 2026;176:176.
PubMed

MINNITI G, Tini P, Navarria P, Raza G, et al
Clinical outcomes of three-fraction versus five-fraction stereotactic radiosurgery for resected brain metastases.
J Neurooncol. 2026;176:175.
PubMed Abstract available

KITE T, Harikumar N, Jaffee S, Knox H, et al
A systematic review of stereotactic radiosurgery for pituitary metastases.
J Neurooncol. 2026;176:174.
PubMed Abstract available

UMEZAWA Y, Yamamoto M, Tanaka K, Yoshifuji K, et al
Induction chemotherapy with methotrexate, nimustine, and procarbazine for primary CNS lymphoma in the elderly: a retrospective evaluation of safety and efficacy.
J Neurooncol. 2026;176:173.
PubMed Abstract available

MORAES FY, Isen J, Perry J, Laperriere N, et al
Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial.
J Neurooncol. 2026;176:171.
PubMed

NOBRE L, Ramaswamy V, Coleman C, Dhall G, et al
High-dose chemotherapy and craniospinal irradiation-sparing approach for WNT medulloblastoma of early childhood.
J Neurooncol. 2026;176:172.
PubMed

GENSLER R, Ahmed AK, Alfonzo Horowitz M, Khalifeh JM, et al
Differences in regional developmental origins of glioblastomas revealed by integrated molecular profiling.
J Neurooncol. 2026;176:170.
PubMed

ZUBROWSKA J, Pieniazek M, Polakiewicz-Gilowska A, Kolarova I, et al
Real-world outcomes of sacituzumab govitecan in patients with pretreated triple-negative breast cancer and brain metastases: data from CEBCC-102 study.
J Neurooncol. 2026;176:167.
PubMed

HIMIC V, Lu VM, Mayrand RC, Sass ER, et al
Awake craniotomy for brain tumor resection in the elderly: an institutional experience.
J Neurooncol. 2026;176:169.
PubMed Abstract available

GRASSL N, Suwala AK, Kessler T, Bunse L, et al
Early distant progression in adult Histone-3 K27-altered diffuse midline gliomas.
J Neurooncol. 2026;176:166.
PubMed Abstract available

SHIREMAN JM, Ammanuel S, Cheng L, Distler E, et al
Glioblastoma immunotherapy in the context of the aging immune system: a systematic review and meta-analysis.
J Neurooncol. 2026;176:164.
PubMed Abstract available

WANG Q, Wang H, Hong W, Bashir S, et al
Correction to: Local cranial radiation combined with third-generation tyrosine kinase inhibitors improve leptomeningeal metastasis disease-free survival in patients with EGFR-mutated non-small cell lung cancer and brain metastasis.
J Neurooncol. 2026;176:163.
PubMed

NAKAJIMA R, Kinoshita M, Okita H, Tamai S, et al
Surgical history and temporal muscle thickness as predictors of successful awake surgery in older patients with glioma.
J Neurooncol. 2026;176:161.
PubMed

FORTUNATO JT, Scharf A, Shuman AG, Diamond EL, et al
Staging prognostic discussions about glioblastoma.
J Neurooncol. 2026;176:162.
PubMed Abstract available

ROBINSON SD, Kingdon S, Williams ST, Hill CS, et al
Understanding the difference in symptoms and outcomes between glioblastoma patients diagnosed based on histological or molecular criteria: a retrospective cohort analysis from the Histo-Mol GBM collaborative.
J Neurooncol. 2026;176:157.
PubMed Abstract available

HARPER SD, Alderete JA, Baisiwala S, Bergsneider BH, et al
Vaccine therapy for pediatric high-grade glioma: current landscape, challenges, and future directions.
J Neurooncol. 2026;176:158.
PubMed Abstract available

HU W, Rao Q, Zhu D, Yao S, et al
Clinicopathological features and outcomes in non-functioning pituitary neuroendocrine tumors: a transcription factor-driven subtype analysis.
J Neurooncol. 2026;176:160.
PubMed Abstract available

CHEN S, Jugl S, Jackson L, Rahman M, et al
Risk of intracranial meningioma requiring surgical intervention among recent hormonal contraceptives users.
J Neurooncol. 2026;176:156.
PubMed

TINI P, Donnini F, Minniti G
EGFR amplification and rapid early progression in glioblastoma: implications for timing and risk stratification.
J Neurooncol. 2026;176:155.
PubMed

AKBAS S, Alan O, Yildiz O, Karakurt M, et al
Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study.
J Neurooncol. 2026;176:152.
PubMed

GU M, Luckett PH, Olufawo M, Dierker D, et al
BOLD complexity characterizes glioblastoma survival via voxel-wise and localized sample entropy.
J Neurooncol. 2026;176:151.
PubMed Abstract available

SANIKOMMU S, Santos AN, Wipplinger C, Dawoud B, et al
Patient-reported outcomes as prognostic indicators for overall survival and progression-free survival in brain tumor patients - a systematic review and meta-analysis of randomized clinical trials.
J Neurooncol. 2026;176:154.
PubMed Abstract available

ZHOU L, Xu Z, Fang C, Ren H, et al
Multiomics reveals the mechanism of KNG1 in promoting tumor progression in adamantinomatous craniopharyngioma.
J Neurooncol. 2026;176:150.
PubMed

HUANG H, Gao F, Quan R, Zhou W, et al
Transcriptome sequencing analysis revealed the molecular mechanism of BNCT inhibiting the growth of U87 subcutaneous tumor.
J Neurooncol. 2026;176:153.
PubMed Abstract available

HONG JP, Hong JB, Lee B, Choi RJ, et al
Pharmacological transglutaminase 2 inhibition enhances temozolomide response in patient-derived glioblastoma tumorspheres.
J Neurooncol. 2026;176:148.
PubMed

LIU CM, Medeiros Geraldo LH, Xiao J, Sulman EP, et al
Retrospective analysis of the impact of antidepressants with anti-acid sphingomyelinase activity on survival of patients with glioblastoma.
J Neurooncol. 2026;176:147.
PubMed

DHO YS, Shin SH, Gwak HS, Yoo H, et al
Re-evaluation of cerebrospinal fluid cytology for diagnosis of leptomeningeal metastasis based on radiological features, patient symptoms/signs, and clinical follow-up.
J Neurooncol. 2026;176:149.
PubMed Abstract available

December 2025

KITE T, Wegner RE, Shepard MJ
Comment on: "Neoadjuvant gamma knife surgery for metastatic brain tumor: clinical use and impact on leptomeningeal seeding".
J Neurooncol. 2025;176:146.
PubMed

KERIC N, Krenzlin H, Lange F, Dauth A, et al
Treatment differences in IDH-wildtype glioma - the impact of surgery and adjuvant therapy.
J Neurooncol. 2025;176:145.
PubMed Abstract available

JEUNG YS, Lee WT, Kim Y, Keam B, et al
Documented advance care planning elements and end-of-life care patterns in malignant glioma vs. major solid tumors: a single-center retrospective study.
J Neurooncol. 2025;176:142.
PubMed Abstract available

CROUZEN J, Mast M, Kerkhof M, Vos M, et al
Paradigm shift in patients with multiple brain metastases from whole brain radiotherapy to high precision multimodality treatment including stereotactic radiotherapy.
J Neurooncol. 2025;176:139.
PubMed Abstract available

ST BRICE K, Parker T, Wouters K, Guzman-Rios ED, et al
Extent of resection and adjuvant treatment in adult cerebellar glioblastoma: systematic review and meta-analysis of survival outcomes.
J Neurooncol. 2025;176:138.
PubMed Abstract available

KIM J, Shin K, Lee A, Lee J, et al
Prognostic impact of endocrine therapy and BDNF-TrkB axis in breast cancer brain metastases.
J Neurooncol. 2025;176:140.
PubMed Abstract available

MORAES FCA, Rodrigues PB, Vital LDS, Talah BAD, et al
Prevalence of human cytomegalovirus in glioblastoma multiforme: a systematic review and meta-analysis.
J Neurooncol. 2025;176:143.
PubMed

LIU J, Ha JH, Abikenari M, Sjoholm MA, et al
Adaptive immunotherapeutic paradigms in diffuse midline glioma: integrating epigenetic reprogramming, neuron-glioma interactions, and tumor microenvironment modulation.
J Neurooncol. 2025;176:144.
PubMed Abstract available

NAHLS NS, Anttonen A, Kitti P, Leskela RL, et al
Early palliative care decision in patients with primary brain tumor reduces emergency department visits and hospitalization at the end of life.
J Neurooncol. 2025;176:137.
PubMed Abstract available

RON GN, Ron IG, Kantor H, Fening E, et al
Effect of combining targeted therapies or chemotherapy with stereotactic radiosurgery (SRS) on the prognosis of patients with brain metastases from non-small cell lung cancer (NSCLC).
J Neurooncol. 2025;176:135.
PubMed Abstract available

AMIRKHANI N, Maroufi F, Pour-Rashidi A, Shirani M, et al
Impact of anti-seizure medication duration on postoperative seizures following supratentorial high-grade glioma resection: a mixed-model and tree-based approach.
J Neurooncol. 2025;176:134.
PubMed Abstract available

EVERS SMITH JW, Alzate JD, Power L, Wei W, et al
The impact of the molecular and genetic properties of glioblastoma on patient outcomes following stereotactic radiosurgery at recurrence.
J Neurooncol. 2025;176:132.
PubMed

BELLOMO J, Gonel M, Sutter J, Zeitlberger AM, et al
Postoperative absence of residual intracranial tumor volume is associated with improved survival and intracranial disease control in non-small cell lung cancer brain metastases.
J Neurooncol. 2025;176:131.
PubMed Abstract available

HUANG G, Wei Y, Hou X, Jia X, et al
ANG peptide-modified exosomes loaded with oleanolic acid target GPX4 for enhanced breast cancer brain metastasis therapy.
J Neurooncol. 2025;176:130.
PubMed

PALERMO M, Massimi L, Tamburrini G, Olivi A, et al
Algorithm-based assessment of T-cell dysfunction and exclusion to forecast ICB sensitivity in pediatric brain ependymoma.
J Neurooncol. 2025;176:128.
PubMed Abstract available

SISTIAGA IL, Chen J, Mittelman L, Syed S, et al
Connectomics in brain tumor surgery: large-scale clinical feasibility and hypothesis-generating tractometry findings.
J Neurooncol. 2025;176:129.
PubMed Abstract available

LUO S, Liu R, Li P, Tu H, et al
Combined stereotactic radiotherapy and immunotherapy improves survival in driver-gene-negative NSCLC patients with brain oligo-metastases: a multicenter real-world study.
J Neurooncol. 2025;176:127.
PubMed Abstract available

HU Y, Liu F, Mi R
Glioma cells achieve malignant progression by fusion with macrophages to gain high SLC7A5 expression.
J Neurooncol. 2025;176:126.
PubMed

LEISTNER T, Terrapon APR, Hostettler IC, Bozinov O, et al
Adverse events in meningioma surgery classified using the therapy-disability-neurology (TDN) grading system.
J Neurooncol. 2025;176:125.
PubMed Abstract available

BOFFELLI L, Fimiani C, Nunez NG, Kienzler JC, et al
Synergy of radiotherapy, focused ultrasound, and immunotherapy in the treatment of brain metastases.
J Neurooncol. 2025;176:124.
PubMed Abstract available

JHANDI S, Jhandi AS, Cannon DM, Burt LM, et al
Stereotactic radiosurgery for radiation?induced meningiomas: long?term institutional outcomes with patient- and lesion?level analyses and an updated meta?analysis.
J Neurooncol. 2025;176:122.
PubMed

SAMPATH SG, Manriquez AH, Haile H, Botkiss M, et al
Socioeconomic disparities in patient-reported outcomes, health literacy, and access to care among patients with primary brain tumors: findings from the All of Us Research Program.
J Neurooncol. 2025;176:123.
PubMed

PARKER M, Carmichael A, Arbuiso AG, Jiang K, et al
Brain metastases from renal cell carcinoma: a large retrospective claims-based oncology cohort analysis of prevalence, chronicity, and survival outcomes.
J Neurooncol. 2025;176:119.
PubMed

DAMANTE MA, Finger G, Juncker RB, Kreatsoulas DC, et al
Management of intermediate-sized brain metastases of the primary motor cortex.
J Neurooncol. 2025;176:120.
PubMed

SCAGLIOTTI E, Capetti B, Conti L, Fiore G, et al
Effects of proton therapy on cognition in adults with brain tumors: a systematic review.
J Neurooncol. 2025;176:121.
PubMed

DRAPPATZ J, Mantica M
Treatment strategies and innovation for recurrent high-grade glioma.
J Neurooncol. 2025;176:118.
PubMed Abstract available

UYSAL E, Reinhardt P, Schmidhalter D, Wagner F, et al
Oncological value of MRI in brain metastasis: exploring the potential of combining post-contrast T1 TSE (SPACE) and T1 GRE (MPRAGE) for stereotactic radiosurgery planning and surveillance.
J Neurooncol. 2025;176:117.
PubMed Abstract available

SARFRAZ Z, Ranjan T, Mustafayev FNA, Jaramillo M, et al
Emerging therapies for glioblastoma.
J Neurooncol. 2025;176:116.
PubMed Abstract available

ZHOU DJ, Chang K, Jaskir M, Davis KA, et al
Free water elimination tractometry reveals local and remote white matter alterations in diffuse gliomas.
J Neurooncol. 2025;176:115.
PubMed Abstract available

WANG D, Wang Z, Xu J, Cai Y, et al
Identification of NEK6 as a potential biomarker for prognosis in glioma and its functional implications.
J Neurooncol. 2025;176:113.
PubMed Abstract available

ZHU Y, Qiu Z, Zhu L, Lu C, et al
Prognostic factors and quality of life in non-small cell lung cancer with leptomeningeal metastasis: a dichotomous pattern based on parenchymal involvement.
J Neurooncol. 2025;176:114.
PubMed Abstract available

HSUEH B, Steuart SJ, Odukoya AO, Prager BC, et al
Immunotherapy and targeted therapy for high grade gliomas: current and future directions.
J Neurooncol. 2025;176:112.
PubMed Abstract available

SCHWENDNER M, Kram L, Zhang H, Krieg SM, et al
Preoperative nTMS-based mapping of a verbal semantic association task allows for the identification of extensive bihemispheric cortical and subcortical networks.
J Neurooncol. 2025;176:108.
PubMed Abstract available

UWAMARIYA D, Niyodusenga E, Surwumwe JB, Umutesi A, et al
Accuracy of intra-operative brain tumor squash cytology compared to large excision biopsy: a comparative study at the University Teaching Hospital of Kigali (CHUK), Rwanda.
J Neurooncol. 2025;176:109.
PubMed Abstract available

GRUTZA M, Mitschang D, Sydorenko V, Dugas M, et al
Quantitative pupillometry as a sensitive tool for detecting tumor-related mass effect in the posterior fossa: a prospective feasibility study comparing metastatic versus skull base lesions.
J Neurooncol. 2025;176:110.
PubMed Abstract available

YANG C, Wang H, Liu M, Cai Y, et al
Perovskite nanocrystal probes for intraoperative in vitro pathological detection of IDH1 mutation status in glioma.
J Neurooncol. 2025;176:111.
PubMed

HARARY PM, Hori YS, Annagiri S, Abe K, et al
Enhancing radiation sensitivity in malignant brain tumors with chloroquine: a systematic review.
J Neurooncol. 2025;176:106.
PubMed Abstract available

KITYA D, Ssembatya JM, Taremwa BM, Adil SM, et al
Descriptive epidemiology and surgical outcomes of intracranial tumors in southwestern uganda: a cross-sectional study.
J Neurooncol. 2025;176:107.
PubMed Abstract available

ROCHE J, Guerra A, Remaud J, Liger C, et al
Disruption of cognitive flexibility and planning skills after childhood brain tumor treatment: clinical issues and comprehensive assessment.
J Neurooncol. 2025;176:104.
PubMed

SBAIH O, Singh A, Li A, Kolady R, et al
Factors affecting postoperative seizure risk and perioperative outcomes in pediatric brain tumor resections.
J Neurooncol. 2025;176:105.
PubMed

SUN L, Li J, Lv Y, Li L, et al
Unravelling genomic differences in cerebrospinal fluid: patients with lung cancer with combined brain parenchymal and meningeal metastasis versus exclusive meningeal metastasis.
J Neurooncol. 2025;175:1163-1176.
PubMed Abstract available

JIANG Z, Jin X, Xue H, Zhang J, et al
TMEM164 enhances radioresistance of GBM cells by inhibiting the FASN-NADPH-ROS axis.
J Neurooncol. 2025;175:1011-1026.
PubMed Abstract available

SONKSEN M, Bison B, Bussenius L, Rascon J, et al
One-year follow-up of the new European reference network for pediatric cancers (ERN PaedCan) tumor board for pediatric CNS tumors: lessons learnt and future prospects.
J Neurooncol. 2025;175:1415-1423.
PubMed Abstract available

BRAND A, Agolli L, Tas KT, Lishwiski P, et al
Long-term outcomes of modern radiation therapy for pituitary adenoma - different techniques: single institute experience.
J Neurooncol. 2025;175:1039-1050.
PubMed Abstract available

ZHAO J, Liang L, Li J, Li Q, et al
Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center study.
J Neurooncol. 2025;175:1103-1113.
PubMed Abstract available

CHAKRAVARTI S, Oak A, Tang L, Mao Y, et al
Community-level social capital and postoperative outcomes following intracranial tumor surgery: an exploration of the Social Capital Atlas in neurosurgical oncology.
J Neurooncol. 2025;175:1455-1463.
PubMed Abstract available

ARRIETA O, Diaz-Alba A, Moreno-Jimenez S, Rodriguez-Camacho A, et al
Real-world experience outcome in patients with central nervous system metastases: information on 2,226 patients during a 15-year period.
J Neurooncol. 2025;175:1227-1234.
PubMed Abstract available

MAHAPATRA S, Seltzer L, Osorio N, Miller M, et al
A prospective study of minimally invasive keyhole craniotomy and stereotactic brachytherapy for new brain oligometastases.
J Neurooncol. 2025;175:1051-1064.
PubMed Abstract available

RYBA A, Mohme T, Kerschbaumer J, von Bronewski E, et al
Benign or aggressive? Understanding spinal melanocytomas in comparison to malignant melanoma.
J Neurooncol. 2025;176:102.
PubMed Abstract available

CHO WJ, Choi K, Han K, Choi SH, et al
Clinical and molecular characteristics and prognostic factors of diffuse astrocytoma, IDH-wildtype, not elsewhere classified.
J Neurooncol. 2025;176:103.
PubMed Abstract available

November 2025

ROLDAN URGOITI G, de Robles P, Tsang RY, Willson M, et al
A phase I-II study of niacin in patients with newly diagnosed glioblastoma: safety and interim phase II analysis.
J Neurooncol. 2025;176:101.
PubMed

YOO J, Jung IH, Chang WS, Jung HH, et al
Neoadjuvant gamma knife surgery for metastatic brain tumor: clinical use and impact on leptomeningeal seeding.
J Neurooncol. 2025;176:100.
PubMed

VARGAS LO, Himic V, Otaner F, Abikenari M, et al
Modulating the glioma microenvironment with laser interstitial thermal therapy: mechanisms and therapeutic implications.
J Neurooncol. 2025;176:99.
PubMed Abstract available

DARKO K, Chen J, Eckel-Passow JE, Fonkem E, et al
Short-course radiotherapy with or without temozolomide in elderly patients with newly diagnosed glioblastoma: a time-to-event meta-analysis of overall and progression-free survival.
J Neurooncol. 2025;176:98.
PubMed

PAHWA B, Pahwa N, Sheehan JP
Single session versus hypofractionated stereotactic radiosurgery for large meningiomas (> 8 cc): a systematic review and meta analysis.
J Neurooncol. 2025;176:97.
PubMed Abstract available

BASARAN AE, Fahsold L, Lordick F, Nicolay NH, et al
Treatment modalities in recurrent brain metastases: a combined institutional and individual patient data meta-analysis of post-recurrence survival and local progression-free survival.
J Neurooncol. 2025;176:96.
PubMed Abstract available

MASTRONUZZI A, Franceschi E, D'Antonio F, Bennicelli E, et al
Diagnostic and predictive molecular biomarkers in brain tumors across the lifespan: an age-stratified consensus statement.
J Neurooncol. 2025;176:95.
PubMed Abstract available

RICHARDSON GE, Mustafa MA, Clynch AL, Islim AI, et al
Immunohistochemistry markers of molecular subtype do not correlate with the growth behaviour for recurrent meningiomas - a cohort study.
J Neurooncol. 2025;176:94.
PubMed

YAMANISHI S, Nagashima H, Tanaka K, Ikeuchi Y, et al
Tumor-associated M2 macrophages shape the cerebrospinal fluid immunoprofile, and the soluble CD163/type I interferon ratio correlates with prognosis in high grade glioma.
J Neurooncol. 2025;176:93.
PubMed Abstract available

GULSUNA B, Stevens B, Gulsuyu B, Wood E, et al
Correction to: Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review.
J Neurooncol. 2025;176:90.
PubMed

RAGHU A, Killar S, Cohen AL
Effects of temozolomide dosing on outcome in glioblastoma.
J Neurooncol. 2025;176:89.
PubMed Abstract available

VEGH L, Benninger F, Tamir I
Seizure characteristics in epilepsy patients with a primary brain tumor.
J Neurooncol. 2025;176:92.
PubMed

COWAN D, Lopez-Rivera V, Akinwunmi-Williams T, Jani J, et al
Timing of complications following stereotactic brain biopsy: implications for same-day discharge feasibility.
J Neurooncol. 2025;176:91.
PubMed Abstract available

BUCCILLI B, Lucke-Wold B
Performance of artificial intelligence for brain tumor segmentation, treatment planning, and outcome prediction: a comprehensive systematic review and meta-analysis.
J Neurooncol. 2025;176:88.
PubMed

MANORANJAN B, Zeller S, Demere Z, Reiner AS, et al
Clinical and genomic characterization of brain metastasis in thyroid cancer.
J Neurooncol. 2025;176:87.
PubMed Abstract available

WACH J, Weber F, Wende T, Vychopen M, et al
GLIMMER: an interim subgroup analysis from an ongoing prospective study evaluating hyperspectral imaging for MGMT promoter methylation in gliomas.
J Neurooncol. 2025;176:86.
PubMed Abstract available

DONG J, Liu L, Zhao Z, Huang G, et al
China National Glioma Registry (CNGR): protocol for a prospective observational registry study.
J Neurooncol. 2025;176:83.
PubMed Abstract available

TERRY F, Brito A, Vascones-Roman FF, Rivera V, et al
Post-ablation volume threshold for brain metastasis control using LITT: a systematic review and critical appraisal.
J Neurooncol. 2025;176:85.
PubMed Abstract available

ALBARRACIN CARDENAS CI, Caballero Rojas H, Ochoa Vera ME, Luna Gonzalez ML, et al
Survival of nervous system tumors in a Colombian population cancer registry.
J Neurooncol. 2025;176:84.
PubMed Abstract available

DUFFAU H
Return to intensive sport activities following awake functional-guided surgical resection of IDH-mutated low-grade glioma.
J Neurooncol. 2025;176:82.
PubMed Abstract available

KANN MR, Srinivasan ES, Benedetti JR, Ostrom QT, et al
Epidemiology and survival of adolescent and young adults with brain metastases compared to older adults.
J Neurooncol. 2025;176:81.
PubMed

TOTH AJ, Robert SM, Fahy T, Wang SY, et al
Multidisciplinary review outperforms qualitative MR perfusion in distinguishing post-radiation brain metastasis recurrence versus radionecrosis.
J Neurooncol. 2025;176:80.
PubMed Abstract available

BUCCILLI B, Yoon J, Hussein A, Faraji AH, et al
Correction to: Comparative safety and survival outcomes of immune checkpoint inhibitors in brain metastases from lung cancer: a propensity-matched cohort study.
J Neurooncol. 2025;176:79.
PubMed

YANG X, Wang L, Wu H, Li C, et al
GABA treatment promoting cell apoptosis in meningioma correlates with EGFR/BCL-2/BAX axis.
J Neurooncol. 2025;176:78.
PubMed

CHOLE V, Moolchandani J, Verma S, Satone S, et al
PSF-GRBM: brain tumor classification and grading using optimized gated recurrent unit-deep bidirectional long short-term memory.
J Neurooncol. 2025;176:76.
PubMed Abstract available

GUIMARAES MM, Matushita H
Intratumoral tocilizumab in children with cystic craniopharyngiomas: targeted therapy.
J Neurooncol. 2025;176:75.
PubMed

SAMIMI K, Saini AS, Cullison K, Herr J, et al
EGFR pathway alterations correlate with rapid early progression in glioblastoma.
J Neurooncol. 2025;176:77.
PubMed Abstract available

GAO F, Huang H, Zuo D, Zhuang R, et al
Dual tumor control and neuroprotective efficacy of Boron Neutron Capture Therapy in orthotopic mouse glioma model.
J Neurooncol. 2025;176:74.
PubMed

AKDEMIR EY, Gutierrez AN, Zhang Y, Yarlagadda S, et al
Evaluating the efficacy of a federated AI algorithm in assisting in the detection and segmentation of brain metastases: limitations and opportunities.
J Neurooncol. 2025;176:70.
PubMed

RAMAMURTHY K, Randazzo DM, Cort N, Herndon JE 2nd, et al
Clinical trial of feasibility for mindfulness intervention for patients with newly diagnosed high grade glioma.
J Neurooncol. 2025;176:71.
PubMed Abstract available

HO VKY, Gijtenbeek JMM, Maas SLN, Taal W, et al
Adult ependymoma: results from the Dutch Brain Tumour Registry on primary treatment and survival.
J Neurooncol. 2025;176:73.
PubMed

SHAHIN M, Singh J, Mansoori S, Vasant S, et al
Expanding morphological spectrum of pilocytic astrocytomas: insights from integrated histopathological and multiomic profiling.
J Neurooncol. 2025;176:69.
PubMed Abstract available

YEBOA DN, Whitfield BT, Lin R, Ejezie CL, et al
Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses : Treatment intensification, margin reduction and epigenetic stratified outcomes with radiation therap
J Neurooncol. 2025;176:72.
PubMed Abstract available

BIN-ALAMER O, Taori S, Abou-Al-Shaar H, Flickinger JC, et al
Early outcomes of Gamma Knife stereotactic radiosurgery for symptomatic intracranial meningiomas in octogenarians: technique analysis and rationale.
J Neurooncol. 2025;176:67.
PubMed Abstract available

CAN DDT, Giang NDH, Van ND, Tuan PA, et al
Surgical characteristics and survival outcomes of pediatric pineal region tumors: a cohort study in Vietnam.
J Neurooncol. 2025;176:68.
PubMed Abstract available

CHUCK C, Teshome A, Lin A, Sayeed S, et al
Redefining the therapeutic landscape of glioblastomas and brain metastasis through cesium brachytherapy and low-kV intra-operative radiation therapy (IORT).
J Neurooncol. 2025;176:66.
PubMed Abstract available

VAZIRI T, Liu IC, Bettegowda C, Croog V, et al
Correction to: Stereotactic radiosurgery for patients with extensive brain metastases across the disease course.
J Neurooncol. 2025;176:62.
PubMed

KATTAA AH, Persad AR, Hori YS, Harary PM, et al
Peripheral neural crest tumor brain metastases management: a single-institution retrospective study.
J Neurooncol. 2025;176:65.
PubMed

NAKAGAWA H, Yui Y, Suzuki T, Tamura M, et al
Investigation of 6-thioguanine as a strategy to overcome methotrexate resistance in a mouse model of leptomeningeal carcinomatosis.
J Neurooncol. 2025;176:64.
PubMed Abstract available

GULSUNA B, Lopez R, Kemp RDW, Yurtluk MD, et al
The current status of immune checkpoint inhibitors in pediatric CNS tumors: a systematic review with a representative case of CMMRD-associated glioma.
J Neurooncol. 2025;176:63.
PubMed Abstract available

CHANDLER KE, Grigorian JN, Pisharody VA, Chisango Z, et al
Clinical and genomic factors differ in pediatric and adult pilocytic astrocytoma: a single-center experience with over 350 patients.
J Neurooncol. 2025;175:539-547.
PubMed Abstract available

KIM S, Son Y, Oh J, Kim S, et al
Global burden of brain and central nervous system cancer in 185 countries, and projections up to 2050: a population-based systematic analysis of GLOBOCAN 2022.
J Neurooncol. 2025;175:673-685.
PubMed Abstract available

BLOBNER J, Ruf V, Weller J, Teske N, et al
Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3.
J Neurooncol. 2025;175:763-774.
PubMed Abstract available

PAN Z, Ye X, Huang Y, Tai P, et al
Intrathecal pemetrexed for newly diagnosed leptomeningeal metastases: a multicenter, open-label, phase I/II study.
J Neurooncol. 2025;175:857-868.
PubMed Abstract available

CARDONA JJ, Park DJ, Al Gharyani MF, Wang JY, et al
Stereotactic radiosurgery for intracranial and spinal adenoid cystic carcinoma: systematic review and illustrative case presentation.
J Neurooncol. 2025;175:493-505.
PubMed Abstract available

IUSUPOVSKAIA E, Isaev N, Antonian A, Boromangnaeva AK, et al
Enhancing the therapeutic effect on tumor cells through wireless optoelectronic stimulation.
J Neurooncol. 2025;175:741-752.
PubMed Abstract available

ZAYED S, Ruschin M, Atenafu EG, Chen H, et al
Prognostic factors for local failure and overall survival in patients with epidural disease at the cauda equina following stereotactic body radiotherapy: a clinical, anatomic and dosimetric analysis.
J Neurooncol. 2025;175:621-631.
PubMed Abstract available

HUGHES JG, Cozzi FM, Phillips V, Price SJ, et al
Shared decision-making interventions in neuro-oncology practice: a systematic review.
J Neurooncol. 2025;175:471-479.
PubMed Abstract available

GAGLIARDI F, Roncelli F, Snider S, De Domenico P, et al
Circulating levels of glutamate predict brain disease in patients with advanced lung and breast cancer: a prospective study.
J Neurooncol. 2025;175:825-836.
PubMed Abstract available

October 2025

ZHONG W, Li Z, Lv S, Chen G, et al
Multimodal pathomics and clinical features predict postresection permanent hydrocephalus in pediatric medulloblastoma.
J Neurooncol. 2025;176:59.
PubMed Abstract available

BERTHOLD C, Boudreault A, Simonyan D, Fournier-Loiselle J, et al
Hormonal factors predisposing to the development of meningiomas in men: a case-control study.
J Neurooncol. 2025;176:61.
PubMed

MAHDI J, Gust JA, Vitanza NA, Scott B, et al
Neurotoxicity in central nervous system tumors treated with CAR T cell therapy: a review.
J Neurooncol. 2025;176:60.
PubMed Abstract available

CARMICHAEL A, Arshad U, Heinemann DM, Reddy SC, et al
Radiologic characterization and clinical management of multinodular and vacuolating neuronal tumor (MVNT): a retrospective institutional cohort study.
J Neurooncol. 2025;176:57.
PubMed Abstract available

GULSUNA B, Stevens B, Gulsuyu B, Wood E, et al
Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review.
J Neurooncol. 2025;176:58.
PubMed Abstract available

GECICI NN, Stepniak A, Habib A, Ghoche MT, et al
Predictors and clinical implications of surgical site infections following glioma resection: a matched case-control study.
J Neurooncol. 2025;176:55.
PubMed Abstract available

CHEN ZHOU ZH, Hilario A, Salvador Alvarez E, Cardenas Del Carre A, et al
Percentage of signal recovery (PSR): a more accurate marker than rCBV for differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiosurgery.
J Neurooncol. 2025;176:53.
PubMed Abstract available

PEETERS S, Kim WJ, Armellini A, Haist B, et al
The activity of cold atmospheric plasma against high-grade glioma: a review.
J Neurooncol. 2025;176:52.
PubMed Abstract available

DEL BALDO G, Di Ruscio V, Cacchione A, Lo Sasso A, et al
Clinical, toxicity and long-term neurocognitive outcomes of first-line intensive chemotherapy in infant medulloblastoma: a single-center cohort study following AIEOP recommendations.
J Neurooncol. 2025;176:54.
PubMed Abstract available

ZHANG W, Cao K, Zhang X, Cao N, et al
Potential clinical value of circulating tumor cells in predicting progression for atypical teratoid rhabdoid tumor in young children.
J Neurooncol. 2025;176:51.
PubMed Abstract available

BUCCILLI B, Yoon J, Hussein A, Faraji A, et al
Comparative safety and survival outcomes of immune checkpoint inhibitors in brain metastases from lung cancer: a propensity-matched cohort study.
J Neurooncol. 2025;176:50.
PubMed Abstract available

SUN Y, Hamo M, Atchley T, Markert JM, et al
Survival outcomes associated with antidepressant use in glioblastoma: a cohort study.
J Neurooncol. 2025;176:47.
PubMed Abstract available

JI P, Li C, Wang Y, Guo S, et al
Clinical and survival differences between thalamic glioblastoma and thalamic diffuse midline glioma, H3 K27-altered.
J Neurooncol. 2025;176:46.
PubMed Abstract available

LI L, Shao MY, Zou SC, Xiao ZF, et al
Retraction Note: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44.
J Neurooncol. 2025;176:44.
PubMed

MYNENI S, Bhandarkar S, Akbari H, Mayne R, et al
The Craniopharyngioma Quality of Life (C-QOL) Index: a preliminary disease-specific, patient-centered tool for assessing patient reported outcomes in adult craniopharyngioma patients.
J Neurooncol. 2025;176:45.
PubMed Abstract available

TOPKAN E, Ozturk D
Letter to the editor: a comparison of outcomes after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases: an international multi-center study.
J Neurooncol. 2025;176:48.
PubMed

ANEMAWU B, Tirist A, Mohamedsaid A, Belay SA, et al
The magnitude of surgical site infection and its associated factors among pediatric central nervous system (CNS) tumor patients at tertiary referral hospitals in Ethiopia: a multi-center study.
J Neurooncol. 2025;176:49.
PubMed Abstract available

ZHANG XF, Liang YZ, Wu HY, Chen JL, et al
Navigating heterogeneity in resected brain metastases: molecular stratification and multimodal therapeutic strategies.
J Neurooncol. 2025;176:43.
PubMed

TAS KT, Hoft FS, Agolli L, Mohamed TA, et al
Long-term outcomes and toxicity of radiotherapy for WHO Grade II and III meningiomas: a retrospective analysis of 98 patients.
J Neurooncol. 2025;176:41.
PubMed Abstract available

GHALIBAFIAN M, Mirzaei S, Sadeghi Y, Afsar N, et al
Diffuse pontine glioma (DPG): shorter or longer treatment time?
J Neurooncol. 2025;176:40.
PubMed Abstract available

HOOSEMANS LJN, Panayotopoulos LF, van Kuijk SMJ, Verduin M, et al
Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis.
J Neurooncol. 2025;176:42.
PubMed Abstract available

REN L, Deng J, Xu J, Chan L, et al
SUV-max of (68)Ga-DOTATATE PET/CT correlates with WHO grade and RNA risk classification in meningioma.
J Neurooncol. 2025;176:37.
PubMed Abstract available

TARIQ R, Dadario NB, Shlobin NA, Yeung J, et al
Brain state theory as a comprehensive model for addressing the "non-eloquent" brain in glioma surgery.
J Neurooncol. 2025;176:39.
PubMed Abstract available

BAJWA MH, Sufiyan S, Amin W, Aftab K, et al
Investigating glioblastoma chemoresistance: a meta-analysis of microRNA signatures and gene networks.
J Neurooncol. 2025;176:38.
PubMed Abstract available

LAGHARI AA, Sufiyan S, Amin W, Ilyas S, et al
miR-21 as a diagnostic and prognostic biomarker in glioma: tissue and serum expression analysis in a Pakistani cohort.
J Neurooncol. 2025;176:34.
PubMed Abstract available

PUCCIO DJ, Wei CZ, Pillai A, Deng H, et al
Stereotactic radiosurgery for patients with brain metastases from nasopharyngeal carcinoma.
J Neurooncol. 2025;176:35.
PubMed Abstract available

GONZALEZ-APONTE MF, Huang Y, Leidig WA, Simon T, et al
Circadian variation in MGMT promoter methylation and expression predicts sensitivity to temozolomide in glioblastoma.
J Neurooncol. 2025;176:36.
PubMed Abstract available

HOTSINPILLER WS, Thomas EM, Tsekouras I, Popple RA, et al
Frameless linac-based radiosurgery for benign intracranial tumors treated with HyperArc: analysis of tumor control and toxicity.
J Neurooncol. 2025;176:33.
PubMed Abstract available

SUN K, Wang J, Gao M, Zhang J, et al
MiR-148a-3p/SIRT7 axis promotes glioma progression and regulates temozolomide chemosensitivity.
J Neurooncol. 2025;176:31.
PubMed Abstract available

MALIK N, Chow WD, Loron AG, You HB, et al
Clinical utility of repeat brain biopsy in recurrent or refractory primary CNS lymphoma - a diagnostic dilemma.
J Neurooncol. 2025;176:32.
PubMed Abstract available

NICHOLS CS, Lesha E, Graham D, Laird DG, et al
Post-operative events following elective craniotomy for tumor in children.
J Neurooncol. 2025;176:28.
PubMed Abstract available

HU Y, Liu X, Lv K, Geng D, et al
Dynamic reorganization of individual-level morphological networks in unilateral frontal lobe low-grade gliomas: a longitudinal study.
J Neurooncol. 2025;176:29.
PubMed

KRUPA P, Kotek F, Krupova M, Paulikova S, et al
Perioperative leukocyte-plateletcrit shift as a prognostic signature in glioblastoma.
J Neurooncol. 2025;176:27.
PubMed Abstract available

PRICE M, Ballard CAP, Waite KA, Ostrom QT, et al
Using data for novel discoveries in neuro-oncology research.
J Neurooncol. 2025;176:30.
PubMed Abstract available

VAZIRI T, Liu IC, Bettegowda C, Croog V, et al
Stereotactic radiosurgery for patients with extensive brain metastases across the disease course.
J Neurooncol. 2025;176:24.
PubMed Abstract available

HARLAY V, Bequet C, Appay R, Bertucci A, et al
Autonomy duration in patients with biopsy-only unresectable IDH wild-type glioblastomas.
J Neurooncol. 2025;176:20.
PubMed Abstract available

DASGUPTA P, Dagher SA, Chi X, Soomro Z, et al
Genomic determinants of the diffusely infiltrative gliomatosis cerebri phenotype.
J Neurooncol. 2025;176:19.
PubMed

GOULENKO V, Sinha S, Madhugiri VS, Almeida ND, et al
Modulating the pace: systemic targeted therapy, brain metastasis velocity, and outcomes after Gamma Knife radiosurgery in breast cancer brain metastases.
J Neurooncol. 2025;176:21.
PubMed

ROUX A, Tauziede-Espariat A, Simboli GA, Elia A, et al
High-grade glioma, IDH- and H3-wildtype in young adults: a rare condition with a distinct epigenetic landscape.
J Neurooncol. 2025;176:22.
PubMed Abstract available

BASELGA M, Berna S, Perez VMM, Soriano M, et al
Three-dimensional ultrastructural analysis of glioblastoma reveals spheresome-mediated intercellular communication.
J Neurooncol. 2025;176:23.
PubMed

NECHAEVA A, Ulitin A, Sitovskaya D, Yudintceva N, et al
Fluorescence molecular imaging of high-grade gliomas and brain metastases using the RAS70 peptide targeting plasma membrane-bound Hsp70 on tumor cells.
J Neurooncol. 2025;176:15.
PubMed Abstract available

JHANDI S, Goold E, Jensen RL
Meningioma grade and molecular markers of proliferation, hypoxia, and vascularity as predictors of outcome in a cohort with long-term patient follow-up.
J Neurooncol. 2025;176:18.
PubMed Abstract available

BHARDWAJ S, Singh J, Singh S, Roy C, et al
Unveiling MMR deficiency in pediatric and AYA high-grade gliomas: insights from multiomic profiling.
J Neurooncol. 2025;176:16.
PubMed

HONG S, Takami H, Umekawa M, Shinya Y, et al
Systemic immune-inflammation index as a prognostic biomarker to predict overall survival after primary stereotactic radiosurgery for brain metastases.
J Neurooncol. 2025;176:12.
PubMed Abstract available

YUILE A, Wei JQ, McKelvey KJ, Colvin EK, et al
Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours.
J Neurooncol. 2025;176:10.
PubMed Abstract available

EL GHALBOUNI A, Snijders TJ, Amerein A, Tolboom N, et al
Efficacy of Intra-arterial [(177)Lu]Lu-DOTATATE monotherapy for treatment-refractory meningioma.
J Neurooncol. 2025;176:8.
PubMed Abstract available

NGUYEN TT, Pham TM, Quy PN, Chalise L, et al
Premature mortality due to malignancies of the central nervous system in Japan: a nationwide descriptive analysis from 2000 to 2020.
J Neurooncol. 2025;176:11.
PubMed Abstract available

VAN DEN BERG L, Wilbers J, de Vos FYFL, van Kouwenhoven MCM, et al
Chemotherapy in adult patients with pilocytic astrocytoma: a retrospective multicenter cohort study.
J Neurooncol. 2025;176:7.
PubMed Abstract available

ANDREOTTI A, Ferroni E, Guzzinati S, Baracco S, et al
Incidence and survival of adult central nervous system tumors in the Veneto region: a population-based registry study (2016-2020).
J Neurooncol. 2025;176:9.
PubMed Abstract available

TINI P, Novi F, Donnini F, Perrella A, et al
Assessing ChatGPT-4 as a clinical decision support tool in neuro-oncology radiotherapy: a prospective comparative study.
J Neurooncol. 2025;176:13.
PubMed Abstract available

ZIEBART A, Onken J, Nadji-Ohl M, Jungk C, et al
Low tumour burden is associated with observation after surgery in patients with grade 2 astrocytoma and oligodendroglioma: results from the prospective multicentre LoG-Glio registry.
J Neurooncol. 2025;176:14.
PubMed Abstract available

GUZZINO J, Crompton DJ, Agarwal S, Kern S, et al
Rapid early progression of glioblastoma: evaluation of a novel prognostic radiologic biomarker.
J Neurooncol. 2025;176:5.
PubMed Abstract available

DAI X, He S, Qi Y, Li H, et al
Predictive markers for molecular subtypes and WHO grade: T1rho-MRI in adult-type diffuse gliomas.
J Neurooncol. 2025;176:6.
PubMed Abstract available

KIM E, Lee HI, Roh TH, Kim YZ, et al
Hypofractionated vs. conventional fractionated radiotherapy in the temozolomide era for elderly patients with glioblastoma: a systematic review and meta-analysis by the Korean society for neuro-oncology.
J Neurooncol. 2025;176:3.
PubMed Abstract available

KOAY JM, Dion C, Michaelides L, Chaichana K, et al
Cognitive impact of repeated surgical resections for the management of high-grade glioma.
J Neurooncol. 2025;176:4.
PubMed Abstract available

DAS S, Walker-Dilks C, Nicholas G, Sahgal A, et al
Executive summary of organizational guidance for the care of patients with central nervous system tumours in Ontario: consensus recommendations.
J Neurooncol. 2025;175:419-429.
PubMed Abstract available

CHEN W, Yuan J, Liu G, Cui L, et al
Metagenomic next-generation sequencing and chromosomal copy number variation analysis in cerebrospinal fluid for the detection of meningeal carcinomatosis.
J Neurooncol. 2025;175:175-181.
PubMed Abstract available

WEI CZ, Deng H, Ashwat E, Albano L, et al
Tumor control and motor function in patients with metastases located in the primary motor cortex after stereotactic radiosurgery.
J Neurooncol. 2025;175:63-70.
PubMed Abstract available

ABIKENARI M, Liu J, Ha JH, Annagiri S, et al
Emerging trends in cell-based therapies: contemporary advances and ethical considerations in translational neurosurgical oncology.
J Neurooncol. 2025;175:1-20.
PubMed Abstract available

SARIKAYA C, Yaltirik CK, Varol E, Yuvruk E, et al
The role of MRI patterns in predicting neurologic deficits in spinal ependymomas.
J Neurooncol. 2025;175:313-322.
PubMed Abstract available

ARENDT CT, Lohlau M, Roder L, Burger MC, et al
Susceptibility- and T2*-weighted MRI features of CNS large B-cell lymphoma in a large single-center cohort: prevalence, patterns, and clinical associations.
J Neurooncol. 2025;175:231-241.
PubMed Abstract available

IVREN M, Yalman D, Ishak B, Ille S, et al
Beyond surgical radicality in intramedullary spinal cord metastases: neurological function and systemic disease burden drive patient outcomes.
J Neurooncol. 2025;175:431-442.
PubMed Abstract available

GENSLER R, Xia Y, Horowitz MA, Abdulrahim M, et al
Outcomes of leptomeningeal disease after only vertebral osseous metastases: a real-world analysis using the TriNetX database.
J Neurooncol. 2025;175:219-229.
PubMed Abstract available

ORSMOND A, De Sousa SMC, McCormack A
The landscape of germline variants in breast and colorectal cancer susceptibility genes in patients with pituitary tumours.
J Neurooncol. 2025;175:379-388.
PubMed Abstract available

BECKHAM TH, Cha EE, Rooney MK, Tom MC, et al
Cesium-131 collagen tile brachytherapy for salvage of recurrent intracranial metastases.
J Neurooncol. 2025;175:165-174.
PubMed Abstract available

SHAH KH, Khalafallah AM, Knott MV, Berke CN, et al
Predictors of prolonged length of stay in patients undergoing laser interstitial thermal therapy for intracranial tumors.
J Neurooncol. 2025;175:91-99.
PubMed Abstract available

RAMMELOO E, Young JS, Schouten JW, Bos EM, et al
Preoperative assessment of tumor eloquence and resectability: an international survey.
J Neurooncol. 2025;175:47-59.
PubMed Abstract available

FIEDLER C, Kordes UR, Thomas C, Hasselblatt M, et al
CPT-SIOP registry: evaluation of risk factors for disease progression in pediatric choroid plexus papilloma.
J Neurooncol. 2025;175:333-343.
PubMed Abstract available

September 2025

KHATRI VM, Mestres-Villanueva MA, Daniel S, Yarlagadda S, et al
Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report.
J Neurooncol. 2025 Sep 30. doi: 10.1007/s11060-025-05230.
PubMed Abstract available

SHIBAHARA I, Kumabe T
Comment on: "Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma".
J Neurooncol. 2025 Sep 30. doi: 10.1007/s11060-025-05226.
PubMed Abstract available

AN X, Wang J, Yuan J, Zhou X, et al
Prognostic value of temporal muscle thickness in pediatric medulloblastoma patients aged 3-12 years.
J Neurooncol. 2025 Sep 29. doi: 10.1007/s11060-025-05229.
PubMed Abstract available

DIAZ LS, Agrup M, Asklid A, Embring A, et al
Correction to: Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study.
J Neurooncol. 2025 Sep 29. doi: 10.1007/s11060-025-05235.
PubMed

PEDERSEN V, Knudsen AM, Michaelsen SR, Dahlrot RH, et al
Tumor and immune cell distribution in the tumor core and outer part of glioblastoma, IDH wildtype.
J Neurooncol. 2025 Sep 25. doi: 10.1007/s11060-025-05232.
PubMed Abstract available

TINI P, Donnini F, Marampon F, Pastina P, et al
Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas-prognostic significance in different biological sub-groups.
J Neurooncol. 2025 Sep 25. doi: 10.1007/s11060-025-05215.
PubMed Abstract available

BASHIR S, Jian S, Hong W, Wang H, et al
Development and validation of a predictive nomogram for leptomeningeal metastasis risk in NSCLC brain metastases: role of tumor location, driver mutations, and stereotactic radiosurgery.
J Neurooncol. 2025 Sep 18. doi: 10.1007/s11060-025-05220.
PubMed Abstract available

GURANDA A, Guresir E, Ruder AM, Giordano FA, et al
Intra-cavitary radiotherapy for surgically resected brain metastases: a comprehensive analysis including an individual patient data meta-analysis of intraoperative radiotherapy (IORT) and brachytherapy (IBT).
J Neurooncol. 2025 Sep 17. doi: 10.1007/s11060-025-05227.
PubMed Abstract available

DEBOEUF L, Keraudy A, Picart T, Haddad G, et al
Prevalence, natural history and surgical outcome of spinal meningiomas in NF2-related schwannomatosis.
J Neurooncol. 2025 Sep 16. doi: 10.1007/s11060-025-05231.
PubMed Abstract available

ROH H, Park C, Kim W, Choi J, et al
Impact of EGFR mutation subtypes and TKI generations on clinical outcomes in lung adenocarcinoma patients with brain metastases treated with gamma knife radiosurgery.
J Neurooncol. 2025 Sep 16. doi: 10.1007/s11060-025-05149.
PubMed Abstract available

OI Y, Minamoto H, Taniyama I, Fukuzawa M, et al
Novel predictors of tumor growth by exploratory quantitative analysis of radiomics features from MRI data for incidentally discovered meningioma.
J Neurooncol. 2025 Sep 16. doi: 10.1007/s11060-025-05186.
PubMed Abstract available

NAEWWAN N, Talabnin K, Trasaktaweesakul T, Khuansonthi P, et al
Piperlongumine induces meningioma cell death via the ROS-mediated endoplasmic reticulum stress and the alteration of the ubiquitin-proteasome system.
J Neurooncol. 2025 Sep 15. doi: 10.1007/s11060-025-05219.
PubMed Abstract available

PAHWA B, Mahajan S, Pahwa N, Panico N, et al
Linear regression models predict survival and complication rates in patients undergoing gamma knife radiosurgery for recurrent and residual craniopharyngiomas: a meta-analysis of 743 tumors.
J Neurooncol. 2025 Sep 15. doi: 10.1007/s11060-025-05196.
PubMed Abstract available

TREWIN-NYBRATEN CB, Lambert PC, Marienhagen K, Andreassen L, et al
Unveiling regional differences in glioblastoma patient survival with real-world data from the Norwegian brain tumor quality registry.
J Neurooncol. 2025 Sep 11. doi: 10.1007/s11060-025-05218.
PubMed Abstract available

RENOVANZ M, Hippler M, Kuchen R, Doerner L, et al
Physician-led versus questionnaire-based psychosocial screening in adults with high-grade glioma: a cluster-randomized controlled trial (GLIOPT).
J Neurooncol. 2025 Sep 10. doi: 10.1007/s11060-025-05223.
PubMed Abstract available

SU M, Duan H, Lei Q, Tan Z, et al
Utility and performance of cerebrospinal fluid cytology in discriminating central nervous system infections and brain tumors.
J Neurooncol. 2025 Sep 10. doi: 10.1007/s11060-025-05214.
PubMed Abstract available

AKUTAGAWA K, Miki S, Yamada E, Sakamoto N, et al
Correction to: PIK3R2 immunostaining status predicts prognosis in patients with newly diagnosed glioblastoma treated with an autologous tumor vaccine.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05203.
PubMed

PRICE G, Frederico SC, Colan J, Rentzeperis F, et al
Photodynamic therapy for glioblastoma: a narrative review.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05217.
PubMed Abstract available

KOJUNDZIC I, Fritz JL, Said BI, Vuong S, et al
Clinical-pathological patterns and prognosis of young women with breast cancer brain metastases: a single-center retrospective study.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05212.
PubMed Abstract available

KAMBE A, Ochiai R, Makishima K, Yasuda S, et al
Microvessel density as a prognostic and predictive biomarker in newly diagnosed glioblastoma: correlations with radiological features and bevacizumab efficacy.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05210.
PubMed Abstract available

KESUMAYADI I, Kambe A, Amisaki H, Hosoya T, et al
Prognostic value of hypertension timing for survival in glioblastoma patients receiving bevacizumab: a retrospective single centre analysis.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05209.
PubMed Abstract available

EIBL T, Liebert A, Ritter L, Neher M, et al
Role of patient frailty in resection of newly diagnosed motor eloquent glioblastomas guided by a navigated transcranial magnetic stimulation and tractography approach.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05206.
PubMed Abstract available

DOIG M, Lee J, Kwok Y, MacEwan I, et al
Impact of substructure radiation dose on health-related quality of life in children with brain tumors: a Pediatric Proton/Photon Consortium Registry (PPCR) study.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05211.
PubMed Abstract available

SADAGOPAN NS, Gomez M, Tripathi S, Billingham LK, et al
NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas.
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05208.
PubMed Abstract available

HALL JC, Goel K, Lozko Y, Chang SD, et al
Repeat stereotactic radiosurgery for treatment of brain metastases locally recurrent following initial radiosurgery.
J Neurooncol. 2025 Sep 7. doi: 10.1007/s11060-025-05201.
PubMed Abstract available

HO A, Horbinski C, Sachdev S
Thromboembolism in gliomas: an under-recognized danger.
J Neurooncol. 2025 Sep 5. doi: 10.1007/s11060-025-05204.
PubMed

ZARE A, Zare A, Hajikarimloo B, Mohammadi B, et al
Radiosurgery for central nervous system ependymomas: a systematic review and meta-analysis.
J Neurooncol. 2025;174:315-327.
PubMed Abstract available

XIE Q, Hu J, Liu Y, Tabengwa GT, et al
Retrospective study of leptomeningeal metastasis: unveiling the indolent and rapid progression phases.
J Neurooncol. 2025;174:357-368.
PubMed Abstract available

LIPATNIKOVA A, Kling T, Denes A, Carstam L, et al
CDKN2A/B status versus morphology in diagnosing WHO grade 4 IDH-mutated astrocytomas: what is the clinical relevance?
J Neurooncol. 2025;174:449-458.
PubMed Abstract available

KRISCH JM, Ermoian RP, Indelicato DJ, Lee JY, et al
Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): results from the Pediatric Proton/Photon Consortium Registry (PPCR).
J Neurooncol. 2025;174:369-380.
PubMed Abstract available

GIANTINI-LARSEN AM, Brown S, Reiner AS, Giandalone SD, et al
Financial toxicity in pediatric and adolescent neurosurgical oncology.
J Neurooncol. 2025;174:349-356.
PubMed Abstract available

KHALAFALLAH AM, Susic N, Shah KH, Knott MV, et al
Evaluating safety and feasibility of same-day discharge after laser interstitial thermal therapy: a pilot study with a matched control group.
J Neurooncol. 2025;174:341-347.
PubMed Abstract available

AREGA G, Hailu D, Fikad G, Nigusie M, et al
Patterns, clinical presentations, and time to diagnosis in pediatric central nervous system tumors: insights from a pediatric neuro-oncology tumor board team at a tertiary referral hospital in Ethiopia.
J Neurooncol. 2025;174:587-598.
PubMed Abstract available

WANG J, Yang Q, Li X, Li Q, et al
Engineering overexpressing SYNGR1 inhibited the progression of GBM cells by suppressing the intracellular FGF1-mediated LDs accumulation and cytoskeleton remodeling.
J Neurooncol. 2025;174:667-687.
PubMed Abstract available

CHEN JY, Schultz A, Khoury NM, Rangavajhula K, et al
Optimizing workflows for metastatic central nervous system disease: a systematic review and proposed guidelines.
J Neurooncol. 2025;174:557-585.
PubMed Abstract available

August 2025

ARACELI T, Haj A, Doenitz C, Stoerr EM, et al
Complete resection of brain metastases - when does it matter?
J Neurooncol. 2025 Aug 22. doi: 10.1007/s11060-025-05193.
PubMed Abstract available

SHIH JJ, Jain B, Patel R, Jain U, et al
Stereotactic radiosurgery for brain metastases: evolving practice patterns from the national cancer database (2004-2020).
J Neurooncol. 2025 Aug 22. doi: 10.1007/s11060-025-05178.
PubMed

GIORDANO C, Sassu CM, Marchetti C, Guerri G, et al
Brain metastases from ovarian cancer: neuroradiological profile and survival overview of neurosurgical cases.
J Neurooncol. 2025 Aug 21. doi: 10.1007/s11060-025-05192.
PubMed Abstract available

WANG CY, Lin CF, Yang HC, Liu CY, et al
Gamma knife radiosurgery for breast cancer brain metastasis: survival outcomes, prognotic factors, and the role of repeat treatment.
J Neurooncol. 2025 Aug 21. doi: 10.1007/s11060-025-05188.
PubMed Abstract available

LIN CA, Lin C, Rhodes CT, Moseley MC, et al
Takeaways from meta-analysis: indications of combinational treatments for glioblastoma.
J Neurooncol. 2025 Aug 21. doi: 10.1007/s11060-025-05205.
PubMed Abstract available

YOGENDRAN LV, Kareddy A, Abbas SO, Scharf Z, et al
Effects of re-challenge with temozolomide in grade 2/3 IDH mutant gliomas at first progression.
J Neurooncol. 2025 Aug 20. doi: 10.1007/s11060-025-05087.
PubMed Abstract available

PENG TC, Hsieh MH, Lin CF, Kuan AS, et al
Repeated stereotactic radiosurgery for high grade meningioma.
J Neurooncol. 2025 Aug 13. doi: 10.1007/s11060-025-05165.
PubMed Abstract available

NEU M, Shiban E, Krauss P, Sommer B, et al
Comparing intraoperative radiotherapy (IORT) and hypofractionated stereotactic radiotherapy (HSRT) after brain metastasis surgery: impact on oncological outcome and radionecrosis.
J Neurooncol. 2025 Aug 13. doi: 10.1007/s11060-025-05152.
PubMed Abstract available

SUN MZ, Contreras E, Treger J, Imbroane M, et al
Immunotherapeutic targeting of NY-ESO-1 in malignant meningiomas with TCR-transduced T-cells.
J Neurooncol. 2025 Aug 13. doi: 10.1007/s11060-025-05200.
PubMed Abstract available

MAO M, Li Z, Zheng W, Xia H, et al
Collagen type I alpha 1 induces radio-resistance in hypoxic glioblastoma cells by promoting autophagy.
J Neurooncol. 2025 Aug 12. doi: 10.1007/s11060-025-05132.
PubMed Abstract available

RAMIREZ FERRER E, Zuluaga-Garcia JP, Alzate JD, Mayorga-Corvacho J, et al
Impact of healthcare disparities on the treatment and survival of patients with high-grade gliomas in Colombia: a multicenter inverse probability-weighted cohort analysis.
J Neurooncol. 2025 Aug 12. doi: 10.1007/s11060-025-05198.
PubMed Abstract available

BRASCHI EL, Trumble O, Casper A, Amdur RJ, et al
Pattern of recurrence with 1.0 cm CTV in brain glioblastoma treated with radiotherapy.
J Neurooncol. 2025 Aug 11. doi: 10.1007/s11060-025-05195.
PubMed Abstract available

NISHIWAKI T, Kudo U, Nakamura S, Kuse Y, et al
Synergistic antitumor and radiosensitizing effects of alpha-sulfoquinovosyl-acylpropanediol (SQAP) via PI3K/Akt inhibition and DNA repair impairment in glioblastoma.
J Neurooncol. 2025 Aug 11. doi: 10.1007/s11060-025-05194.
PubMed Abstract available

URIAS E, DeCesaris C
Comment on "A comparison of outcomes after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases: an international multi-center study".
J Neurooncol. 2025 Aug 8. doi: 10.1007/s11060-025-05187.
PubMed

KHATUA S, Bouffet E
Summary of the collection on 'immunotherapy in pediatric brain tumors-an update'.
J Neurooncol. 2025 Aug 6. doi: 10.1007/s11060-025-05191.
PubMed

JENSEN LR, Maier AD, Juratli TA, Goutagny S, et al
The concept, intention, and evaluation of the term treatment-refractory meningioma.
J Neurooncol. 2025 Aug 4. doi: 10.1007/s11060-025-05154.
PubMed Abstract available

CRISPI V, Peat S, Bolton WS, Chapman S, et al
Mixed reality with 3D brain imaging for patient consultation in neurosurgery: an IDEAL stage 2a feasibility study.
J Neurooncol. 2025;174:143-156.
PubMed Abstract available

MO C, Liu X, Guo Y, Liang D, et al
Clinical characteristics and pathological features of growth hormone-secreting pituitary adenoma combined with hyperprolactinemia.
J Neurooncol. 2025;174:131-141.
PubMed Abstract available

GARCIA CR, Highsmith K, Knight S, Andrade IP, et al
Single center experience of IDH inhibitors in recurrent high-grade gliomas.
J Neurooncol. 2025 Aug 1. doi: 10.1007/s11060-025-05183.
PubMed Abstract available

July 2025

HAGAN AJ, Hill RM, Kingston A, Bailey S, et al
The utility of long-term methylphenidate in preserving intellectual development in survivors of childhood brain tumour.
J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05177.
PubMed Abstract available

BEVER N, Shukla IY, Ebada A, Wan B, et al
Disparities in meningioma resection outcomes: a retrospective analysis of patients with public versus private insurance.
J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05179.
PubMed

LAN TL, Lin CF, Lee YY, Chang FC, et al
Recurrent meningioma treated with boron neutron capture therapy: a feasibility study with dosimetric and clinical correlates.
J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05184.
PubMed Abstract available

JAIN TK, Vohra M, Sharma BS, Loyal A, et al
Is 18F-PSMA PET/CT a reliable imaging modality to evaluate the status of recurrent/residual brain tumors in post-treatment patients?
J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05167.
PubMed Abstract available

BANDOPADHAY J, Pichardo-Rojas PS, Cho R, Tavakkol E, et al
Assessment of the RANO-resect criteria in elderly patients with glioblastoma.
J Neurooncol. 2025 Jul 31. doi: 10.1007/s11060-025-05168.
PubMed Abstract available

CHEN D, Ye L, Yu Z, Lei T, et al
Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases.
J Neurooncol. 2025 Jul 29. doi: 10.1007/s11060-025-05061.
PubMed Abstract available

LARIBI L, Scheepens JCC, Zamanipoor Najafabadi AH, Vos MJ, et al
Correction to: Antiseizure medication in patients with meningioma: a retrospective cohort study on the long-term impact on depression, anxiety and neurocognitive functioning.
J Neurooncol. 2025 Jul 28. doi: 10.1007/s11060-025-05147.
PubMed

MATSUDA R, Takatani T, Hayashi H, Matsuoka R, et al
Intraoperative neuromonitoring with direct cortical stimulation motor-evoked potentials in supratentorial glioma surgeries with preoperative moderate-to-severe motor weakness.
J Neurooncol. 2025 Jul 28. doi: 10.1007/s11060-025-05185.
PubMed Abstract available

PICHARDO-ROJAS PS, Bandopadhay J, Nunez LC, Dono A, et al
Impact of maximal and supramaximal resections on postoperative diffusion-weighted imaging changes and clinical outcomes in IDH-wildtype glioblastoma.
J Neurooncol. 2025 Jul 28. doi: 10.1007/s11060-025-05169.
PubMed Abstract available

PIENKOWSKI T, Mojsak P, Kowalczyk T, Cysewski D, et al
Proteomic profiling reveals dynamic regulation of vesicle trafficking across glioma grades.
J Neurooncol. 2025 Jul 24. doi: 10.1007/s11060-025-05151.
PubMed Abstract available

AYDEMIR I, Tutkun G, Akcit ET, Kocak O, et al
Combined effects of escitalopram and vitamin E on phoenixin-20 secretion and neuroregulatory mechanisms in glioblastoma cells: a neuro-nutritional perspective.
J Neurooncol. 2025 Jul 24. doi: 10.1007/s11060-025-05176.
PubMed Abstract available

LO SS, Halasz LM, Choi S, Kumthekar P, et al
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of radiotherapy in the management of patients with diffuse low grade glioma in adults: update.
J Neurooncol. 2025 Jul 24. doi: 10.1007/s11060-025-05074.
PubMed Abstract available

LANMAN TA, Gross H, Faria CM, Miller JJ, et al
Factors associated with cognitive impairment in long-term IDH-mutant glioma survivors.
J Neurooncol. 2025 Jul 23. doi: 10.1007/s11060-025-05155.
PubMed Abstract available

DELGADO-LOPEZ PD, Montalvo-Afonso A, Garcia-Leal R, Martin-Garcia S, et al
Surgical outcomes in octogenarian meningioma patients: a multicenter retrospective analysis of frailty and radiological predictors : Frailty in octogenarians undergoing meningioma resection.
J Neurooncol. 2025 Jul 22. doi: 10.1007/s11060-025-05174.
PubMed Abstract available

DU Z, Luo Y, Sun J, Long H, et al
(18)F-NOTA-NFB PET/MRI in glioma recurrence: comparison with (11)C-methionine PET/MRI and contrast-enhanced MRI.
J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05159.
PubMed Abstract available

KITE T, Bossinger B, Yadlapalli V, Jaffee S, et al
Stereotactic radiosurgery for recurrent high-grade gliomas: a systematic review.
J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05156.
PubMed Abstract available

ALFONZO HOROWITZ M, Li M, Parker M, Arbuiso A, et al
Incidence, demographics, and survival of patients with brain metastases from stage IV colorectal cancer: a population-based study from 2013 to 2023.
J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05107.
PubMed Abstract available

ISHIKAWA T, Matsuda M, Kaneda Y, Ishikawa E, et al
Hemagglutinating virus of Japan envelope encapsulating microRNA-34a-5p robustly induces apoptosis of malignant meningioma cells by suppressing survivin.
J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05172.
PubMed Abstract available

HAEDENKAMP TM, Gotz L, Ansafi T, Gerken M, et al
Dietary habits in relation to outcome and therapy-related toxicity in patients with glioblastoma - a retrospective cohort study.
J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05137.
PubMed

PICHARDO-ROJAS PS, Hajikarimloo B, Sheehan JP
Further points to consider regarding the resection strategy of eloquent brain metastasis in the era of postoperative stereotactic radiotherapy.
J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05153.
PubMed Abstract available

VENKATARATNAM Y, Mukherjee V, Rai N, Mahalingaswamy M, et al
Tunneling nanotubes between glioblastoma cells and T cells and hijack of mitochondria.
J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05150.
PubMed Abstract available

PARKER M, Jiang K, Kalluri A, Arbuiso AG, et al
Prevalence, therapeutic approaches, and survival rates of brain metastases in non-small cell lung cancer: a multi-institutional claims-based study from 2014 to 2024.
J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05139.
PubMed Abstract available

CAO H, Yan Z, Li M, Wang J, et al
SIN1 facilitates glioma progression and is associated with the KRAS/ERK pathway.
J Neurooncol. 2025 Jul 21. doi: 10.1007/s11060-025-05166.
PubMed Abstract available

LIU J, Meng Z, Wang R, Zhao G, et al
CLOCK promotes proliferation of glioblastoma cells through acetylating PRPS1/2.
J Neurooncol. 2025 Jul 19. doi: 10.1007/s11060-025-05163.
PubMed Abstract available

SEOL MY, Choi SH, Yoon HI
Targeting ataxia-telangiectasia mutated and cystine/glutamate antiporter enhances radiotherapy efficacy and tumor suppression in glioblastoma.
J Neurooncol. 2025 Jul 17. doi: 10.1007/s11060-025-05128.
PubMed Abstract available

CORAZZELLI G, Corvino S, Sigona L, Cioffi V, et al
Evaluating the role of gross total resection in primary spinal cord glioblastoma: evidence from a multicenter cohort and meta-analysis.
J Neurooncol. 2025 Jul 16. doi: 10.1007/s11060-025-05158.
PubMed Abstract available

LU MJS, Michaelsen SR, Locallo A, Eickhart-Dalboge CS, et al
Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study.
J Neurooncol. 2025 Jul 16. doi: 10.1007/s11060-025-05162.
PubMed Abstract available

CHEUNKARNDEE T, Ritter Z, Saint-Germain M, Ghanem P, et al
Distinct size and spatial distribution patterns of ALK-inhibitor-naive versus ALK-inhibitor exposed ALK-positive NSCLC brain metastases.
J Neurooncol. 2025 Jul 16. doi: 10.1007/s11060-025-05148.
PubMed Abstract available

POUR-RASHIDI A, Zandpazandi S, Hsu S, Shakeri A, et al
Comparative analysis of monotherapy versus duotherapy with antiseizure medications for intraoperative and early postoperative seizure control in glioma patients undergoing awake craniotomy.
J Neurooncol. 2025 Jul 15. doi: 10.1007/s11060-025-05133.
PubMed Abstract available

HAISRAELY O, Vedala S, Al-Sharfeen A, Manzar GS, et al
Glioblastoma in young adult patients: contemporary patterns of care and survival in the United States.
J Neurooncol. 2025 Jul 15. doi: 10.1007/s11060-025-05135.
PubMed

LAN R, Zhang N, Chen R, Chen J, et al
Correction to: Identification of RASL11A as a gene conferring radiosensitivity in glioblastoma.
J Neurooncol. 2025 Jul 8. doi: 10.1007/s11060-025-05142.
PubMed

TORRES J, Bundrant BE, Dono A, Pichardo-Rojas PS, et al
Cystic glioblastoma IDH-wildtype: genetic alterations and outcomes.
J Neurooncol. 2025 Jul 3. doi: 10.1007/s11060-025-05143.
PubMed Abstract available

MALLEREAU CH, Dannhoff G, Todeschi J, Severac F, et al
Tips and tricks of spinal cord biopsy: insights from a multicenter series of 61 patients.
J Neurooncol. 2025;173:719-729.
PubMed Abstract available

LESHA E, Laird DG, Nichols CS, Miller LE, et al
Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population.
J Neurooncol. 2025;173:759-767.
PubMed Abstract available

DAGHER SA, Johnson JM, Mohamed RMM, Ansari S, et al
Study of 18 F-fluciclovine PET for serial assessment of glioblastoma tumor volumes during surgery and radiotherapy.
J Neurooncol. 2025 Jul 1. doi: 10.1007/s11060-025-05146.
PubMed Abstract available

ZHAO C, Liang B, Li X, Ma P, et al
Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma.
J Neurooncol. 2025 Jul 1. doi: 10.1007/s11060-025-05144.
PubMed Abstract available

June 2025

KOCYIGIT S, Chavez MM, Orhun O, O'Brien J, et al
Posterior parasagittal meningiomas display aggressive features independent of size: a multicenter analysis.
J Neurooncol. 2025 Jun 26. doi: 10.1007/s11060-025-05103.
PubMed Abstract available

DASGUPTA P, Lin H, Kumar G, Soomro Z, et al
Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastoma.
J Neurooncol. 2025 Jun 25. doi: 10.1007/s11060-025-05131.
PubMed Abstract available

LIKHOMANOVA R, Oganesyan E, Yudintceva N, Fofanov G, et al
Glioblastoma cell motility and invasion is regulated by membrane-associated heat shock protein Hsp70.
J Neurooncol. 2025 Jun 24. doi: 10.1007/s11060-025-05127.
PubMed

KRAUS LM, Goldberg M, Ursu E, Demirbag K, et al
Postoperative hydrocephalus in patients with infratentorial brain metastases may be influenced by preoperative treatment: a single-center cohort study.
J Neurooncol. 2025 Jun 23. doi: 10.1007/s11060-025-05125.
PubMed Abstract available

NOCERA G, Sanvito F, Yao J, Oshima S, et al
Independent histological validation of MR-derived radio-pathomic maps of tumor cell density using image-guided biopsies in human brain tumors.
J Neurooncol. 2025 Jun 21. doi: 10.1007/s11060-025-05105.
PubMed Abstract available

MADHUGIRI VS, Goulenko V, Seth L, Wang R, et al
Evaluation of clinical and volumetric outcomes following adaptive gamma knife radiosurgery for brain metastases.
J Neurooncol. 2025 Jun 20. doi: 10.1007/s11060-025-05138.
PubMed Abstract available

ZULUAGA-GARCIA JP, Ramirez-Ferrer E, Peeters SF, DeMonte F, et al
Management of skull base meningiomas with extracranial extension: resection, recurrence, and prognostic factors.
J Neurooncol. 2025 Jun 19. doi: 10.1007/s11060-025-05111.
PubMed Abstract available

JUNG K, Sivadas SD, Fitzgerald X, Phillips C, et al
Long-term clinical outcomes of bevacizumab for treatment of stereotactic radiosurgery-induced radiation necrosis in patients with brain metastases.
J Neurooncol. 2025 Jun 19. doi: 10.1007/s11060-025-05121.
PubMed Abstract available

ROSE ML, Bajaj BVM, Jimenez R, Dennehy S, et al
Quality of life in pediatric patients treated with adjuvant proton radiation for craniopharyngiomas.
J Neurooncol. 2025 Jun 18. doi: 10.1007/s11060-025-05112.
PubMed Abstract available

WANG Q, Wang H, Hong W, Bashir S, et al
Local cranial radiation combined with third-generation tyrosine kinase inhibitors improve leptomeningeal metastasis disease-free survival in patients with EGFR-mutated non-small cell lung cancer and brain metastasis.
J Neurooncol. 2025 Jun 18. doi: 10.1007/s11060-025-05045.
PubMed Abstract available

LOESCHNER D, Wagle PR, Jung A, Neumeister A, et al
The communication of a high-grade glioma diagnosis- patients' reflections and perspectives based on a study-specific questionnaire.
J Neurooncol. 2025 Jun 17. doi: 10.1007/s11060-025-05129.
PubMed Abstract available

SHEN H, Li J, Jia Y, Liu F, et al
The oncogenic role of CCDC34 in lower-grade gliomas: prognostic significance and therapeutic potential.
J Neurooncol. 2025 Jun 16. doi: 10.1007/s11060-025-05090.
PubMed Abstract available

FAN H, Li X, Zhao Y, Song L, et al
Decoding meningioma prognosis with multi-omics: macrophage diversity, immune-CNV interplay, and novel SPP1-targeted strategies.
J Neurooncol. 2025 Jun 16. doi: 10.1007/s11060-025-05116.
PubMed Abstract available

SEIDEL JA, Alder L, Salama AKS, Anders CK, et al
Management outcomes for biopsy-proven radiation necrosis in patients with brain metastases in the era of immune-checkpoint blockade.
J Neurooncol. 2025 Jun 16. doi: 10.1007/s11060-025-05120.
PubMed Abstract available

CHAKRAVARTI S, Tang L, Shah HA, Singh A, et al
Patient nutritional status is associated with surgical site infections in meningioma patients undergoing craniotomy for tumor resection.
J Neurooncol. 2025 Jun 16. doi: 10.1007/s11060-025-05123.
PubMed Abstract available

MAO Y, Tang L, Horowitz MA, Myneni S, et al
Automated feature learning and survival prognostication in grade 4 glioma using supervised machine learning models.
J Neurooncol. 2025 Jun 16. doi: 10.1007/s11060-025-05099.
PubMed Abstract available

YARLAGADDA S, Zhang Y, Saxena A, Kutuk T, et al
Assessment of outcomes and machine Learning-based models to predict local failure risk following stereotactic radiosurgery for small brain metastases.
J Neurooncol. 2025 Jun 13. doi: 10.1007/s11060-025-05092.
PubMed Abstract available

TURAN T, Emmez OH, Kaymaz AM, Gonenc A, et al
Clinical utility of GAL-8, ITGBeta-1, and HIF-1alpha as non-invasive diagnostic and prognostic biomarkers for assessing glioma.
J Neurooncol. 2025 Jun 13. doi: 10.1007/s11060-025-05110.
PubMed Abstract available

GIDRON Y, Katan N, Mansour N, Grossman R, et al
The prognostic and protective roles of heart-rate variability in glioblastoma: making GBM less vague.
J Neurooncol. 2025 Jun 12. doi: 10.1007/s11060-025-05010.
PubMed Abstract available

AKUTAGAWA K, Miki S, Yamada E, Sakamoto N, et al
PIK3R2 immunostaining status predicts prognosis in patients with newly diagnosed glioblastoma treated with an autologous tumor vaccine.
J Neurooncol. 2025 Jun 12. doi: 10.1007/s11060-025-05102.
PubMed Abstract available

KREATSOULAS DC, Kim J, Damante M, Orr A, et al
A novel lesion severity index to predict 90-day postoperative survival in brain metastasis patients.
J Neurooncol. 2025 Jun 11. doi: 10.1007/s11060-025-05109.
PubMed Abstract available

METWALLY SM, El-Ayadi M, Maher E, El-Minawi MS, et al
Impact of partial substitution of cisplatin with cyclophosphamide on acute toxicities in standard-risk medulloblastoma.
J Neurooncol. 2025 Jun 10. doi: 10.1007/s11060-025-05098.
PubMed Abstract available

SAVIOLA F, Zigiotto L, Jovicich J, Sarubbo S, et al
Predicting attention deficits and functional recovery after glioma resection through functional executive networks: insights from dynamic properties.
J Neurooncol. 2025 Jun 10. doi: 10.1007/s11060-025-05079.
PubMed Abstract available

LARIBI L, Scheepens JCC, Zamanipoor Najafabadi AH, Vos MJ, et al
Antiseizure medication in patients with meningioma: a retrospective cohort study on the long-term impact on depression, anxiety and neurocognitive functioning.
J Neurooncol. 2025 Jun 6. doi: 10.1007/s11060-025-05025.
PubMed Abstract available

JACQUERIE A, Macamo A, Hoeben A, Eekers DBP, et al
IDO2-AhR axis as central regulator of the kynurenine pathway in glioblastoma.
J Neurooncol. 2025 Jun 5. doi: 10.1007/s11060-025-05106.
PubMed Abstract available

ROBERT SM, Toth A, Lev S, Bowden SG, et al
Antibody drug conjugates in metastatic brain tumors: current landscape, therapeutic potential and challenges.
J Neurooncol. 2025 Jun 5. doi: 10.1007/s11060-025-05083.
PubMed Abstract available

WHITTLE IR
Complete resolution of peritumoral FLAIR hyperintensity is infrequent in surgically treated patients with intracranial meningiomas.
J Neurooncol. 2025 Jun 3. doi: 10.1007/s11060-025-05097.
PubMed

WEI CZ, Shanahan R, Puccio D, Deng H, et al
A comparison of outcomes after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases: an international multi-center study.
J Neurooncol. 2025 Jun 3. doi: 10.1007/s11060-025-05093.
PubMed Abstract available

MARINO S, Menna G, Doglietto F, Quaranta D, et al
A white matter-centered approach to investigate recurrence pathways in high-grade gliomas: a single-center retrospective study.
J Neurooncol. 2025 Jun 3. doi: 10.1007/s11060-025-05050.
PubMed Abstract available

RAYMOND C, Yao J, Kolkovsky ALL, Feiweier T, et al
Super-resolution sodium MRI of human gliomas at 3T using physics-based generative artificial intelligence.
J Neurooncol. 2025 Jun 3. doi: 10.1007/s11060-025-05094.
PubMed Abstract available

TINKA P, Pokorna P, Kyr M, Pavelka Z, et al
Individualized therapeutic approaches for relapsed and refractory pediatric ependymomas: a single institution experience.
J Neurooncol. 2025;173:479-488.
PubMed Abstract available

JIN J, Qin J, Qi X, Zhang J, et al
Serum exosomal miRNA contributes to the diagnosis of leptomeningeal carcinomatosis.
J Neurooncol. 2025;173:419-428.
PubMed Abstract available

NOBEL H, Ofer J, Borenstein SF, Limon D, et al
Long-term impact of bevacizumab for the treatment of brain radiation necrosis.
J Neurooncol. 2025;173:289-296.
PubMed Abstract available

WOO PYM, Pu JKS, Li LF, Wong DKK, et al
Impact of alternating electric fields therapy for newly diagnosed WHO grade 4 astrocytoma on patient survival: a real-world propensity-score adjusted prospective multicenter study.
J Neurooncol. 2025;173:317-330.
PubMed Abstract available

May 2025

NAKHATE V, Ly I, Muzikansky A, Rapalino O, et al
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104.
J Neurooncol. 2025 May 28. doi: 10.1007/s11060-025-05020.
PubMed Abstract available

YADAV N, Xiao A, Zhong Q, Kumar P, et al
Synergistic activity of simvastatin and irinotecan chemotherapy against glioblastoma converges on TGF-beta signaling.
J Neurooncol. 2025 May 28. doi: 10.1007/s11060-025-05089.
PubMed Abstract available

IBANEZ-JULIA MJ, Bataller L, Cabello-Murgui FJ, Nguyen-Them L, et al
Clinical and radiological features of pseudoprogression in brain tumors treated with immune checkpoint inhibitors.
J Neurooncol. 2025 May 27. doi: 10.1007/s11060-025-05091.
PubMed Abstract available

BERTOLINI G, Trombini T, Zenesini C, Mazza S, et al
Prognostic impact of second surgical resection in IDH wildtype recurrent glioblastoma following chemo-radiation therapy: a propensity score analysis cohort study.
J Neurooncol. 2025 May 27. doi: 10.1007/s11060-025-05096.
PubMed Abstract available

SCHRODER C, Haghighi N, Phillips C, Udovicich C, et al
A feasibility trial of delayed resection for brain metastases following pre-operative stereotactic radiosurgery.
J Neurooncol. 2025 May 26. doi: 10.1007/s11060-025-05081.
PubMed Abstract available

SENTURK YE, Canturk EM, Peker A, Yuzkan S, et al
Predictive value of early DCE and DSC perfusion MRI parameters for midterm clinical outcomes in lung cancer brain metastases treated with stereotactic radiosurgery.
J Neurooncol. 2025 May 23. doi: 10.1007/s11060-025-05054.
PubMed Abstract available

HANI L, Nasiri D, Gachter A, Klimov A, et al
Reconsideration of the resection strategy of eloquent brain metastasis in the era of postoperative stereotactic radiotherapy: a comparative analysis with non-eloquent metastasis.
J Neurooncol. 2025 May 23. doi: 10.1007/s11060-025-05075.
PubMed Abstract available

VAN DIJCK JTJM, Ardon H, Balvers RK, Bos EM, et al
Survival prediction in glioblastoma: 10-year follow-up from the Dutch Neurosurgery Quality Registry.
J Neurooncol. 2025 May 23. doi: 10.1007/s11060-025-05080.
PubMed Abstract available

LI Y, Wang Y, Han X, Xu J, et al
Correction to: Glioma-derived SPARCL1 promotes the formation of peritumoral neuron-glioma synapses.
J Neurooncol. 2025 May 22. doi: 10.1007/s11060-025-05069.
PubMed

TANG T, Wu Y, Dong X, Zhai X, et al
Multimodal MRI radiomics enhances epilepsy prediction in pediatric low-grade glioma patients.
J Neurooncol. 2025 May 22. doi: 10.1007/s11060-025-05073.
PubMed Abstract available

ZHOU M, Wu W, Wang Y, Zhang B, et al
Targeting COL5A1 enhances anoikis thus attenuating malignancy of glioblastoma via inhibiting the Wnt/beta-catenin signaling pathway.
J Neurooncol. 2025 May 22. doi: 10.1007/s11060-025-05036.
PubMed Abstract available

WILLIAMS A, Neth B, Webb M, Schwartz J, et al
Diffuse hemispheric glioma, H3 G34-mutant: defining the clinical picture through a single institution case series and literature analysis.
J Neurooncol. 2025 May 22. doi: 10.1007/s11060-025-05028.
PubMed Abstract available

SHU Y, Dong Y, Li B, Wang Y, et al
Knockdown of STK39 inhibits lung cancer brain metastasis by suppressing the CPSF4/NFkappaB/COX2 pathway.
J Neurooncol. 2025 May 21. doi: 10.1007/s11060-025-05072.
PubMed Abstract available

ABIKENARI M, Regev A, Himic V, Choi J, et al
The hormonal nexus in PIK3CA-mutated meningiomas: implications for targeted therapy and clinical trial design.
J Neurooncol. 2025 May 20. doi: 10.1007/s11060-025-05082.
PubMed Abstract available

ALDEEVA IA, Glebova EV, Sarkisyan RA, Romanova EN, et al
Long-term neurocognitive sequelae in pediatric medulloblastoma survivors treated according to the HIT protocol.
J Neurooncol. 2025 May 16. doi: 10.1007/s11060-025-05070.
PubMed Abstract available

BOMMIREDDY A, Mayo ZS, Reddy CA, Billena C, et al
Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases.
J Neurooncol. 2025 May 13. doi: 10.1007/s11060-025-05062.
PubMed Abstract available

IYER HG, Ariwodo OK, Mckevitt C, Meade PS, et al
Predictors of return to work following surgery in patients with glioblastoma: a retrospective multicenter study.
J Neurooncol. 2025 May 13. doi: 10.1007/s11060-025-05066.
PubMed Abstract available

WEIDL D, Capper D, Onken J, Liu I, et al
Epidemiology of WHO grade 2 and grade 3 gliomas from 2009 to 2021 in Germany.
J Neurooncol. 2025 May 13. doi: 10.1007/s11060-025-05068.
PubMed Abstract available

SHUKLA IY, Ebada A, Bever N, Traylor JI, et al
Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival.
J Neurooncol. 2025 May 12. doi: 10.1007/s11060-025-05057.
PubMed Abstract available

BADVE C, Nirappel A, Lo S, Orringer DA, et al
Congress of neurological surgeons systematic review and evidence-based guidelines for the role of imaging in newly diagnosed WHO grade II diffuse glioma in adults: update.
J Neurooncol. 2025 May 8. doi: 10.1007/s11060-025-05043.
PubMed Abstract available

NA MK, Oh Y, Lee D, Park J, et al
Comparison of the biological characteristics of glioblastoma tumorspheres obtained from fresh and cryopreserved glioblastoma tissues.
J Neurooncol. 2025 May 5. doi: 10.1007/s11060-025-05052.
PubMed Abstract available

PICHARDO-ROJAS PS, Garcia-Torrico F, Espinosa-Cantu CB, Rodriguez-Elvir FA, et al
Current trends in reoperation for recurrent glioblastoma: a meta-analysis (2007-2023).
J Neurooncol. 2025 May 2. doi: 10.1007/s11060-025-05058.
PubMed Abstract available

ZHENG GH, Zhang YW, Liu YX, Liu WH, et al
Clinical characteristics and prognostic factors of primary spinal subependymoma: a single-center cohort study and systematic review.
J Neurooncol. 2025;172:675-685.
PubMed Abstract available

ANDEREGGEN L, Christ E
Predictors of favorable long-term outcomes in first-line surgery for microprolactinomas.
J Neurooncol. 2025;172:613-623.
PubMed Abstract available

GU W, Zhang W, Wu Z, Cai Y, et al
Cabergoline-induced NDFIP1 upregulation in pituitary neuroendocrine tumor cells activates mTOR signaling and contributes to cabergoline resistance.
J Neurooncol. 2025;172:587-597.
PubMed Abstract available

FILHO AM, Znaor A, Sunguc C, Zahwe M, et al
Cancers of the brain and central nervous system: global patterns and trends in incidence.
J Neurooncol. 2025;172:567-578.
PubMed Abstract available

MANSOORIAN S, Schmidt M, Weissmann T, Delev D, et al
Reirradiation for recurrent glioblastoma: the significance of the residual tumor volume.
J Neurooncol. 2025 May 1. doi: 10.1007/s11060-025-05042.
PubMed Abstract available

FINK L, von Sass C, Golla H, Voltz R, et al
Epidemiology and palliative care of in-patient cerebral metastases cases in Germany.
J Neurooncol. 2025;173:37-48.
PubMed Abstract available

THERKELSEN KE, Cao T, Roy-O'Reilly M, Stocksdale B, et al
Molecular testing and targeting for solid tumors with CNS metastases.
J Neurooncol. 2025;173:1-10.
PubMed Abstract available

MENNA G, Riva D, Marino S, Garber J, et al
Simulation tools in neuro-oncological surgery: a scoping review of perioperative and training applications.
J Neurooncol. 2025;173:21-35.
PubMed Abstract available

FRAZZINI V, Mathon B, Shor N, Nichelli L, et al
The Mickey Mouse's hand sign in brain MRI points out multinodular and vacuolating neuronal tumors in mesial temporal lobe structures.
J Neurooncol. 2025;173:217-223.
PubMed Abstract available

LIU KX, Salans M, Easwaran TP, Phuong C, et al
The association between postoperative photon radiotherapy dose and disease control and salvage treatment in pediatric and adolescent ependymoma: a multi-institutional investigation.
J Neurooncol. 2025;173:167-177.
PubMed Abstract available

RYU H, Li X, Lee TH, Kim TM, et al
Distribution and failure patterns of primary central nervous system lymphoma related to the hippocampus: implications for hippocampal avoidance irradiation.
J Neurooncol. 2025;173:95-104.
PubMed Abstract available

April 2025

WAGNER-BALLON C, Moreira A, Houessinon A, Boone M, et al
Defining end-of-life in glioblastoma multiforme: a systematic review.
J Neurooncol. 2025 Apr 29. doi: 10.1007/s11060-025-05051.
PubMed Abstract available

LA ROSA A, Mittauer KE, Rzepczynski AE, Chuong MD, et al
Temporospatial tumor dynamic changes in glioblastoma during radiotherapy.
J Neurooncol. 2025 Apr 29. doi: 10.1007/s11060-025-05060.
PubMed Abstract available

MICHEL A, Rauschenbach L, Karadachi H, Gumus M, et al
Surgical treatment of multiple breast cancer brain metastases: clinical characteristics and factors impacting postoperative survival.
J Neurooncol. 2025 Apr 29. doi: 10.1007/s11060-025-05048.
PubMed Abstract available

DIN SU, Sufiyan S, Shah AA, Fatima H, et al
HMGA1 as a prognostic biomarker for gliomas: expression patterns, survival correlations, and clinical insights from a Pakistani cohort.
J Neurooncol. 2025 Apr 28. doi: 10.1007/s11060-025-05031.
PubMed Abstract available

MARWAHA AS, Shepard MJ, Karlovits SM, Herbst J, et al
Advancements in adaptive MR-guided radiotherapy for high-grade gliomas.
J Neurooncol. 2025 Apr 24. doi: 10.1007/s11060-025-05053.
PubMed Abstract available

YI GZ, Lin JF, Lu YX, Li ZY, et al
Clinical, pathological, radiological features and prognosis of epithelioid glioblastoma: a retrospective single center study.
J Neurooncol. 2025 Apr 23. doi: 10.1007/s11060-025-05046.
PubMed Abstract available

AKDEMIR EY, Gurdikyan S, Reyes TC, Odia Y, et al
Integrating a novel tablet-based digital neurocognitive assessment tool in brain metastases patients.
J Neurooncol. 2025 Apr 22. doi: 10.1007/s11060-025-05038.
PubMed Abstract available

LALLY AR, Ghosh SR, Pecorari IL, Reynolds J, et al
Do the benefits of IDH mutations in high-grade glioma persist beyond the first recurrence? A multi-institutional retrospective analysis.
J Neurooncol. 2025 Apr 22. doi: 10.1007/s11060-025-05049.
PubMed Abstract available

PERRON R, Iorio-Morin C, Chytka T, Simonova G, et al
International multicenter study of stereotactic radiosurgery for bladder cancer brain metastases.
J Neurooncol. 2025 Apr 18. doi: 10.1007/s11060-025-05039.
PubMed Abstract available

YUN YC, Jende JME, Garhofer F, Wolf S, et al
Combined peritumoral radiomics and clinical features predict 12-month progression free survival in glioblastoma.
J Neurooncol. 2025 Apr 17. doi: 10.1007/s11060-025-05037.
PubMed Abstract available

DUFFAU H
The capability to successfully study and to be graduated in students who underwent awake surgical resection for a low-grade glioma.
J Neurooncol. 2025 Apr 17. doi: 10.1007/s11060-025-05044.
PubMed Abstract available

LAPIDUS AH, Devitt B, Herbison H, Tran S, et al
A Delphi study of current practices and establishing consensus regarding assessment of fitness to drive among patients with brain tumours.
J Neurooncol. 2025 Apr 16. doi: 10.1007/s11060-025-05030.
PubMed Abstract available

LIU X, Hao S, Sun S, Xie J, et al
Increased cortical iron deposition in glioma patients: a quantitative susceptibility mapping study.
J Neurooncol. 2025 Apr 16. doi: 10.1007/s11060-025-05027.
PubMed Abstract available

RASHID NS, Lamba N, Catalano PJ, Elhalawani H, et al
Impact of brain metastasis size at the time of radiotherapy on local control and radiation necrosis.
J Neurooncol. 2025 Apr 15. doi: 10.1007/s11060-025-05023.
PubMed Abstract available

DIAZ LS, Agrup M, Askild A, Embring A, et al
Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study.
J Neurooncol. 2025 Apr 15. doi: 10.1007/s11060-025-05016.
PubMed Abstract available

ZSCHERNACK V, Pinto G, Friker LL, Klein R, et al
Pitfalls in the evaluation of CDKN2A copy number status in meningioma.
J Neurooncol. 2025 Apr 14. doi: 10.1007/s11060-025-05029.
PubMed Abstract available

LI Y, Wang Y, Han X, Xu J, et al
Glioma-derived SPARCL1 promotes the formation of peritumoral neuron-glioma synapses.
J Neurooncol. 2025 Apr 14. doi: 10.1007/s11060-025-05007.
PubMed Abstract available

SANVITO F, Kryukov I, Yao J, Teraishi A, et al
Advanced imaging characterization of post-chemoradiation glioblastoma stratified by diffusion MRI phenotypes known to predict favorable anti-VEGF response.
J Neurooncol. 2025 Apr 14. doi: 10.1007/s11060-025-05019.
PubMed Abstract available

BAXTER SM, Bjorge T, Bjerkvig R, Cardwell C, et al
Use of psychotropic medications among glioma patients in Denmark, Norway, Sweden, and Wales.
J Neurooncol. 2025 Apr 10. doi: 10.1007/s11060-025-04996.
PubMed Abstract available

SUFIYAN S, Salam H, Ilyas S, Amin W, et al
Prognostic implications of DNA methylation machinery (DNMTs and TETs) expression in gliomas: correlations with tumor grading and patient survival.
J Neurooncol. 2025 Apr 10. doi: 10.1007/s11060-025-05032.
PubMed Abstract available

NOGUCHI M, Koide Y, Shindo Y, Aoyama T, et al
Repeat stereotactic radiosurgery for recurrent brain metastases: a retrospective comparison of local progression and distant brain metastases after prior radiosurgery.
J Neurooncol. 2025 Apr 9. doi: 10.1007/s11060-025-05035.
PubMed Abstract available

PANDEY K, Mishra S, Garg K, Garg A, et al
Patterns of response following gamma knife radiosurgery for tectal plate gliomas.
J Neurooncol. 2025 Apr 9. doi: 10.1007/s11060-025-05034.
PubMed Abstract available

SUN Y, Estevez-Ordonez D, Atchley TJ, Nabors B, et al
The association of neighborhood-level deprivation with glioblastoma outcomes: a single center cohort study.
J Neurooncol. 2025 Apr 7. doi: 10.1007/s11060-025-05002.
PubMed Abstract available

FU AY, Bernstein K, Zhang J, Silverman J, et al
Outcomes of concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for melanoma brain metastases.
J Neurooncol. 2025 Apr 4. doi: 10.1007/s11060-025-05026.
PubMed Abstract available

ZHUANG L, Yin X, Liu X, Liu D, et al
Efficacy and safety of aumolertinib in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis: a single?center retrospective study.
J Neurooncol. 2025;172:461-470.
PubMed Abstract available

ZHAO X, Zhang Y, Wang Y, Ren X, et al
Prognostic and clinical significance of contrast enhancement in WHO grade 2 oligodendrogliomas.
J Neurooncol. 2025;172:481-490.
PubMed Abstract available

BAKES E, Cheng R, Manucat-Tan N, Ramaswamy V, et al
Advances in molecular prognostication and treatments in ependymoma.
J Neurooncol. 2025;172:317-326.
PubMed Abstract available

LAN R, Zhang N, Chen R, Chen J, et al
Identification of RASL11A as a gene conferring radiosensitivity in glioblastoma.
J Neurooncol. 2025 Apr 1. doi: 10.1007/s11060-025-05013.
PubMed Abstract available

March 2025

RIEGEL DC, Bureau BL, Conlon P, Chavez G, et al
Long-term survival, patterns of progression, and patterns of use for patients with newly diagnosed glioblastoma treated with or without Tumor Treating Fields (TTFields) in a real-world setting.
J Neurooncol. 2025 Mar 31. doi: 10.1007/s11060-025-04946.
PubMed Abstract available

TAORI S, Wei Z, Hadjipanayis CG, Niranjan A, et al
Long-term outcomes following upfront single-session gamma knife stereotactic radiosurgery for large volume meningiomas.
J Neurooncol. 2025 Mar 31. doi: 10.1007/s11060-025-05000.
PubMed Abstract available

TOSI U, Schwartz TH
Resection of craniopharyngiomas: comparison between gross total resection and subtotal resection with adjuvant radiation.
J Neurooncol. 2025 Mar 31. doi: 10.1007/s11060-025-05017.
PubMed Abstract available

GUO H, Li X, Tong H, Fang J, et al
Longitudinal analysis of radiologic progression patterns in glioblastoma: investigating prognosis using a multi-state model.
J Neurooncol. 2025 Mar 31. doi: 10.1007/s11060-025-05022.
PubMed Abstract available

HOROWITZ MA, Brown NJ, Gendreau J, Pennington Z, et al
The association of hospital volume status with treatment and survival outcomes of intracranial meningioma patients: a multivariable analysis of the National Cancer Database.
J Neurooncol. 2025 Mar 28. doi: 10.1007/s11060-025-05011.
PubMed Abstract available

SHEN H, Zhou Z, Zhang X, Xu M, et al
Comparative analysis of pyrosequencing and next-generation sequencing for assessing MGMT methylation in glioma patients.
J Neurooncol. 2025 Mar 26. doi: 10.1007/s11060-025-05015.
PubMed Abstract available

GHOSH SR, Lally AR, Pecorari IL, Reynolds J, et al
The impact of sociodemographic background on clinical presentation of high-grade gliomas: a multi-institutional retrospective analysis.
J Neurooncol. 2025 Mar 25. doi: 10.1007/s11060-025-05012.
PubMed Abstract available

MAZA EJL, Pavoni JF, Leoni RF
Early and late structural brain changes after radiation therapy: an MRI study in glioma patients.
J Neurooncol. 2025 Mar 21. doi: 10.1007/s11060-025-05008.
PubMed Abstract available

NEIMANTAITE A, Carstam L, Gomez Vecchio T, Haggstrom I, et al
Survival prediction with radiomics for patients with IDH mutated lower-grade glioma.
J Neurooncol. 2025 Mar 18. doi: 10.1007/s11060-025-05006.
PubMed Abstract available

MULLER HL
Long-term quality of life and hypothalamic dysfunction after craniopharyngioma.
J Neurooncol. 2025 Mar 17. doi: 10.1007/s11060-025-04987.
PubMed Abstract available

DE DOMENICO P, Gagliardi F, Roncelli F, Snider S, et al
Tumor-infiltrating and circulating B cells mediate local and systemic immunomodulatory mechanisms in Glioblastoma.
J Neurooncol. 2025 Mar 13. doi: 10.1007/s11060-025-04989.
PubMed Abstract available

MA ST, Ahn YC, Lim DH, Lee JI, et al
Gamma Knife Radiosurgery for optic nerve sheath meningioma: comparison of efficacy and costs with radiotherapy under Korean health insurance system.
J Neurooncol. 2025 Mar 11. doi: 10.1007/s11060-025-04986.
PubMed Abstract available

CERRETTI G, Bosio A, Librizzi G, Pintacuda G, et al
Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience.
J Neurooncol. 2025 Mar 10. doi: 10.1007/s11060-025-04992.
PubMed Abstract available

HARARY PM, Rajaram S, Hori YS, Park DJ, et al
The spectrum of radiation therapy options for craniopharyngioma: a systematic review.
J Neurooncol. 2025 Mar 10. doi: 10.1007/s11060-025-05001.
PubMed Abstract available

SARIKONDA A, Quraishi D, Mitchell Self D, Sami A, et al
Introducing the operative value index for glioma surgery: an integration of quality-adjusted life years with time-driven activity-based costing.
J Neurooncol. 2025 Mar 10. doi: 10.1007/s11060-025-04997.
PubMed Abstract available

NETH BJ, Kraft RM, Eschbacher KL, Johnson DR, et al
Characterizing the molecular and spatial heterogeneity of midline gliomas in adults: a single institution analysis.
J Neurooncol. 2025 Mar 6. doi: 10.1007/s11060-025-04994.
PubMed Abstract available

LAAJAVA J, Niemela M, Korja M
Peritumoral edema resolves infrequently in surgically treated patients with intracranial meningioma- a retrospective study of 279 meningioma patients.
J Neurooncol. 2025 Mar 6. doi: 10.1007/s11060-025-04964.
PubMed Abstract available

TORRES-TENOR JL, Garcia-Leal A, Hui D, Bruera E, et al
Unscheduled hospitalization as a potential trigger for specialist palliative care referral in patients with high grade glioma: a retrospective analysis in a tertiary hospital.
J Neurooncol. 2025 Mar 6. doi: 10.1007/s11060-025-04993.
PubMed Abstract available

FARAJ CA, McCutcheon IE, Gubbiotti MA, Perni S, et al
Extra-central nervous system metastasis from high-grade glioma: a single-institution experience.
J Neurooncol. 2025 Mar 6. doi: 10.1007/s11060-025-04977.
PubMed Abstract available

FARES J, Wan Y, Gurung B, Nazar T, et al
Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor.
J Neurooncol. 2025 Mar 5. doi: 10.1007/s11060-025-04991.
PubMed Abstract available

JOSHI N, Mueller S, Kline C
Current clinical trials for craniopharyngiomas: what's on the horizon?
J Neurooncol. 2025 Mar 5. doi: 10.1007/s11060-024-04899.
PubMed Abstract available

SHIREMAN JM, Distler E, Schepp C, Tao Y, et al
Impact of pregnancy on the treatment and outcomes of glioma: a cohort study.
J Neurooncol. 2025 Mar 5. doi: 10.1007/s11060-025-04961.
PubMed Abstract available

AGNER KE, Larkins MC
Population-based histologic analysis of craniopharyngioma demographics and treatment in the US from 2000 to 2020.
J Neurooncol. 2025 Mar 5. doi: 10.1007/s11060-025-04988.
PubMed Abstract available

SAINI S, Gadet JAMA, Freeman GJ, Chiocca EA, et al
Improving IL12 immunotherapy in glioblastoma by targeting the long noncoding RNA INCR1.
J Neurooncol. 2025 Mar 4. doi: 10.1007/s11060-025-04978.
PubMed Abstract available

ADIDA S, Sefcik RK, Gerszten PC
Comment on "The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management".
J Neurooncol. 2025 Mar 3. doi: 10.1007/s11060-025-04983.
PubMed

VERMA O, Mishra S, Tripathi M, Sheehan JP, et al
Role of stereotactic radiosurgery for intracranial epidermoid tumors: a systematic review to assess its safety, efficacy, and complication profile.
J Neurooncol. 2025;172:13-30.
PubMed Abstract available

ZHU JW, Shum M, Qazi MA, Sahgal A, et al
Cerebral spinal fluid analyses and therapeutic implications for leptomeningeal metastatic disease.
J Neurooncol. 2025;172:31-40.
PubMed Abstract available

DINAKARAN D, Moore-Palhares D, Yang F, Hill JB, et al
Precision radiotherapy with molecular-profiling of CNS tumours.
J Neurooncol. 2025;172:51-75.
PubMed Abstract available

JALAL AHB, Gunn H, Gunasekara B, Gan HW, et al
Endocrine effects of MEK and BRAF inhibitor therapy in paediatric patients: a tertiary centre experience.
J Neurooncol. 2025;172:257-263.
PubMed Abstract available

OSAKO R, Hayano A, Kawaguchi A, Yamanaka R, et al
Single-cell RNA-seq reveals diverse molecular signatures associated with Methotrexate resistance in primary central nervous system lymphoma cells.
J Neurooncol. 2025;172:163-173.
PubMed Abstract available

ONISHI S, Yamasaki F, Amatya VJ, Yonezawa U, et al
Prognostic value of immunohistochemical staining for H3K27me3 and EZH2 in astrocytoma, IDH-mutant.
J Neurooncol. 2025;172:185-194.
PubMed Abstract available

HASKELL-MENDOZA AP, Gonzalez AT, Reason EH, Flusche AM, et al
The LITT Fit in neuro-oncology: indications, imaging, and adjunctive therapies.
J Neurooncol. 2025;172:1-11.
PubMed Abstract available

February 2025

YU J, Ren L, Wu T, Hua L, et al
Establishment and transcriptomic characteristics of radio-resistant meningioma cell lines.
J Neurooncol. 2025 Feb 28. doi: 10.1007/s11060-025-04966.
PubMed Abstract available

WU Q, Chen S, Xie X, Yan H, et al
Glioblastoma- derived exosomes (GBM-Exo) regulate microglial M2 polarization via the RAC1/AKT/NRF2 pathway.
J Neurooncol. 2025 Feb 28. doi: 10.1007/s11060-024-04934.
PubMed Abstract available

LI Y, Shi J, Liu C, Ma D, et al
Ciprofol reduces postoperative glioma recurrence by promoting MAPK11-PML phosphorylation: insights from transcriptomic and proteomic analysis.
J Neurooncol. 2025 Feb 28. doi: 10.1007/s11060-024-04906.
PubMed Abstract available

REDDY SC, Mao Y, Gendreau J, Ahmed AK, et al
Clinical predictors of overall survival in very elderly meningioma patients: a surveillance, epidemiology, and end results (SEER) database analysis.
J Neurooncol. 2025 Feb 28. doi: 10.1007/s11060-025-04982.
PubMed Abstract available

KOSANAM AR, Ma J, White AJ, Murayi R, et al
Comparison of adjuvant radiation versus observation and salvage radiation after subtotal resection of a WHO grade I skull base meningioma: a propensity score-adjusted analysis.
J Neurooncol. 2025 Feb 25. doi: 10.1007/s11060-025-04980.
PubMed Abstract available

KARSY M, Kshettry VR, Little AS
RAPID, a multicenter collaboration for the study of craniopharyngiomas: challenges, opportunities, and future directions.
J Neurooncol. 2025 Feb 24. doi: 10.1007/s11060-025-04981.
PubMed

ZHU J, Wang T, Liu X, Lu T, et al
Overexpression of LSR suppresses glioma proliferation and invasion via regulating FOXO3a.
J Neurooncol. 2025 Feb 24. doi: 10.1007/s11060-025-04976.
PubMed Abstract available

WACH J, Vychopen M, Guresir E
Prognostic revalidation of RANO categories for extent of resection in glioblastoma: a reconstruction of individual patient data.
J Neurooncol. 2025 Feb 24. doi: 10.1007/s11060-025-04950.
PubMed Abstract available

Correction to: Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study.
J Neurooncol. 2025 Feb 20. doi: 10.1007/s11060-024-04924.
PubMed

DAMANTE M, Cua S, Kreatsoulas D, Giglio P, et al
Papillary craniopharyngioma management in the era of BRAF and MEK inhibition.
J Neurooncol. 2025 Feb 20. doi: 10.1007/s11060-025-04969.
PubMed Abstract available

VAN DER WEIDE HL, Buunk AM, Siebenga FF, Langendijk JA, et al
Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort study.
J Neurooncol. 2025 Feb 20. doi: 10.1007/s11060-025-04973.
PubMed Abstract available

DUBE CJ, Lai M, Zhang Y, Saha S, et al
T-type calcium channels regulate medulloblastoma and can be targeted for therapy.
J Neurooncol. 2025 Feb 17. doi: 10.1007/s11060-025-04967.
PubMed Abstract available

BALAGUER-LLUNA L, Olaciregui NG, Aschero R, Resa-Pares C, et al
Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas.
J Neurooncol. 2025 Feb 17. doi: 10.1007/s11060-025-04954.
PubMed Abstract available

GAL O, Mehta MP, Kotecha R
The role of upfront radiation therapy for brain metastases in the era of CNS-active systemic therapies: a narrative review of clinical trial design and lessons learned.
J Neurooncol. 2025 Feb 17. doi: 10.1007/s11060-025-04970.
PubMed Abstract available

ZHU X, Yuan F, Sun Q, Yang C, et al
N-acetylcysteine remodels the tumor microenvironment of primary and recurrent mouse glioblastoma.
J Neurooncol. 2025 Feb 15. doi: 10.1007/s11060-025-04971.
PubMed Abstract available

LIU J, Guo S, Li Q, Yang L, et al
Correction to: Phosphoglycerate dehydrogenase induces glioma cells proliferation and invasion by stabilizing forkhead box M1.
J Neurooncol. 2025 Feb 14. doi: 10.1007/s11060-025-04960.
PubMed

STEC NE, Barker FG 2nd, Brastianos PK
Targeted treatment for craniopharyngioma.
J Neurooncol. 2025 Feb 14. doi: 10.1007/s11060-025-04942.
PubMed Abstract available

ONG CV, Samlowski W
Timing of brain metastases in relation to outcome during first-line ipilimumab plus nivolumab therapy for metastatic melanoma in a community oncology practice.
J Neurooncol. 2025 Feb 11. doi: 10.1007/s11060-025-04951.
PubMed Abstract available

WASILEWSKI D, Eitner C, Ates R, Murad S, et al
Clinical characteristics and outcomes in leptomeningeal disease with or without brain metastasis: insights from an explorative data analysis of the Charite LMD registry.
J Neurooncol. 2025 Feb 11. doi: 10.1007/s11060-025-04937.
PubMed Abstract available

SAKURADA K, Sato I, Ikeda M, Narita Y, et al
Mental health status and associated factors of caregivers of patients with malignant brain tumors.
J Neurooncol. 2025 Feb 7. doi: 10.1007/s11060-025-04963.
PubMed Abstract available

JESSURUN CAC, Siddi F, Nawabi NLA, Hulsbergen AFC, et al
Hyperprogression of brain metastases following initiation of immune checkpoint inhibitors.
J Neurooncol. 2025 Feb 7. doi: 10.1007/s11060-025-04955.
PubMed Abstract available

VIOZZI I, Hannink G, Ardon H, Balvers RK, et al
Between-hospital variation in biopsy indication for patients with newly diagnosed glioblastoma in the Dutch Quality Registry for Neurosurgery.
J Neurooncol. 2025 Feb 6. doi: 10.1007/s11060-025-04959.
PubMed Abstract available

PHAM J, Cote DJ, Kang K, Briggs RG, et al
Treatment practices and survival outcomes for IDH-wildtype glioblastoma patients according to MGMT promoter methylation status: insights from the U.S. National Cancer Database.
J Neurooncol. 2025 Feb 5. doi: 10.1007/s11060-025-04952.
PubMed Abstract available

STUMMER W, Gerwing M, Bilgin SS, Thomas C, et al
Sonodynamic therapy with a single neoadjuvant, diffuse delivery of low-intensity ultrasound with 5-ALA in treatment naive glioblastoma results in tumor-specific cytotoxic edema and increased apoptosis.
J Neurooncol. 2025 Feb 4. doi: 10.1007/s11060-025-04957.
PubMed Abstract available

SHEEHAN JP
Brain metastases from small cell lung cancer: focal therapies improve outcomes in the contemporary era.
J Neurooncol. 2025 Feb 4. doi: 10.1007/s11060-025-04943.
PubMed

JANI JA, Cowan D, Ouonkap L, Adesina D, et al
Missing the message to brain tumor patients: a 2023 twitter analysis among patients, informal caregivers, and healthcare professionals in glioblastoma multiforme.
J Neurooncol. 2025 Feb 3. doi: 10.1007/s11060-025-04948.
PubMed Abstract available

LESHA E, Roach JT, Miller LE, Nichols CS, et al
Length of stay following elective craniotomy for tumor resection in children and young adults: a retrospective case series.
J Neurooncol. 2025;171:651-658.
PubMed Abstract available

RODRIGUEZ B, Rivera D, Zhang JY, Brown C, et al
Innovations in intraoperative therapies in neurosurgical oncology: a narrative review.
J Neurooncol. 2025;171:549-557.
PubMed Abstract available

January 2025

HUANG JY, Yeh TC, Liu HC, Hou JY, et al
Computerized assessment of neuropsychological functioning in pediatric brain tumor patients.
J Neurooncol. 2025 Jan 31. doi: 10.1007/s11060-025-04945.
PubMed Abstract available

PETERSON RK, Choi JH, King TZ
Demographic, medical, and neighborhood barriers to clinical neuropsychological services in pediatric medulloblastoma patients treated in the United States.
J Neurooncol. 2025 Jan 28. doi: 10.1007/s11060-025-04940.
PubMed Abstract available

ROSENSTOCK T, Picht T, Engelhardt M, Grittner U, et al
Improving postsurgical paresis in brain tumor patients by transcranial magnetic stimulation.
J Neurooncol. 2025 Jan 23. doi: 10.1007/s11060-024-04931.
PubMed Abstract available

UMEDA T, Otani Y, Fujii K, Ishida J, et al
Identification of factors related to functional prognoses in craniopharyngiomas.
J Neurooncol. 2025 Jan 22. doi: 10.1007/s11060-024-04925.
PubMed Abstract available

NAHLS NS, Anttonen A, Nuutinen M, Saarto T, et al
The impact of palliative care contact on the use of hospital resources at the end of life for brain tumor patients; a nationwide register-based cohort study.
J Neurooncol. 2025 Jan 20. doi: 10.1007/s11060-025-04939.
PubMed Abstract available

YAKUBOV R, Kaloti R, Persaud P, McCracken A, et al
It's all downstream from here: RTK/Raf/MEK/ERK pathway resistance mechanisms in glioblastoma.
J Neurooncol. 2025 Jan 16. doi: 10.1007/s11060-024-04930.
PubMed Abstract available

ZHONG S, Zuo J, Fu X, Wu C, et al
Leptomeningeal dissemination in H3 K27M- mutant diffuse midline gliomas: clinical characteristics, risk factors, and prognostic insights.
J Neurooncol. 2025 Jan 15. doi: 10.1007/s11060-024-04933.
PubMed Abstract available

REDJAL N, Ziu M, Choi S, Ng PR, et al
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of surgery in the management of patients with diffuse low grade glioma: update.
J Neurooncol. 2025 Jan 13. doi: 10.1007/s11060-024-04871.
PubMed Abstract available

WACH J, Vychopen M, Basaran AE, Tatagiba M, et al
Overall survival and progression-free survival in pediatric meningiomas: a systematic review and individual patient-level meta-analysis.
J Neurooncol. 2025 Jan 9. doi: 10.1007/s11060-024-04917.
PubMed Abstract available

TINI P, Donnini F, Minniti G
Refining target delineation strategies for multifocal glioblastoma: a step towards personalized radiotherapy.
J Neurooncol. 2025 Jan 7. doi: 10.1007/s11060-024-04926.
PubMed

NARSINH KH, Kumar K, Bankiewicz K, Martin AJ, et al
A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma.
J Neurooncol. 2025 Jan 6. doi: 10.1007/s11060-024-04904.
PubMed Abstract available

WU Y, Chen Z, Shi M, Qiu S, et al
Nimotuzumab and bevacizumab combined with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma multiforme: a retrospective single-arm study.
J Neurooncol. 2025 Jan 6. doi: 10.1007/s11060-024-04932.
PubMed Abstract available

KAZEMI F, Gendreau JL, Parker M, Chakravarti S, et al
Creating a predictive model and online calculator for high-value care outcomes following glioblastoma resection: incorporating neighborhood socioeconomic status index.
J Neurooncol. 2025 Jan 4. doi: 10.1007/s11060-024-04927.
PubMed Abstract available

DAI Q, Wei J, Li Z, Li T, et al
Mifepristone achieves tumor suppression and ferroptosis through PR/p53/HO1/GPX4 axis in meningioma cells.
J Neurooncol. 2025 Jan 3. doi: 10.1007/s11060-024-04918.
PubMed Abstract available

MIAO Y, Wu D, Li Y, Ji Y, et al
Radiation therapy for childhood-onset craniopharyngioma: systematic review and meta-analysis.
J Neurooncol. 2025 Jan 3. doi: 10.1007/s11060-024-04914.
PubMed Abstract available

MANDELBERG N, Hodges TR, Wang TJC, McGranahan T, et al
Congress of Neurological Surgeons systematic review and evidence based guideline on neuropathology for WHO grade II diffuse glioma: update.
J Neurooncol. 2025 Jan 2. doi: 10.1007/s11060-024-04898.
PubMed Abstract available

LIM S, Clarke NH, Maloney SL, Sener UT, et al
Bevacizumab exerts dose-dependent risk for intracranial hemorrhage in patients with malignant gliomas.
J Neurooncol. 2025 Jan 2. doi: 10.1007/s11060-024-04916.
PubMed Abstract available

SHOSHAN Y, Gomori MJ, Moss L, Bari SE, et al
Stereotactic implantation of diffusing alpha-emitters radiation therapy sources in the swine brain: a potential new focal therapy for brain tumors.
J Neurooncol. 2025 Jan 2. doi: 10.1007/s11060-024-04919.
PubMed Abstract available

RANDRIAN V, Portales F, Bouche O, Thezenas S, et al
The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors.
J Neurooncol. 2025 Jan 2. doi: 10.1007/s11060-024-04905.
PubMed Abstract available

MAROUFI SF, Maroufi SP, Fallahi MS, Sheehan JP, et al
Long-term trends of publications in journal of neuro-oncology: a bibliographic study of a core journal in the field of neuro-oncology.
J Neurooncol. 2025;171:329-341.
PubMed Abstract available

KIM I, Yan M, Sourour M, Heaton R, et al
Pituitary neuroendocrine tumors treated with stereotactic radiosurgery.
J Neurooncol. 2025;171:423-430.
PubMed Abstract available

ROMANOVA E, Deviaterikova A, Tolchennikova V, Karelin A, et al
Short-term sensorimotor training incorporating cognitive tasks for pediatric survivors of posterior fossa tumors: a pilot study.
J Neurooncol. 2025;171:393-402.
PubMed Abstract available

KLEIN BR, Levi DJ, Shah AH, Ivan ME, et al
Social media "SoMe" in neuro-oncology: a review of the literature.
J Neurooncol. 2025;171:11-19.
PubMed Abstract available

RINCON-TORROELLA J, Rakovec M, Kalluri AL, Jiang K, et al
Impact of upfront adjuvant chemoradiation on survival in patients with molecularly defined oligodendroglioma: the benefits of PCV over TMZ.
J Neurooncol. 2025;171:35-45.
PubMed Abstract available

PAHWA B, Singh G, Kale SS
The 4S of spinal astrocytoma: specific location, syrinx, spasticity and score on Modified Mccormick Scale (MMS) predict long term outcomes in patients undergoing surgical resection of intramedullary spinal astrocytomas.
J Neurooncol. 2025;171:131-138.
PubMed Abstract available

LIM-FAT MJ, Roberto K, Wen PY
Clinical trial design for novel targeted agents in neuro-oncology.
J Neurooncol. 2025;171:21-33.
PubMed Abstract available

December 2024

BANGASH AH, Poudel P, Alshuqayfi KM, Ahmed M, et al
Treatment-induced ripple effect: a systematic review exploring the abscopal phenomenon in Glioblastoma multiforme.
J Neurooncol. 2024 Dec 19. doi: 10.1007/s11060-024-04912.
PubMed Abstract available

GREWAL EP, Nahed BV, Carter BS, Gerstner ER, et al
Clinical progress in the development of CAR T cells to treat malignant glioma.
J Neurooncol. 2024 Dec 18. doi: 10.1007/s11060-024-04909.
PubMed Abstract available

CHEN H, Tan G, Zhong L, Hu Y, et al
MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy - a comparative study with chemo-radiation induced pseudoprogression and radiation necrosis.
J Neurooncol. 2024 Dec 17. doi: 10.1007/s11060-024-04910.
PubMed Abstract available

BARRAGAN-PEREZ EJ, Alvarez-Amado DE, Dies-Suarez P, Tobon SH, et al
Retraction Note: Compassionate use of Quantum Magnetic Resonance Therapy for treatment of children with Diffuse Brainstem Glioma in Mexico City: a single institutional experience.
J Neurooncol. 2024 Dec 16. doi: 10.1007/s11060-024-04915.
PubMed

OBARA T, Blonski M, Forest-Dodelin M, Rech F, et al
Health-related quality of life in 62 patients with diffuse low-grade glioma during a non-therapeutic and progression-free phase: a cross-sectional study.
J Neurooncol. 2024 Dec 16. doi: 10.1007/s11060-024-04888.
PubMed Abstract available

TAORI S, Habib A, Adida S, Gecici NN, et al
Circulating biomarkers in high-grade gliomas: current insights and future perspectives.
J Neurooncol. 2024 Dec 13. doi: 10.1007/s11060-024-04903.
PubMed Abstract available

MONDIA MWL, Hooks RE, Maragkos GA, Smith VL, et al
Primary diffuse leptomeningeal glioblastoma: a case report and literature review.
J Neurooncol. 2024 Dec 12. doi: 10.1007/s11060-024-04908.
PubMed Abstract available

MARWAHA AS, Liang Y, Shepard MJ, Yu A, et al
Patterns of failure after stereotactic radiosurgery for brain metastases from small cell lung cancer: outcomes in the immunotherapy era.
J Neurooncol. 2024 Dec 7. doi: 10.1007/s11060-024-04895.
PubMed Abstract available

MOTAMED-SANAYE A, Mortezaei A, Afshari AR, Saadatian Z, et al
Angiogenesis inhibitors effects on overall survival and progression-free survival in newly diagnosed primary glioblastoma multiforme: a meta-analysis of twelve randomized clinical trials.
J Neurooncol. 2024 Dec 5. doi: 10.1007/s11060-024-04865.
PubMed Abstract available

WASILEWSKI D, Araceli T, Bischoff P, Fruh A, et al
TTF-1 negativity in synchronous M1b/M1c wildtype lung adenocarcinoma brain metastases predicts worse survival with increased risk of intracranial progression.
J Neurooncol. 2024 Dec 4. doi: 10.1007/s11060-024-04885.
PubMed Abstract available

ZHEN J, Chen L, Wang H, Li D, et al
Intrathecal anti-PD-1 treatment in metastatic melanoma patients with leptomeningeal disease (LMD): real-world data and evidence.
J Neurooncol. 2024;170:665-673.
PubMed Abstract available

YANG W, Chai X, Zhang N, Zhi Z, et al
Predicting cerebellar mutism syndrome in children using lesion map combined with clinical features.
J Neurooncol. 2024;170:591-599.
PubMed Abstract available

BADARY A, Kertam A, El-Ramly TA, Abomera NE, et al
Understanding metastatic involvement of the conus medullaris: a systematic review of clinical presentations, diagnostic approaches, treatment options, and patient outcomes.
J Neurooncol. 2024;170:495-507.
PubMed Abstract available

November 2024

LIU Y, Cai L, Wang H, Yao L, et al
BRD4 promotes immune escape of glioma cells by upregulating PD-L1 expression.
J Neurooncol. 2024 Nov 28. doi: 10.1007/s11060-024-04889.
PubMed Abstract available

SHABO E, Potthoff AL, Zeyen T, Layer JP, et al
Transient and permanent hydrocephalus following resection of brain metastases located in the posterior fossa: incidence, risk factors and the necessity of perioperative external ventricular drainage placement.
J Neurooncol. 2024 Nov 28. doi: 10.1007/s11060-024-04890.
PubMed Abstract available

DEVARAJAN A, Seah C, Zhang JY, Vasan V, et al
A four-hit mechanism is sufficient for meningioma development.
J Neurooncol. 2024 Nov 25. doi: 10.1007/s11060-024-04877.
PubMed Abstract available

BHARDWAJ S, Sanjay, Yadav AK
Higher isoform of hnRNPA1 confer Temozolomide resistance in U87MG & LN229 glioma cells.
J Neurooncol. 2024 Nov 25. doi: 10.1007/s11060-024-04831.
PubMed Abstract available

HERMELO I, Haapala I, Makela M, Jacome Sanz D, et al
Patient-derived glioma organoids real time identification of IDH mutation, 1p/19q-codeletion and CDKN2A/B homozygous deletion with differential ion mobility spectrometry.
J Neurooncol. 2024 Nov 23. doi: 10.1007/s11060-024-04891.
PubMed Abstract available

BADANI A, Ozair A, Khasraw M, Woodworth GF, et al
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions.
J Neurooncol. 2024 Nov 21. doi: 10.1007/s11060-024-04881.
PubMed Abstract available

ZIU M, Halasz LM, Kumthekar PU, McGranahan TM, et al
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update.
J Neurooncol. 2024 Nov 20. doi: 10.1007/s11060-024-04861.
PubMed Abstract available

SUERO MOLINA E, Azemi G, Ozdemir Z, Russo C, et al
Predicting intraoperative 5-ALA-induced tumor fluorescence via MRI and deep learning in gliomas with radiographic lower-grade characteristics.
J Neurooncol. 2024 Nov 19. doi: 10.1007/s11060-024-04875.
PubMed Abstract available

KRENZLIN H, Jankovic D, Dauth A, Lange F, et al
Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis.
J Neurooncol. 2024 Nov 19. doi: 10.1007/s11060-024-04810.
PubMed Abstract available

TANG L, Chakravarti S, Li E, Mao Y, et al
Optimal treatment regimen for very elderly patients with atypical meningioma: an analysis of survival outcomes using the National Cancer Database (NCDB).
J Neurooncol. 2024 Nov 19. doi: 10.1007/s11060-024-04886.
PubMed Abstract available

VAN OPIJNEN MP, Sadigh Y, Dijkstra ME, Young JS, et al
The impact of intraoperative mapping during re-resection in recurrent gliomas: a systematic review.
J Neurooncol. 2024 Nov 18. doi: 10.1007/s11060-024-04874.
PubMed Abstract available

PULCINI S, Beaussire-Trouvay L, Marguet F, Viailly PJ, et al
The clinical impact of EGFR alterations in elderly glioblastoma patients: results from a real-life cohort.
J Neurooncol. 2024 Nov 16. doi: 10.1007/s11060-024-04879.
PubMed Abstract available

WANG B, Bukowski A, Kaidar-Person O, Choi JM, et al
Association between tumor location and toxicity outcomes after stereotactic radiosurgery for brain metastases.
J Neurooncol. 2024 Nov 15. doi: 10.1007/s11060-024-04866.
PubMed Abstract available

HERR S, Kite T, Vyas P, Karlovits S, et al
The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management.
J Neurooncol. 2024 Nov 14. doi: 10.1007/s11060-024-04873.
PubMed Abstract available

TINI P, Cinelli E, Yavorska M, Donnini F, et al
Serum lactate dehydrogenase as a prognostic marker for treatment response in IDH wild-type glioblastoma patients undergoing stupp protocol.
J Neurooncol. 2024 Nov 14. doi: 10.1007/s11060-024-04862.
PubMed Abstract available

PETITT JC, Murayi R, El-Abtah ME, Momin A, et al
Outcomes of adjuvant radiation treatment following subtotal resection of world health organization grade II meningiomas.
J Neurooncol. 2024 Nov 13. doi: 10.1007/s11060-024-04878.
PubMed Abstract available

SABAHI M, Fathi Jouzdani A, Sadeghian Z, Dabbagh Ohadi MA, et al
CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws.
J Neurooncol. 2024 Nov 13. doi: 10.1007/s11060-024-04876.
PubMed Abstract available

MOKOENA X, Mabeta P, Cordier W, Flepisi BT, et al
Glioblastoma cells alter brain endothelial cell homeostasis and tight junction protein expression in vitro.
J Neurooncol. 2024 Nov 13. doi: 10.1007/s11060-024-04870.
PubMed Abstract available

KALLURI AL, Lee JH, Lucas CG, Rincon-Torroella J, et al
Implications of molecular classifications in glioma surgery.
J Neurooncol. 2024 Nov 12. doi: 10.1007/s11060-024-04883.
PubMed Abstract available

EL-HAJJ VG, Ranganathan S, Hoang H, Ghaith AK, et al
The impact of adjuvant radiotherapy on overall survival in spinal low-grade gliomas: a propensity score-matched analysis.
J Neurooncol. 2024 Nov 11. doi: 10.1007/s11060-024-04880.
PubMed Abstract available

IRSHAD HA, Rizvi SBA, Bajwa MH, Khalid MU, et al
Epidemiology of glioblastoma in Pakistan: a secondary analysis of the Pakistan Brain Tumor Epidemiology Study (PBTES).
J Neurooncol. 2024 Nov 11. doi: 10.1007/s11060-024-04872.
PubMed Abstract available

LAWRENCE LSP, Maralani PJ, Das S, Sahgal A, et al
Magnetic resonance imaging techniques for monitoring glioma response to chemoradiotherapy.
J Neurooncol. 2024 Nov 11. doi: 10.1007/s11060-024-04856.
PubMed Abstract available

FAN Z, Gao A, Zhang J, Meng X, et al
Study of prediction model for high-grade meningioma using fractal geometry combined with radiological features.
J Neurooncol. 2024 Nov 4. doi: 10.1007/s11060-024-04867.
PubMed Abstract available

BAIG MIRZA A, Fayez F, Rashed S, Burn L, et al
Ethnicity in neuro-oncology research: How are we doing and how can we do better?
J Neurooncol. 2024;170:223-233.
PubMed Abstract available

ROSE ML, Moen E, Ager B, Bajaj B, et al
Radiotherapy dosing in intracranial ependymoma using the national cancer database.
J Neurooncol. 2024;170:387-395.
PubMed Abstract available

October 2024

CHEN L, Rizk E, Sherief M, Chang M, et al
Molecular characterization of gliosarcoma reveals prognostic biomarkers and clinical parallels with glioblastoma.
J Neurooncol. 2024 Oct 30. doi: 10.1007/s11060-024-04859.
PubMed Abstract available

ZHANG P, Li C, Wang Y, Chi X, et al
Expression features of targets for anti-glioma CAR-T cell immunotherapy.
J Neurooncol. 2024 Oct 28. doi: 10.1007/s11060-024-04855.
PubMed Abstract available

CACCIOTTI C, Tabori U, Hawkins C, Bennett J, et al
Targeting the RAS/MAPK pathway in children with glioma.
J Neurooncol. 2024 Oct 25. doi: 10.1007/s11060-024-04857.
PubMed Abstract available

WON YK, Kim ES, Jo IY, Oh HJ, et al
Comparative analysis of hypofractionated short-course versus standard radiation therapy in elderly patients with glioblastoma: analysis of nationwide database.
J Neurooncol. 2024 Oct 21. doi: 10.1007/s11060-024-04853.
PubMed Abstract available

PHAM DQ, Sheehan DE, Sheehan KA, Katsos K, et al
Quality of life after stereotactic radiosurgery for brain metastasis: an assessment from a prospective national registry.
J Neurooncol. 2024 Oct 21. doi: 10.1007/s11060-024-04854.
PubMed Abstract available

WETZEL EA, Nohman AI, Hsieh AL, Reuss D, et al
A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design.
J Neurooncol. 2024 Oct 21. doi: 10.1007/s11060-024-04852.
PubMed Abstract available

MADHUGIRI VS, Prasad D
Early experience with an artificial intelligence-based module for brain metastasis detection and segmentation.
J Neurooncol. 2024 Oct 18. doi: 10.1007/s11060-024-04851.
PubMed Abstract available

TERRELL D, Camarano J, Whipple S, Guthikonda B, et al
Financial toxicity in patients with glioblastoma.
J Neurooncol. 2024 Oct 16. doi: 10.1007/s11060-024-04835.
PubMed Abstract available

ARMOCIDA D, Bianconi A, Zancana G, Jiang T, et al
DTI fiber-tracking parameters adjacent to gliomas: the role of tract irregularity value in operative planning, resection, and outcome.
J Neurooncol. 2024 Oct 15. doi: 10.1007/s11060-024-04848.
PubMed Abstract available

GARDNER MM, Winter SF, Stahl F, Gerstner ER, et al
Brain volume loss after cranial irradiation: a controlled comparison study between photon vs proton radiotherapy for WHO grade 2-3 gliomas.
J Neurooncol. 2024 Oct 14. doi: 10.1007/s11060-024-04850.
PubMed Abstract available

MORROW K, Sloan A, Olson JJ, Ormond DR, et al
Congress of Neurological Surgeons systematic review and evidence?based guidelines on the management of recurrent diffuse low-grade glioma: update.
J Neurooncol. 2024 Oct 14. doi: 10.1007/s11060-024-04838.
PubMed Abstract available

KAMP MA, Fink L, Forster MT, Weiss Lucas C, et al
In-patient neurosurgical tumor treatments for malignant glioma patients in Germany.
J Neurooncol. 2024 Oct 10. doi: 10.1007/s11060-024-04784.
PubMed Abstract available

GRIESSMAIR M, Schramm S, Ziegenfeuter J, Canisius J, et al
Advanced imaging reveals enhanced malignancy in glioblastomas involving the subventricular zone: evidence of increased infiltrative growth and perfusion.
J Neurooncol. 2024 Oct 10. doi: 10.1007/s11060-024-04849.
PubMed Abstract available

YAMANISHI S, Nagashima H, Tanaka K, Uno T, et al
Association of preoperative seizures with reduced expression of soluble CD163, an M2 macrophage marker, in the cerebrospinal fluid in isocitrate dehydrogenase wild-type glioblastoma.
J Neurooncol. 2024 Oct 8. doi: 10.1007/s11060-024-04837.
PubMed Abstract available

PROVLOTSKAYA I, Minnigulova A, Zyryanov A, Takmakov M, et al
How well can simple clinical features predict long-term language recovery after left-hemisphere glioma surgery?
J Neurooncol. 2024 Oct 6. doi: 10.1007/s11060-024-04836.
PubMed Abstract available

FAN KY, Jerzak KJ, Kumar S, Moravan V, et al
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy.
J Neurooncol. 2024 Oct 4. doi: 10.1007/s11060-024-04834.
PubMed Abstract available

NIEDER C, Aanes SG, Stanisavljevic L, Mannsaker B, et al
Return to work in younger patients with brain metastases who survived for 2 years or more.
J Neurooncol. 2024 Oct 1. doi: 10.1007/s11060-024-04840.
PubMed Abstract available

YOUNG CC, Kan P, Chen SR, Lang FF, et al
Endovascular surgical neuro-oncology: advancing a new subspecialty.
J Neurooncol. 2024;170:31-40.
PubMed Abstract available

GOMES FC, Ferreira MY, Larcipretti ALL, Freitas BCB, et al
Sodium fluorescein and 5-aminolevulinic acid fluorescence- guided biopsy in brain lesions: a systematic review and meta-analysis.
J Neurooncol. 2024;170:11-29.
PubMed Abstract available

ZHAO S, Ni K, Xie J, Cheng C, et al
Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM.
J Neurooncol. 2024;170:101-117.
PubMed Abstract available

KANAMORI M, Mugikura S, Iizuka O, Mori N, et al
Clinical significance of cerebral microbleeds in patients with germinoma who underwent long-term follow-up.
J Neurooncol. 2024;170:173-184.
PubMed Abstract available

ROGAWSKI D, Cao T, Ma Q, Roy-O'Reilly M, et al
Durable responses to trastuzumab deruxtecan in patients with leptomeningeal metastases from breast cancer with variable HER2 expression.
J Neurooncol. 2024;170:209-217.
PubMed Abstract available

September 2024

YAVORSKA M, Tomaciello M, Sciurti A, Cinelli E, et al
Correction to: Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.
J Neurooncol. 2024 Sep 27. doi: 10.1007/s11060-024-04832.
PubMed

OHNO M, Takahashi M, Yanagisawa S, Osawa S, et al
Correction to: Development of a scoring system to predict local recurrence in brain metastases following complete resection and observation.
J Neurooncol. 2024 Sep 25. doi: 10.1007/s11060-024-04822.
PubMed

ZHU K, Li S, Yao H, Hei J, et al
Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastases via the TGF-beta/Smad signal pathway.
J Neurooncol. 2024 Sep 25. doi: 10.1007/s11060-024-04797.
PubMed Abstract available

KATZENDOBLER S, Niedermeyer S, Blobner J, Trumm C, et al
Determinants of long-term survival in patients with IDH-mutant gliomas.
J Neurooncol. 2024 Sep 24. doi: 10.1007/s11060-024-04826.
PubMed Abstract available

LAVIV Y, Regev O, Kanner AA, Fichman S, et al
Stem the blood flow: beneficial impact of bevacizumab on survival of subventricular zone glioblastoma patients.
J Neurooncol. 2024 Sep 24. doi: 10.1007/s11060-024-04828.
PubMed Abstract available

AARONSON DM, Laing B, Singhal I, Boerger TF, et al
Survival implications of postoperative restricted diffusion in high-grade glioma and limitations of intraoperative MRI detection.
J Neurooncol. 2024 Sep 24. doi: 10.1007/s11060-024-04767.
PubMed Abstract available

LANDRY AP, Yefet LS, Wang JZ, Zadeh G, et al
Methylation profiling in the contemporary management of meningioma.
J Neurooncol. 2024 Sep 22. doi: 10.1007/s11060-024-04825.
PubMed Abstract available

GAL O, Mehta MP, Kotecha R
Radiotherapeutic advances in the management of glioblastoma.
J Neurooncol. 2024 Sep 13. doi: 10.1007/s11060-024-04824.
PubMed Abstract available

HAN JS, Wenger T, Demetriou AN, Dallas J, et al
Procedural volume is linearly associated with mortality, major complications, and readmissions in patients undergoing malignant brain tumor resection.
J Neurooncol. 2024 Sep 12. doi: 10.1007/s11060-024-04800.
PubMed Abstract available

YAVORSKA M, Tomiciello M, Antonio S, Cinelli E, et al
Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.
J Neurooncol. 2024 Sep 11. doi: 10.1007/s11060-024-04818.
PubMed Abstract available

NANDOLIYA KR, Congivaram H, Youngblood MW, Chen WC, et al
Clinical and methylomic features of spinal meningiomas.
J Neurooncol. 2024 Sep 10. doi: 10.1007/s11060-024-04736.
PubMed Abstract available

BASARAN AE, Arlt F, Guresir E, Vychopen M, et al
Sexual dysfunction after surgery for primary sporadic cranial meningiomas: prevalence and risk factors.
J Neurooncol. 2024 Sep 10. doi: 10.1007/s11060-024-04817.
PubMed Abstract available

BARONE TA, Robinson DL, Qiu J, Gurova KV, et al
FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair.
J Neurooncol. 2024 Sep 9. doi: 10.1007/s11060-024-04819.
PubMed Abstract available

PALAVANI LB, Mitre LP, Camerotte R, Nogueira BV, et al
Advancements and challenges: immunotherapy therapy in high-grade glioma - a meta-analysis of randomized clinical trials.
J Neurooncol. 2024 Sep 4. doi: 10.1007/s11060-024-04813.
PubMed Abstract available

SCHWARTZ C, Ueberschaer MF, Rautalin I, Grauvogel J, et al
Frailty indices predict mortality, complications and functional improvements in supratentorial meningioma patients over 80 years of age.
J Neurooncol. 2024 Sep 4. doi: 10.1007/s11060-024-04780.
PubMed Abstract available

DONG J, Chen Q, Weng S, Liu L, et al
The effect of depression and anxiety on survival in patients with glioma: a systematic review and meta-analysis.
J Neurooncol. 2024 Sep 3. doi: 10.1007/s11060-024-04799.
PubMed Abstract available

EMINOVIC S, Orth T, Dell'Orco A, Baumgartner L, et al
Clinical and imaging manifestations of intracerebral hemorrhage in brain tumors and metastatic lesions: a comprehensive overview.
J Neurooncol. 2024 Sep 2. doi: 10.1007/s11060-024-04811.
PubMed Abstract available

LANDRY AP, Zuccato JA, Patil V, Voisin MR, et al
Establishing the utility of multi-platform liquid biopsy by integrating the CSF methylome and proteome in CNS tumours.
J Neurooncol. 2024;169:233-239.
PubMed Abstract available

SHEEHAN JP, Lee CC, Fadul CE
Progression versus pseudoprogression: radiological differentiation with contrast clearance analysis on brain MRI.
J Neurooncol. 2024;169:695-696.
PubMed

GHEZZI C, Ellingson BM, Lai A, Liu J, et al
Effect of Jardiance on glucose uptake into astrocytomas.
J Neurooncol. 2024;169:437-444.
PubMed Abstract available

OZONO I, Onishi S, Yonezawa U, Taguchi A, et al
Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant.
J Neurooncol. 2024;169:571-579.
PubMed Abstract available

BAKER CR, Pease M, Sexton DP, Abumoussa A, et al
Artificial intelligence innovations in neurosurgical oncology: a narrative review.
J Neurooncol. 2024;169:489-496.
PubMed Abstract available

AHMETI H, Kiese D, Freitag-Wolf S, Kalab M, et al
IDH1 mutation is associated with improved resection rates, progression-free survival and overall survival in patients with anaplastic astrocytomas.
J Neurooncol. 2024;169:423-435.
PubMed Abstract available

STRACK M, Kuckelhaus J, Diebold M, Wuchter P, et al
Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells.
J Neurooncol. 2024;169:329-340.
PubMed Abstract available

IVREN M, Cherkezov A, Reuss D, Haux D, et al
Intracranial angioleiomyoma: a case series of seven patients and review of the literature.
J Neurooncol. 2024;169:399-408.
PubMed Abstract available

August 2024

TANAKA T, Takei J, Sasaki H
Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.
J Neurooncol. 2024 Aug 31. doi: 10.1007/s11060-024-04806.
PubMed

HO VKY, Anten MM, Garst A, Bos EM, et al
Initial management of newly diagnosed WHO grade 2-3 adult meningioma following surgery: results from the Dutch Brain Tumour Registry (2016-2021).
J Neurooncol. 2024 Aug 29. doi: 10.1007/s11060-024-04730.
PubMed Abstract available

ZHU H, Allwin C, Bassous MG, Pouliopoulos AN, et al
Focused ultrasound-mediated enhancement of blood-brain barrier permeability for brain tumor treatment: a systematic review of clinical trials.
J Neurooncol. 2024 Aug 29. doi: 10.1007/s11060-024-04795.
PubMed Abstract available

UCKERMANN O, Ziegler J, Meinhardt M, Richter S, et al
Raman and autofluorescence spectroscopy for in situ identification of neoplastic tissue during surgical treatment of brain tumors.
J Neurooncol. 2024 Aug 28. doi: 10.1007/s11060-024-04809.
PubMed Abstract available

MATHEW-SCHMITT S, Peindl M, Neundorf P, Dandekar G, et al
Blood-tumor barrier in focus - investigation of glioblastoma-induced effects on the blood-brain barrier.
J Neurooncol. 2024 Aug 28. doi: 10.1007/s11060-024-04760.
PubMed Abstract available

HAINFELLNER A, Borkovec M, Seebrecht L, Neuhauser M, et al
Glioblastoma in the real-world setting: patterns of care and outcome in the Austrian population.
J Neurooncol. 2024 Aug 27. doi: 10.1007/s11060-024-04808.
PubMed Abstract available

PIKIS S, Mantziaris G, Protopapa M, Tos SM, et al
Stereotactic radiosurgery for brain metastases from human epidermal receptor 2 positive breast Cancer: an international, multi-center study.
J Neurooncol. 2024 Aug 27. doi: 10.1007/s11060-024-04775.
PubMed Abstract available

ALCICEK S, Pilatus U, Manzhurtsev A, Weber KJ, et al
Amino acid metabolism in glioma: in vivo MR-spectroscopic detection of alanine as a potential biomarker of poor survival in glioma patients.
J Neurooncol. 2024 Aug 27. doi: 10.1007/s11060-024-04803.
PubMed Abstract available

SHAABAN A, Pham D, Tos SM, Mantziaris G, et al
Biological effective dose as a predictor of local tumor control in stereotactic radiosurgery treated parasellar meningioma patients.
J Neurooncol. 2024 Aug 27. doi: 10.1007/s11060-024-04804.
PubMed Abstract available

CHEN H, Koul D, Zhang Y, Ghobadi SN, et al
Pulsed focused ultrasound alters the proteomic profile of the tumor microenvironment in a syngeneic mouse model of glioblastoma.
J Neurooncol. 2024 Aug 24. doi: 10.1007/s11060-024-04801.
PubMed Abstract available

RIVERA CA, Bhatia S, Morell AA, Daggubati LC, et al
Metabolic signatures derived from whole-brain MR-spectroscopy identify early tumor progression in high-grade gliomas using machine learning.
J Neurooncol. 2024 Aug 24. doi: 10.1007/s11060-024-04812.
PubMed Abstract available

ZHOU WT, Niu JH, Liao C, Ren SK, et al
Visual deterioration outcomes following optic pathway glioma treatment: a 12-year single institution retrospective study.
J Neurooncol. 2024 Aug 21. doi: 10.1007/s11060-024-04802.
PubMed Abstract available

WONG CE, Chang Y, Chen PW, Huang YT, et al
Dendritic cell vaccine for glioblastoma: an updated meta-analysis and trial sequential analysis.
J Neurooncol. 2024 Aug 21. doi: 10.1007/s11060-024-04798.
PubMed Abstract available

PICHARDO-ROJAS PS, Vazquez-Alva D, Alvarez-Castro JA, Flores-Patino B, et al
Comparative effectiveness of frame-based and mask-based Gamma Knife stereotactic radiosurgery in brain metastases: A 509 patient meta-analysis.
J Neurooncol. 2024 Aug 17. doi: 10.1007/s11060-024-04738.
PubMed Abstract available

TSUJI S, Kudo U, Takahashi K, Nakamura S, et al
The role of progranulin in macrophages of a glioblastoma model.
J Neurooncol. 2024 Aug 14. doi: 10.1007/s11060-024-04793.
PubMed Abstract available

ONISHI S, Yamasaki F, Akiyama Y, Kawahara D, et al
Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign.
J Neurooncol. 2024 Aug 12. doi: 10.1007/s11060-024-04794.
PubMed Abstract available

KITE T, Shepard MJ
Comment on "Amino-acid PET as a prognostic tool after post-stupp protocol temozolomide therapy in high-grade glioma patients".
J Neurooncol. 2024 Aug 9. doi: 10.1007/s11060-024-04796.
PubMed

XU H, Cao Y, Ruan J, Wang F, et al
The effects of BMP2 and the mechanisms involved in the invasion and angiogenesis of IDH1 mutant glioma cells.
J Neurooncol. 2024 Aug 8. doi: 10.1007/s11060-024-04789.
PubMed Abstract available

LEE M, Karschnia P, Park YW, Choi K, et al
Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance.
J Neurooncol. 2024 Aug 8. doi: 10.1007/s11060-024-04737.
PubMed Abstract available

WANG B, Qiu B, Deng X
Comment on the paper: Wang B, Liu Y, Zhang J, Yin S, Liu B, Ding S, Qiu B, Deng X. Evaluating contouring accuracy and dosimetry impact of current MRI-guided adaptive radiation therapy for brain metastases: a retrospective study. J Neurooncol 167(1):12
J Neurooncol. 2024 Aug 7. doi: 10.1007/s11060-024-04791.
PubMed

Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study.
J Neurooncol. 2024 Aug 6. doi: 10.1007/s11060-024-04705.
PubMed Abstract available

BELTRAN-BLESS AA, Alshamsan B, Jia J, Lo V, et al
Perception of pneumocystis jirovecii pneumonia (PJP) prophylaxis in glioma patients receiving concurrent temozolomide and radiation- a patient and physician survey.
J Neurooncol. 2024 Aug 6. doi: 10.1007/s11060-024-04764.
PubMed Abstract available

RILINGER RG, Guo L, Sharma A, Volovetz J, et al
Tumor-related epilepsy in high-grade glioma: a large series survival analysis.
J Neurooncol. 2024 Aug 5. doi: 10.1007/s11060-024-04787.
PubMed Abstract available

OHNO M, Takahashi M, Yanagisawa S, Osawa S, et al
Development of a scoring system to predict local recurrence in brain metastases following complete resection and observation.
J Neurooncol. 2024 Aug 5. doi: 10.1007/s11060-024-04790.
PubMed Abstract available

VANHAUWAERT D, Silversmit G, Vanschoenbeek K, Coucke G, et al
Association of hospital volume with survival but not with postoperative mortality in glioblastoma patients in Belgium.
J Neurooncol. 2024 Aug 2. doi: 10.1007/s11060-024-04776.
PubMed Abstract available

MRUGALA MM, Shi W, Iwomoto F, Lukas RV, et al
Global post?marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022.
J Neurooncol. 2024;169:25-38.
PubMed Abstract available

YU C, Xu T, Fang H, Wang X, et al
High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer.
J Neurooncol. 2024;169:203-213.
PubMed Abstract available

ZHANG S, Patel K, Dusenbery K, Alshreef A, et al
Dosimetric evaluation and treatment planning considerations for GammaTile permanent brain implants - a pilot, institutional experience.
J Neurooncol. 2024;169:11-23.
PubMed Abstract available

SCHULZ N, Nichelli L, Schenone L, Ursu R, et al
Primary central nervous system lymphomas in immunocompromised patients require specific response criteria.
J Neurooncol. 2024;169:51-60.
PubMed Abstract available

YANG Y, Wadhwani N, Shimomura A, Zheng S, et al
Long-term outcomes of central neurocytoma - an institutional experience.
J Neurooncol. 2024;169:195-201.
PubMed Abstract available

RAUSCHENBACH L, Kolbe P, Engel A, Ahmadipour Y, et al
Predictors and surgical outcome of hemorrhagic metastatic brain malignancies.
J Neurooncol. 2024;169:165-173.
PubMed Abstract available

YOUSEFI Y, Nejati R, Eslahi A, Alizadeh F, et al
Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O(6)-methylguanine DNA methyltransferase (MGMT).
J Neurooncol. 2024;169:129-135.
PubMed Abstract available

SCHLIEPER-SCHERF S, Hebach N, Hausmann D, Azorin DD, et al
Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models.
J Neurooncol. 2024 Aug 1. doi: 10.1007/s11060-024-04786.
PubMed Abstract available

KAISMAN-ELBAZ T, Blumenfeld P, Wygoda M, Feldman J, et al
Recovery of cranial nerve neuropathies after LINAC-based stereotactic radiosurgery for benign cavernous sinus meningioma.
J Neurooncol. 2024 Aug 1. doi: 10.1007/s11060-024-04783.
PubMed Abstract available

July 2024

NATSUME K, Yoshida A, Sakakima H, Yonezawa H, et al
Age-independent benefits of postoperative rehabilitation during chemoradiotherapy on functional outcomes and survival in patients with glioblastoma.
J Neurooncol. 2024 Jul 30. doi: 10.1007/s11060-024-04785.
PubMed Abstract available

FERREIRA MY, Antonia O M Pereira M, Hemais M, Bocanegra-Becerra JE, et al
Comparative efficacy and safety of sodium fluorescein-guided surgery versus standard white light for resection of brain metastases: a systematic review and meta-analysis.
J Neurooncol. 2024 Jul 30. doi: 10.1007/s11060-024-04768.
PubMed Abstract available

DU H, Sun J, Wang X, Zhao L, et al
FOSL2-mediated transcription of ISG20 induces M2 polarization of macrophages and enhances tumorigenic ability of glioblastoma cells.
J Neurooncol. 2024 Jul 29. doi: 10.1007/s11060-024-04771.
PubMed Abstract available

ASFAW ZK, Young T, Brown C, Germano IM, et al
Charting the success of neuronavigation in brain tumor surgery: from inception to adoption and evolution.
J Neurooncol. 2024 Jul 24. doi: 10.1007/s11060-024-04778.
PubMed Abstract available

PANEK WK, Toedebusch RG, Mclaughlin BE, Dickinson PJ, et al
The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues.
J Neurooncol. 2024 Jul 24. doi: 10.1007/s11060-024-04766.
PubMed Abstract available

BOCCUNI L, Roca-Ventura A, Buloz-Osorio E, Leno-Colorado D, et al
Non-invasive prehabilitation to foster widespread fMRI cortical reorganization before brain tumor surgery: lessons from a case series.
J Neurooncol. 2024 Jul 23. doi: 10.1007/s11060-024-04774.
PubMed Abstract available

SCANLON SE, Shanahan RM, Bin-Alamer O, Bouras A, et al
Sonodynamic therapy for adult-type diffuse gliomas: past, present, and future.
J Neurooncol. 2024 Jul 23. doi: 10.1007/s11060-024-04772.
PubMed Abstract available

FERNANDEZ-GIL BI, Schiapparelli P, Navarro-Garcia de Llano JP, Otamendi-Lopez A, et al
Effects of PreOperative radiotherapy in a preclinical glioblastoma model: a paradigm-shift approach.
J Neurooncol. 2024 Jul 22. doi: 10.1007/s11060-024-04765.
PubMed Abstract available

YAMADA S, Umehara T, Sonehara K, Kijima N, et al
Genome-wide association study on meningioma risk in Japan: a multicenter prospective study.
J Neurooncol. 2024 Jul 13. doi: 10.1007/s11060-024-04727.
PubMed Abstract available

KARABACAK M, Jagtiani P, Carrasquilla A, Jain A, et al
Simplifying synthesis of the expanding glioblastoma literature: a topic modeling approach.
J Neurooncol. 2024 Jul 11. doi: 10.1007/s11060-024-04762.
PubMed Abstract available

PICHARDO-ROJAS PS, Pichardo-Rojas D, Marin-Castaneda LA, Palacios-Cruz M, et al
Prognostic value of surgical resection over biopsy in elderly patients with glioblastoma: a meta-analysis.
J Neurooncol. 2024 Jul 11. doi: 10.1007/s11060-024-04752.
PubMed Abstract available

JEISING S, Nickel AC, Trubel J, Felsberg J, et al
A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases.
J Neurooncol. 2024 Jul 10. doi: 10.1007/s11060-024-04763.
PubMed Abstract available

MAHAJAN A, Goldberg SL, Weiss SA, Tran T, et al
Patterns of brain metastases response to immunotherapy with pembrolizumab.
J Neurooncol. 2024 Jul 4. doi: 10.1007/s11060-024-04754.
PubMed Abstract available

KAHL KH, Krauss PE, Neu M, Maurer CJ, et al
Intraoperative radiotherapy after neurosurgical resection of brain metastases as institutional standard treatment- update of the oncological outcome form a single center cohort after 117 procedures.
J Neurooncol. 2024 Jul 4. doi: 10.1007/s11060-024-04691.
PubMed Abstract available

WAGNER S, Ewald C, Freitag D, Herrmann KH, et al
Radiomics and visual analysis for predicting success of transplantation of heterotopic glioblastoma in mice with MRI.
J Neurooncol. 2024 Jul 3. doi: 10.1007/s11060-024-04725.
PubMed Abstract available

ZHOU J, Sun W, Li H, Song X, et al
Application of 5T glutamate chemical exchange saturation transfer imaging in brain tumors: preliminary results.
J Neurooncol. 2024 Jul 3. doi: 10.1007/s11060-024-04759.
PubMed Abstract available

SHETTY A, Wang S, Khan AB, English CW, et al
Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data.
J Neurooncol. 2024;168:515-524.
PubMed Abstract available

TAN LF, Lim M
Reply to "Elevating the findings by substituting in 'ISarcoPRM'".
J Neurooncol. 2024;168:563-564.
PubMed

DA SILVA EB JR, Ramina R, Novak Filho JL, Jung GS, et al
Pharmaceutical equivalent 5-aminolevulinic acid fluorescence guided resection of central nervous system tumors: feasibility, safeness and cost-benefit considerations.
J Neurooncol. 2024;168:555-562.
PubMed Abstract available

MATSUDA R, Maeoka R, Morimoto T, Nakazawa T, et al
Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator.
J Neurooncol. 2024;168:487-494.
PubMed Abstract available

KNOBLAUCH AL, Blass BI, Steiert C, Neidert N, et al
Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease.
J Neurooncol. 2024;168:537-545.
PubMed Abstract available

COLE KL, Earl ER, Findlay MC, Sherrod BA, et al
Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation era.
J Neurooncol. 2024 Jul 1. doi: 10.1007/s11060-024-04749.
PubMed Abstract available

June 2024

GUIDARA S, Seyve A, Poncet D, Leonce C, et al
Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location.
J Neurooncol. 2024 Jun 27. doi: 10.1007/s11060-024-04733.
PubMed Abstract available

IANNALFI A, Riva G, Lillo S, Ciccone L, et al
Proton therapy for intracranial meningioma: a single-institution retrospective analysis of efficacy, survival and toxicity outcomes.
J Neurooncol. 2024 Jun 25. doi: 10.1007/s11060-024-04751.
PubMed Abstract available

ERSOY TF, Brainman D, Coras R, Berger B, et al
Defining the role of surgery for patients with multiple brain metastases.
J Neurooncol. 2024 Jun 25. doi: 10.1007/s11060-024-04739.
PubMed Abstract available

ROUX A, Elia A, Hudelist B, Benzakoun J, et al
Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification.
J Neurooncol. 2024 Jun 24. doi: 10.1007/s11060-024-04747.
PubMed Abstract available

PARK J, Kim YJ, Lee M, Kim D, et al
Correlation of LLT-1 and NLRC4 inflammasome and its effect on glioblastoma prognosis.
J Neurooncol. 2024 Jun 22. doi: 10.1007/s11060-024-04750.
PubMed Abstract available

ROUX A, Zanello M, Pallud J
Comment on "Clinical course after Carmustine wafer implantation for newly-diagnosed adult-type diffuse gliomas; a controlled propensity matched analysis of a single center cohort".
J Neurooncol. 2024 Jun 21. doi: 10.1007/s11060-024-04756.
PubMed

NIEDERMEYER S, Schmutzer-Sondergeld M, Weller J, Katzendobler S, et al
Neurosurgical resection of multiple brain metastases: outcomes, complications, and survival rates in a retrospective analysis.
J Neurooncol. 2024 Jun 21. doi: 10.1007/s11060-024-04744.
PubMed Abstract available

DECRAENE B, Coppens G, Spans L, Solie L, et al
A novel methylation signature predicts extreme long-term survival in glioblastoma.
J Neurooncol. 2024 Jun 19. doi: 10.1007/s11060-024-04741.
PubMed Abstract available

GELMERS F, Timmerman ME, Siebenga FF, van der Weide HL, et al
Clusters of resilience and vulnerability: executive functioning, coping and mental distress in patients with diffuse low-grade glioma.
J Neurooncol. 2024 Jun 19. doi: 10.1007/s11060-024-04704.
PubMed Abstract available

GOMEZ D, Feng JJ, Cheok S, Shah I, et al
Incidence of brain metastasis according to patient race and primary cancer origin: a systematic review.
J Neurooncol. 2024 Jun 19. doi: 10.1007/s11060-024-04748.
PubMed Abstract available

CAI L, Liu Y, Li Y, Liu B, et al
TRIM37 interacts with EZH2 to epigenetically suppress PTCH1 and regulate stemness in glioma stem cells through sonic hedgehog pathway.
J Neurooncol. 2024 Jun 17. doi: 10.1007/s11060-024-04726.
PubMed Abstract available

ZHU H, Li Y, Ding Y, Liu Y, et al
Multi-pool chemical exchange saturation transfer MRI in glioma grading, molecular subtyping and evaluating tumor proliferation.
J Neurooncol. 2024 Jun 14. doi: 10.1007/s11060-024-04729.
PubMed Abstract available

JOO B, Kim JH, Ahn SG, Park M, et al
De novo versus recurrent metastatic breast cancer affects the extent of brain metastases.
J Neurooncol. 2024 Jun 12. doi: 10.1007/s11060-024-04735.
PubMed Abstract available

DHARNIPRAGADA R, Shah RA, Reynolds M, Dusenbery K, et al
Laser interstitial thermal therapy followed by consolidation stereotactic radiosurgery (LITT-cSRS) in patients with newly diagnosed brain metastasis.
J Neurooncol. 2024 Jun 12. doi: 10.1007/s11060-024-04712.
PubMed Abstract available

DAGHER R, Gad M, da Silva de Santana P, Sadeghi MA, et al
Correction to: Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in differentiating between brain tumor progression versus pseudoprogression and radionecrosis.
J Neurooncol. 2024 Jun 10. doi: 10.1007/s11060-024-04718.
PubMed

ZINSZ A, Ahrari S, Becker J, Mortada A, et al
Amino-acid PET as a prognostic tool after post Stupp protocol temozolomide therapy in high-grade glioma patients.
J Neurooncol. 2024 Jun 6. doi: 10.1007/s11060-024-04722.
PubMed Abstract available

TOYODA M, Shibahara I, Shigeeda R, Fujitani K, et al
Clinical and molecular features of patients with IDH1 wild-type primary glioblastoma presenting unexpected short-term survival after gross total resection.
J Neurooncol. 2024 Jun 5. doi: 10.1007/s11060-024-04687.
PubMed Abstract available

KUTUK T, Zhang Y, Akdemir EY, Yarlagadda S, et al
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis.
J Neurooncol. 2024 Jun 5. doi: 10.1007/s11060-024-04706.
PubMed Abstract available

HOCKING MC, Schultz RT, Yerys BE, Minturn JE, et al
White matter connectivity and social functioning in survivors of pediatric brain tumor.
J Neurooncol. 2024 Jun 5. doi: 10.1007/s11060-024-04724.
PubMed Abstract available

PICART T, Hervey-Jumper S
Central nervous system regulation of diffuse glioma growth and invasion: from single unit physiology to circuit remodeling.
J Neurooncol. 2024 Jun 4. doi: 10.1007/s11060-024-04719.
PubMed Abstract available

BRAY DP, Stubbs NM, Chow J, Jahangiri A, et al
Frailty in patients with IDH-mutant gliomas: experience from a high-volume tumor center.
J Neurooncol. 2024 Jun 4. doi: 10.1007/s11060-024-04685.
PubMed Abstract available

BELLOMO J, Zeitlberger AM, Padevit L, Stumpo V, et al
Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis.
J Neurooncol. 2024 Jun 3. doi: 10.1007/s11060-024-04728.
PubMed Abstract available

CAPATINA C, Hanzu FA, Hinojosa-Amaya JM, Fleseriu M, et al
Medical treatment of functional pituitary adenomas, trials and tribulations.
J Neurooncol. 2024;168:197-213.
PubMed Abstract available

LAWSON MCLEAN AC, Lawson McLean A, Ernst T, Forster MT, et al
Benchmarking palliative care practices in neurooncology: a german perspective.
J Neurooncol. 2024;168:333-343.
PubMed Abstract available

BIELAMOWICZ KJ, Littrell MB, Albert GW, Parker LS, et al
Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse.
J Neurooncol. 2024;168:367-373.
PubMed Abstract available

YAMAMURA T, Tamura K, Kobayashi D, Inaji M, et al
Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of (11)C-methionine in IDH-mutant astrocytoma.
J Neurooncol. 2024;168:355-365.
PubMed Abstract available

DUAN L, He Y, Guo W, Du Y, et al
Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma.
J Neurooncol. 2024;168:283-298.
PubMed Abstract available

May 2024

HO CH, Shieh LT, Lin CH, Guo HR, et al
The role of adjuvant radiotherapy for intracranial malignant meningiomas: analysis of a nationwide database.
J Neurooncol. 2024 May 30. doi: 10.1007/s11060-024-04720.
PubMed Abstract available

LI C, Long L, Wang Y, Chi X, et al
Constitutive type-1 interferons signaling activity in malignant gliomas.
J Neurooncol. 2024 May 24. doi: 10.1007/s11060-024-04601.
PubMed Abstract available

LUCKETT PH, Olufawo MO, Park KY, Lamichhane B, et al
Predicting post-surgical functional status in high-grade glioma with resting state fMRI and machine learning.
J Neurooncol. 2024 May 24. doi: 10.1007/s11060-024-04715.
PubMed Abstract available

ONO T, Suzuki H, Nanjo H, Shimizu H, et al
Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort.
J Neurooncol. 2024 May 23. doi: 10.1007/s11060-024-04679.
PubMed Abstract available

SIMON M, Kuschel LP, von Hoff K, Yuan D, et al
Rapid DNA methylation-based classification of pediatric brain tumors from ultrasonic aspirate specimens.
J Neurooncol. 2024 May 21. doi: 10.1007/s11060-024-04702.
PubMed Abstract available

BLAKSTAD H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, et al
The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients.
J Neurooncol. 2024 May 19. doi: 10.1007/s11060-024-04709.
PubMed Abstract available

HUDELIST B, Elia A, Roux A, Paun L, et al
Impact of frailty on survival glioblastoma, IDH-wildtype patients.
J Neurooncol. 2024 May 19. doi: 10.1007/s11060-024-04699.
PubMed Abstract available

DORON O, Wong T, Ablyazova F, Singha S, et al
Correction to: Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma.
J Neurooncol. 2024 May 17. doi: 10.1007/s11060-024-04701.
PubMed

RONSLEY R, Karvonen KA, Cole B, Paulson V, et al
Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors.
J Neurooncol. 2024 May 16. doi: 10.1007/s11060-024-04645.
PubMed Abstract available

PECIU-FLORIANU I, Vannod-Michel Q, Vauleon E, Bonneterre ME, et al
Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240).
J Neurooncol. 2024 May 16. doi: 10.1007/s11060-024-04693.
PubMed Abstract available

GOULENKO V, Madhugiri VS, Bregy A, Recker M, et al
Histopathological correlation of brain tumor recurrence vs. radiation effect post-radiosurgery as detected by MRI contrast clearance analysis: a validation study.
J Neurooncol. 2024 May 15. doi: 10.1007/s11060-024-04697.
PubMed Abstract available

RALEIGH DR, Chen WC, Gondi V, Rogers L, et al
Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice.
J Neurooncol. 2024 May 14. doi: 10.1007/s11060-024-04700.
PubMed

POLETES C, Amanirad B, Santiago AT, Yan M, et al
The incidence of brain metastases in breast cancer according to molecular subtype and stage: a 10-year single institution analysis.
J Neurooncol. 2024 May 13. doi: 10.1007/s11060-024-04707.
PubMed Abstract available

COVELL MM, Roy JM, Gupta N, Raihane AS, et al
Frailty in intracranial meningioma resection: the risk analysis index demonstrates strong discrimination for predicting non-home discharge and in-hospital mortality.
J Neurooncol. 2024 May 7. doi: 10.1007/s11060-024-04703.
PubMed Abstract available

OTTENHAUSEN M, Renovanz M, Bartz I, Poplawski A, et al
Use of complementary therapies and supportive measures of patients with intracranial gliomas-a prospective evaluation in an outpatient clinic.
J Neurooncol. 2024 May 6. doi: 10.1007/s11060-024-04696.
PubMed Abstract available

SHIN I, Sim Y, Choi SH, Park YW, et al
Revisiting prognostic factors of gliomatosis cerebri in adult-type diffuse gliomas.
J Neurooncol. 2024 May 3. doi: 10.1007/s11060-024-04656.
PubMed Abstract available

BAQRI W, Rzadki K, Habbous S, Das S, et al
Treatment, healthcare utilization and outcomes in patients with glioblastoma in Ontario: a 10-year cohort study.
J Neurooncol. 2024 May 3. doi: 10.1007/s11060-024-04690.
PubMed Abstract available

GECICI NN, Gurses ME, Kaye B, Jimenez NLF, et al
Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis.
J Neurooncol. 2024;168:1-11.
PubMed Abstract available

FEHRENBACH MK, Wilhelmy F, Wende T, Guresir E, et al
Perioperative psychological distress in patients with intracranial tumors; a single center study.
J Neurooncol. 2024;168:151-157.
PubMed Abstract available

ABDULSALAM AJ, Kara M, Ozcakar L
Elevating the findings by substituting in "ISarcoPRM".
J Neurooncol. 2024;168:185-186.
PubMed

RODRIGUES AJ, Chernikova SB, Wang Y, Trinh TTH, et al
Repurposing mebendazole against triple-negative breast cancer CNS metastasis.
J Neurooncol. 2024;168:125-138.
PubMed Abstract available

WANG M, Chen M, Ge Y
Comment on "Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control''.
J Neurooncol. 2024;167:525.
PubMed

KASATKIN VN, Romanova EN, Glebova EV, Deviaterikova AA, et al
Effects of cognitive-motor intervention for pediatric posterior fossa tumor survivors: results of a pilot study.
J Neurooncol. 2024;168:57-67.
PubMed Abstract available

LALANCETTE E, Cantin E, Routhier ME, Mailloux C, et al
Impact of trametinib on the neuropsychological profile of NF1 patients.
J Neurooncol. 2024;167:447-454.
PubMed Abstract available

BARBOUR AB, Blouw B, Taylor LP, Graber JJ, et al
Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors.
J Neurooncol. 2024;167:509-514.
PubMed Abstract available

TONG T, Chen H, Mo C, Zhong L, et al
Clinical characteristics and predictive factors of delayed diagnosis in patients with sellar germ cell tumors.
J Neurooncol. 2024;167:467-476.
PubMed Abstract available

DAVISON MA, Lilly DT, Patel AA, Kashkoush A, et al
Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomas.
J Neurooncol. 2024;167:437-446.
PubMed Abstract available

NAKAGAWA K, Takano K, Nishino K, Ohe S, et al
Prognostic impact of clinical and radiological factors on leptomeningeal metastasis from solid cancers.
J Neurooncol. 2024;167:397-406.
PubMed Abstract available

April 2024

LI G, Tian Q, Wang S, Li K, et al
Superficial meningioma with bone involvement: surgical strategies and clinical outcomes.
J Neurooncol. 2024 Apr 30. doi: 10.1007/s11060-024-04604.
PubMed Abstract available

BASREE MM, Li C, Um H, Bui AH, et al
Leveraging radiomics and machine learning to differentiate radiation necrosis from recurrence in patients with brain metastases.
J Neurooncol. 2024 Apr 30. doi: 10.1007/s11060-024-04669.
PubMed Abstract available

DORON O, Wong T, Ablyazova F, Singha S, et al
Results from a first-in-human phase i safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma.
J Neurooncol. 2024 Apr 26. doi: 10.1007/s11060-024-04647.
PubMed Abstract available

WANG S, Zhang D, Wang J, Peng X, et al
PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor.
J Neurooncol. 2024 Apr 25. doi: 10.1007/s11060-024-04655.
PubMed Abstract available

PARKER M, Kazemi F, Ahmed AK, Kuo CC, et al
Exploring the impact of primary care utilization and health information exchange upon treatment patterns and clinical outcomes of glioblastoma patients.
J Neurooncol. 2024 Apr 25. doi: 10.1007/s11060-024-04677.
PubMed Abstract available

JOST J, Volker K, Brandt R, Stummer W, et al
Correction to: Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status.
J Neurooncol. 2024 Apr 24. doi: 10.1007/s11060-024-04686.
PubMed

MAIURI F, Corvino S, Corazzelli G, Del Basso De Caro M, et al
Single versus multiple reoperations for recurrent intracranial meningiomas.
J Neurooncol. 2024 Apr 24. doi: 10.1007/s11060-024-04673.
PubMed Abstract available

OKAMOTO T, Mizuta R, Takahashi Y, Otani Y, et al
Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data.
J Neurooncol. 2024 Apr 23. doi: 10.1007/s11060-024-04628.
PubMed Abstract available

SUN T, Liu B, Cai L, Zhou Y, et al
Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy.
J Neurooncol. 2024 Apr 23. doi: 10.1007/s11060-024-04689.
PubMed Abstract available

KOIDE Y, Nagai N, Adachi S, Ito M, et al
Impact of concurrent antibody-drug conjugates and radiotherapy on symptomatic radiation necrosis in breast cancer patients with brain metastases: a multicenter retrospective study.
J Neurooncol. 2024 Apr 22. doi: 10.1007/s11060-024-04681.
PubMed Abstract available

CZARNOTA GJ
Comment in reply to Chen et al. Journal of Neuro-Oncology (2023) 165:535-545 "Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study".
J Neurooncol. 2024 Apr 19. doi: 10.1007/s11060-024-04675.
PubMed

CONRAD K, Lober-Handwerker R, Hazaymeh M, Rohde V, et al
Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model.
J Neurooncol. 2024 Apr 19. doi: 10.1007/s11060-024-04683.
PubMed Abstract available

DESAI J, Rajkumar S, Shepard MJ, Herbst J, et al
National trends in the treatment of adult diffuse midline gliomas: a rare clinical scenario.
J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04663.
PubMed Abstract available

SALAME AAM, Charchar HLS, de Oliveira Dourado JP, Mendonca B, et al
Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5- a case series.
J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04680.
PubMed Abstract available

MASHIACH E, Alzate JD, De Nigris Vasconcellos F, Adams S, et al
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches.
J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04651.
PubMed Abstract available

GATELY L, Mesia C, Sepulveda JM, Del Barco S, et al
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).
J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04668.
PubMed Abstract available

KOCHER D, Cao L, Guiho R, Langhammer M, et al
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines.
J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04672.
PubMed Abstract available

WILSON L, Atallah A, Romero JM
Preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed and resectable glioblastoma.
J Neurooncol. 2024 Apr 15. doi: 10.1007/s11060-024-04666.
PubMed

SHEEHAN JP, Trifiletti DM, Lehrer EJ
Tissue biopsy before resection in glioblastoma: is there an opportunity to improve outcomes with liquid biopsies and pre-operative stereotactic radiosurgery?
J Neurooncol. 2024 Apr 11. doi: 10.1007/s11060-024-04678.
PubMed

CHEN KT, Huang CY, Pai PC, Yang WC, et al
Correction to: Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study.
J Neurooncol. 2024 Apr 10. doi: 10.1007/s11060-024-04671.
PubMed

KONDO N, Kinouchi T, Natsumeda M, Matsuzaki J, et al
Profile of miRNAs in small extracellular vesicles released from glioblastoma cells treated by boron neutron capture therapy.
J Neurooncol. 2024 Apr 10. doi: 10.1007/s11060-024-04649.
PubMed Abstract available

MIRZAYEVA L, Ucar M, Kaymaz AM, Temel E, et al
Intraoperative magnetic resonance imaging in glioma surgery: a single-center experience.
J Neurooncol. 2024 Apr 3. doi: 10.1007/s11060-024-04660.
PubMed Abstract available

MAHMOODIFAR S, Pangal DJ, Neman J, Zada G, et al
Comparative analysis of the spatial distribution of brain metastases across several primary cancers using machine learning and deep learning models.
J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04630.
PubMed Abstract available

DMUKAUSKAS M, Cioffi G, Waite KA, Sloan AE, et al
Sex differences in adverse events in Medicare individuals >/= 66 years of age post glioblastoma treatment.
J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04652.
PubMed Abstract available

LU VM, Brun JD, Niazi TN, Brun JD, et al
Pediatric neurosurgical medulloblastoma outcomes in La Paz, Bolivia: How a Lower Middle-Income Country (LMIC) institution in South America compares to the United States.
J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04664.
PubMed Abstract available

XIANG Y, Chen Y, Xu Z, Zhou S, et al
Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China.
J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04662.
PubMed Abstract available

JOST J, Volker K, Brandt R, Stummer W, et al
Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status.
J Neurooncol. 2024 Apr 1. doi: 10.1007/s11060-024-04629.
PubMed Abstract available

ROGERS JL, Wall T, Acquaye-Mallory AA, Boris L, et al
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.
J Neurooncol. 2024;167:349-359.
PubMed Abstract available

March 2024

TONG E, Horsley P, Wheeler H, Wong M, et al
Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse.
J Neurooncol. 2024 Mar 29. doi: 10.1007/s11060-024-04643.
PubMed Abstract available

FLORES-PACO P, Vargas-Aliaga A, Guevara MG, Lopera I, et al
A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project.
J Neurooncol. 2024 Mar 27. doi: 10.1007/s11060-024-04618.
PubMed Abstract available

WATANABE G, Young K, Rauber E, Khan MF, et al
A systematic review of extraneural meningioma metastasis: timing, evolution and outlook.
J Neurooncol. 2024 Mar 26. doi: 10.1007/s11060-024-04659.
PubMed Abstract available

STRAUBE C, Combs SE, Bernhardt D, Gempt J, et al
Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers.
J Neurooncol. 2024 Mar 23. doi: 10.1007/s11060-024-04633.
PubMed Abstract available

ANDREWS CE, Zilberberg J, Perez-Olle R, Exley MA, et al
Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy.
J Neurooncol. 2024 Mar 22. doi: 10.1007/s11060-024-04635.
PubMed

ZAKI PG, Herr S, Shepard MJ
Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis.
J Neurooncol. 2024 Mar 22. doi: 10.1007/s11060-024-04602.
PubMed

FINK L, van Oorschot B, von Sass C, Dibue M, et al
Palliative care for in-patient malignant glioma patients in Germany.
J Neurooncol. 2024 Mar 20. doi: 10.1007/s11060-024-04611.
PubMed Abstract available

GEENS W, Vanlaer N, Nijland L, Van Laere S, et al
Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition.
J Neurooncol. 2024 Mar 19. doi: 10.1007/s11060-024-04646.
PubMed Abstract available

BOBHOLZ SA, Hoefs A, Hamburger J, Lowman AK, et al
Correction to: Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response.
J Neurooncol. 2024 Mar 18. doi: 10.1007/s11060-024-04641.
PubMed

ZHU P, Pichardo-Rojas PS, Dono A, Tandon N, et al
The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database.
J Neurooncol. 2024 Mar 16. doi: 10.1007/s11060-024-04644.
PubMed Abstract available

CHAKRAVARTI S, Kuo CC, Kazemi F, Kang A, et al
Correction to: Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients.
J Neurooncol. 2024 Mar 15. doi: 10.1007/s11060-024-04640.
PubMed

JIANG J, Li WB, Xiao SW
Correction to: Prognostic factors analysis of diffuse midline glioma.
J Neurooncol. 2024 Mar 15. doi: 10.1007/s11060-024-04634.
PubMed

PALAVANI LB, Silva GM, Borges PGLB, Ferreira MY, et al
Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis.
J Neurooncol. 2024 Mar 8. doi: 10.1007/s11060-024-04621.
PubMed Abstract available

DI NUNNO V, Lombardi G, Simonelli M, Minniti G, et al
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study.
J Neurooncol. 2024 Mar 8. doi: 10.1007/s11060-024-04589.
PubMed Abstract available

GRAILLON T, Salgues B, Horowitz T, Padovani L, et al
Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysis.
J Neurooncol. 2024 Mar 7. doi: 10.1007/s11060-024-04622.
PubMed Abstract available

SINGH E, Gurses ME, Costello MC, Berke C, et al
Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
J Neurooncol. 2024 Mar 6. doi: 10.1007/s11060-024-04619.
PubMed

YOKOGAMI K, Watanabe T, Yamashita S, Mizuguchi A, et al
Inhibition of BMP signaling pathway induced senescence and calcification in anaplastic meningioma.
J Neurooncol. 2024 Mar 6. doi: 10.1007/s11060-024-04625.
PubMed Abstract available

CHAKRAVARTI S, Kuo CC, Kazemi F, Kang A, et al
Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients.
J Neurooncol. 2024 Mar 4. doi: 10.1007/s11060-024-04627.
PubMed Abstract available

LIM MJR, Zhang Z, Zheng Y, Khoo IWL, et al
Effect of sarcopenia and frailty on outcomes among patients with brain metastases.
J Neurooncol. 2024 Mar 2. doi: 10.1007/s11060-023-04542.
PubMed Abstract available

CHEN Y, Ning J, Shu L, Wen L, et al
CPLX2 is a novel tumor suppressor and improves the prognosis in glioma.
J Neurooncol. 2024 Mar 1. doi: 10.1007/s11060-023-04548.
PubMed Abstract available

KEGOYA Y, Otani Y, Inoue Y, Mizuta R, et al
Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review.
J Neurooncol. 2024 Mar 1. doi: 10.1007/s11060-024-04587.
PubMed Abstract available

SHEEHAN JP, Singh R, Trifiletti DM
Stereotactic radiosurgery for intracranial adenoid cystic carcinoma.
J Neurooncol. 2024;167:229-230.
PubMed

WILSON JS, Main C, Thorp N, Taylor RE, et al
The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review.
J Neurooncol. 2024;167:1-34.
PubMed Abstract available

RANADE M, Epari S, Shetty O, Dhanavade S, et al
CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization.
J Neurooncol. 2024;167:189-198.
PubMed Abstract available

February 2024

YU M, Ge Y, Wang Z, Zhang Y, et al
The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study.
J Neurooncol. 2024 Feb 29. doi: 10.1007/s11060-024-04609.
PubMed Abstract available

CEPEDA S, Garcia-Garcia S, Arrese I, Sarabia R, et al
Non-navigated 2D intraoperative ultrasound: An unsophisticated surgical tool to achieve high standards of care in glioma surgery.
J Neurooncol. 2024 Feb 28. doi: 10.1007/s11060-024-04614.
PubMed Abstract available

JALLOH M, Kankam SB
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence.
J Neurooncol. 2024 Feb 23. doi: 10.1007/s11060-024-04606.
PubMed

YILMAZ MT, Kahvecioglu A, Yazici G, Mohammadipour S, et al
Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years' experience of a single center.
J Neurooncol. 2024 Feb 22. doi: 10.1007/s11060-024-04607.
PubMed Abstract available

JIANG J, Li WB, Xiao SW
Prognostic factors analysis of diffuse midline glioma.
J Neurooncol. 2024 Feb 21. doi: 10.1007/s11060-024-04605.
PubMed Abstract available

EHRET F, Zuhlke O, Schweizer L, Kahn J, et al
Validation of a methylation-based signature for subventricular zone involvement in glioblastoma.
J Neurooncol. 2024 Feb 20. doi: 10.1007/s11060-024-04570.
PubMed Abstract available

DASGUPTA P, Ou A, Lin H, Gregory T, et al
The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab.
J Neurooncol. 2024 Feb 19. doi: 10.1007/s11060-023-04551.
PubMed Abstract available

BACCILI CURY MEGID T, Baskurt Z, Ma LX, Barron CC, et al
Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes.
J Neurooncol. 2024 Feb 19. doi: 10.1007/s11060-024-04576.
PubMed Abstract available

BOBHOLZ SA, Hoefs A, Hamburger J, Lowman AK, et al
Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response.
J Neurooncol. 2024 Feb 19. doi: 10.1007/s11060-024-04593.
PubMed Abstract available

UMEKAWA M, Shinya Y, Hasegawa H, Morshed RA, et al
Ki-67 labeling index predicts tumor progression patterns and survival in patients with atypical meningiomas following stereotactic radiosurgery.
J Neurooncol. 2024 Feb 18. doi: 10.1007/s11060-023-04537.
PubMed Abstract available

ARNOLD LM, Hoshina Y, Lee H, Colman H, et al
Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors.
J Neurooncol. 2024 Feb 16. doi: 10.1007/s11060-024-04588.
PubMed Abstract available

SHEEHAN JP, Mantziaris G, Bunevicius A
Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma.
J Neurooncol. 2024 Feb 16. doi: 10.1007/s11060-024-04592.
PubMed

SHIRAI Y, Ueno T, Kojima S, Ikeuchi H, et al
The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.
J Neurooncol. 2024 Feb 16. doi: 10.1007/s11060-024-04563.
PubMed Abstract available

WASILEWSKI D, Onken J, Horicke P, Bukatz J, et al
Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection.
J Neurooncol. 2024 Feb 15. doi: 10.1007/s11060-024-04590.
PubMed Abstract available

DONO A, Torres J, Nunez L, Arevalo O, et al
Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype.
J Neurooncol. 2024 Feb 13. doi: 10.1007/s11060-024-04575.
PubMed Abstract available

KOAY JM, Michaelides L, Moniz-Garcia DP, Quinones-Hinojosa A, et al
Repeated surgical resections for management of high-grade glioma and its impact on quality of life.
J Neurooncol. 2024 Feb 13. doi: 10.1007/s11060-024-04600.
PubMed Abstract available

ANGELOVA P, Gicheva M
Comment: Additional factors affecting cognitive function in low grade glioma patients.
J Neurooncol. 2024 Feb 13. doi: 10.1007/s11060-024-04598.
PubMed

WATANABE G, Wong JM, Estes B, Khan MF, et al
Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review.
J Neurooncol. 2024 Feb 12. doi: 10.1007/s11060-024-04584.
PubMed Abstract available

FAIRCHILD A, Salama JK, Godfrey D, Wiggins WF, et al
Incidence and imaging characteristics of difficult to detect retrospectively identified brain metastases in patients receiving repeat courses of stereotactic radiosurgery.
J Neurooncol. 2024 Feb 10. doi: 10.1007/s11060-024-04594.
PubMed Abstract available

MIRIAN C, Jensen LR, Juratli TA, Maier AD, et al
The importance of considering competing risks in recurrence analysis of intracranial meningioma.
J Neurooncol. 2024 Feb 10. doi: 10.1007/s11060-024-04572.
PubMed Abstract available

ALHALABI OT, Dao Trong P, Kaes M, Jakobs M, et al
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk-benefit analysis.
J Neurooncol. 2024 Feb 9. doi: 10.1007/s11060-024-04595.
PubMed Abstract available

KERIC N, Krenzlin H, Kalasauskas D, Freyschlag CF, et al
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.
J Neurooncol. 2024 Feb 7. doi: 10.1007/s11060-024-04585.
PubMed Abstract available

AVERBUCH I, Tschernichovsky R, Yust-Katz S, Rotem O, et al
Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment.
J Neurooncol. 2024 Feb 7. doi: 10.1007/s11060-024-04562.
PubMed Abstract available

TRAN S, Lapidus A, Neal A, Peters KB, et al
A systematic review of the impact of brain tumours on risk of motor vehicle crashes.
J Neurooncol. 2024 Feb 6. doi: 10.1007/s11060-024-04586.
PubMed Abstract available

SALANS M, Ni L, Morin O, Ziemer B, et al
Adverse radiation effect versus tumor progression following stereotactic radiosurgery for brain metastases: Implications of radiologic uncertainty.
J Neurooncol. 2024 Feb 5. doi: 10.1007/s11060-024-04578.
PubMed Abstract available

TANG JD, Mills MN, Nakashima J, Dohm AE, et al
Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.
J Neurooncol. 2024 Feb 3. doi: 10.1007/s11060-023-04543.
PubMed Abstract available

ZIMMERMANN MLM, Breedt LC, Centeno EGZ, Reijneveld JC, et al
The relationship between pathological brain activity and functional network connectivity in glioma patients.
J Neurooncol. 2024 Feb 3. doi: 10.1007/s11060-024-04577.
PubMed Abstract available

HAMMER Y, Najjar W, Kahanov L, Joskowicz L, et al
Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline.
J Neurooncol. 2024 Feb 1. doi: 10.1007/s11060-024-04580.
PubMed Abstract available

WANG B, Liu Y, Zhang J, Yin S, et al
Evaluating contouring accuracy and dosimetry impact of current MRI-guided adaptive radiation therapy for brain metastases: a retrospective study.
J Neurooncol. 2024 Feb 1. doi: 10.1007/s11060-024-04583.
PubMed Abstract available

KHOWAL S, Zhang D, Yong WH, Heaney AP, et al
Whole-exome sequencing reveals genetic variants that may play a role in neurocytomas.
J Neurooncol. 2024;166:471-483.
PubMed Abstract available

January 2024

SINGH E, Gurses ME, Costello MC, Lu VM, et al
Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
J Neurooncol. 2024 Jan 31. doi: 10.1007/s11060-024-04582.
PubMed Abstract available

TANAKA T, Tamura R, Takei J, Morimoto Y, et al
An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.
J Neurooncol. 2024 Jan 31. doi: 10.1007/s11060-023-04544.
PubMed Abstract available

GATELY L, Mesia C, Sepulveda JM, Del Barco S, et al
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
J Neurooncol. 2024 Jan 30. doi: 10.1007/s11060-024-04581.
PubMed

DASGUPTA P, Rousseau JF
Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma.
J Neurooncol. 2024 Jan 29. doi: 10.1007/s11060-024-04574.
PubMed Abstract available

PETRONEK MS, Bodeker KL, Lee CY, Teferi N, et al
Iron-based biomarkers for personalizing pharmacological ascorbate therapy in glioblastoma: insights from a phase 2 clinical trial.
J Neurooncol. 2024 Jan 29. doi: 10.1007/s11060-024-04571.
PubMed Abstract available

VAN OPIJNEN MP, Broekman MLD, Cuppen E, Dubbink HJ, et al
Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands: interlaboratory variation in the primary diagnostic and recurrent setting.
J Neurooncol. 2024 Jan 29. doi: 10.1007/s11060-024-04568.
PubMed Abstract available

YEKULA A, Gessler DJ, Ferreira C, Shah R, et al
GammaTile((R)) (GT) as a brachytherapy platform for rapidly proliferating glioblastomas: from case series to clinical trials.
J Neurooncol. 2024 Jan 28. doi: 10.1007/s11060-023-04545.
PubMed Abstract available

GONZALEZ-APONTE MF, Damato AR, Trebucq LL, Simon T, et al
Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma.
J Neurooncol. 2024 Jan 26. doi: 10.1007/s11060-023-04535.
PubMed Abstract available

KREATSOULAS D, Damante M, Cua S, Lonser RR, et al
Adjuvant convection-enhanced delivery for the treatment of brain tumors.
J Neurooncol. 2024 Jan 23. doi: 10.1007/s11060-023-04552.
PubMed Abstract available

MULLER SJ, Khadhraoui E, Ganslandt O, Henkes H, et al
MRI Treatment Response Assessment Maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis.
J Neurooncol. 2024 Jan 23. doi: 10.1007/s11060-024-04573.
PubMed Abstract available

GARCIA MA, Turner A, Brachman DG
The role of GammaTile in the treatment of brain tumors: a technical and clinical overview.
J Neurooncol. 2024 Jan 23. doi: 10.1007/s11060-023-04523.
PubMed Abstract available

REESE JC, Fadel HA, Pawloski JA, Samir M, et al
Laser interstitial thermal therapy for deep-seated perivascular brain tumors is not associated with distal ischemia.
J Neurooncol. 2024 Jan 19. doi: 10.1007/s11060-023-04546.
PubMed Abstract available

RYNDA AY, Rostovthev DM, Zabrodskaya YM, Olyushin VE, et al
Immunotherapy with autologous dendritic cells in the complex treatment of malignant gliomas - results.
J Neurooncol. 2024 Jan 16. doi: 10.1007/s11060-023-04559.
PubMed Abstract available

ON J, Natsumeda M, Takahashi H, Koyama A, et al
Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
J Neurooncol. 2024 Jan 16. doi: 10.1007/s11060-023-04555.
PubMed Abstract available

ZAPANTA RINONOS S, Li T, Pianka ST, Prins TJ, et al
dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma.
J Neurooncol. 2024 Jan 15. doi: 10.1007/s11060-023-04531.
PubMed Abstract available

KUAH XYC, Lucas-Herald AK, McCarrison S, Boyle R, et al
Presentation and outcomes of paediatric craniopharyngioma in the west of Scotland: a 25 year experience.
J Neurooncol. 2024 Jan 15. doi: 10.1007/s11060-023-04490.
PubMed Abstract available

DOGAN E, Yildirim Z, Akalin T, Ozgiray E, et al
Investigating the effects of PTEN mutations on cGAS-STING pathway in glioblastoma tumours.
J Neurooncol. 2024 Jan 12. doi: 10.1007/s11060-023-04556.
PubMed Abstract available

DAGHER R, Gad M, da Silva de Santana P, Sadeghi MA, et al
Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in Differentiating between brain tumor progression versus pseudoprogression and radionecrosis.
J Neurooncol. 2024 Jan 11. doi: 10.1007/s11060-023-04528.
PubMed Abstract available

MIYAKOSHI A, Ubukata N, Miyake H, Shoji-Asahina A, et al
Risk factors for glioblastoma in adults in Japan: an exploratory cohort study based on the Shizuoka Kokuho Database, the Shizuoka study.
J Neurooncol. 2024 Jan 11. doi: 10.1007/s11060-024-04566.
PubMed Abstract available

BERGER A, Mullen R, Bernstein K, Mashiach E, et al
Volumetric growth rate of incidentally found meningiomas on immunotherapy.
J Neurooncol. 2024 Jan 9. doi: 10.1007/s11060-023-04558.
PubMed Abstract available

HUDSON K, Mondia MW, Zhang Y, Saha S, et al
The role of microRNAs in brain metastasis.
J Neurooncol. 2024 Jan 9. doi: 10.1007/s11060-023-04541.
PubMed Abstract available

ZHANG Q, Dai Z, Chen Y, Li Q, et al
Endosome associated trafficking regulator 1 promotes tumor growth and invasion of glioblastoma multiforme via inhibiting TNF signaling pathway.
J Neurooncol. 2024 Jan 8. doi: 10.1007/s11060-023-04527.
PubMed Abstract available

ZEUNER S, Vollmer J, Sigaud R, Oppermann S, et al
Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells.
J Neurooncol. 2024 Jan 7. doi: 10.1007/s11060-023-04526.
PubMed Abstract available

YADAV N, Purow BW
Understanding current experimental models of glioblastoma-brain microenvironment interactions.
J Neurooncol. 2024 Jan 5. doi: 10.1007/s11060-023-04536.
PubMed Abstract available

ZHANG JF, Okai B, Iovoli A, Goulenko V, et al
Bevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma.
J Neurooncol. 2024 Jan 4. doi: 10.1007/s11060-023-04524.
PubMed Abstract available

KAMBE A, Kitao S, Ochiai R, Hosoya T, et al
The utility of arterial spin labeling imaging for predicting prognosis after a recurrence of high-grade glioma in patients under bevacizumab treatment.
J Neurooncol. 2024 Jan 2. doi: 10.1007/s11060-023-04550.
PubMed Abstract available

HESHAM D, On J, Alshahaby N, Amer N, et al
Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations.
J Neurooncol. 2024;166:27-38.
PubMed Abstract available

FADUL CE, Thakur A, Kim J, Kassay-McAllister J, et al
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide.
J Neurooncol. 2024;166:321-330.
PubMed Abstract available

OBRECHT-STURM D, Pfaff E, Mynarek M, Bison B, et al
Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment.
J Neurooncol. 2024;166:359-368.
PubMed Abstract available

EBADI M, Morse M, Gooley T, Ermoian R, et al
Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control.
J Neurooncol. 2024;166:351-357.
PubMed Abstract available

SHEEHAN JP, Michalopoulos GD, Katsos K, Bydon M, et al
The NeuroPoint alliance SRS & tumor QOD registries.
J Neurooncol. 2024;166:257-264.
PubMed Abstract available

FENG J, Zhang J, Chen L, Li C, et al
Treatment outcomes and risk factors of patients with intracranial germ cell tumour with choriocarcinoma element or beta-HCG level higher than 500 IU/L.
J Neurooncol. 2024;166:331-339.
PubMed Abstract available

HONG S, Garces YI, Price KA, Shinya Y, et al
Treatment outcomes of single-fraction stereotactic radiosurgery for adenoid cystic carcinoma: a case series of 55 patients.
J Neurooncol. 2024;166:369-376.
PubMed Abstract available

December 2023

NORIKANE T, Mitamura K, Yamamoto Y, Manabe Y, et al
Comparative evaluation of (11)C-methionine and (18)F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma.
J Neurooncol. 2023 Dec 31. doi: 10.1007/s11060-023-04534.
PubMed Abstract available

GATELY L, Mesia C, Sepulveda JM, Del Barco S, et al
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
J Neurooncol. 2023 Dec 28. doi: 10.1007/s11060-023-04513.
PubMed Abstract available

ARORA H, Mammi M, Patel NM, Zyfi D, et al
Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis.
J Neurooncol. 2023 Dec 27. doi: 10.1007/s11060-023-04549.
PubMed Abstract available

YANG ZC, Yin CD, Yeh FC, Xue BW, et al
Exploring MGMT methylation-driven structural connectivity changes in insular gliomas: a tractography and graph theoretical analysis.
J Neurooncol. 2023 Dec 27. doi: 10.1007/s11060-023-04539.
PubMed Abstract available

BENNEBROEK CA, Schouten CR, Montauban-van Swijndregt MC, Saeed P, et al
Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components.
J Neurooncol. 2023 Dec 27. doi: 10.1007/s11060-023-04516.
PubMed Abstract available

REN L, Chen J, Deng J, Qing X, et al
The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study.
J Neurooncol. 2023 Dec 26. doi: 10.1007/s11060-023-04511.
PubMed Abstract available

CHOU CJ, Yang HC, Chang PY, Chen CJ, et al
Automated identification and quantification of metastatic brain tumors and perilesional edema based on a deep learning neural network.
J Neurooncol. 2023 Dec 22. doi: 10.1007/s11060-023-04540.
PubMed Abstract available

MIJAJLOVIC V, Miler M, Ilic R, Rasic D, et al
Oncogene-induced senescence in meningiomas-an immunohistochemical study.
J Neurooncol. 2023 Dec 20. doi: 10.1007/s11060-023-04532.
PubMed Abstract available

KINSLOW CJ, Siegelin MD, Iwamoto FM, Gallitto M, et al
MGMT promoter methylation in 1p19q-intact gliomas.
J Neurooncol. 2023 Dec 20. doi: 10.1007/s11060-023-04515.
PubMed Abstract available

LU VM, Khalafallah AM, Jaman E, Gurses ME, et al
Clinical course of ventriculoperitoneal shunting for hydrocephalus following glioblastoma surgery: a systematic review and meta-analysis.
J Neurooncol. 2023 Dec 19. doi: 10.1007/s11060-023-04538.
PubMed Abstract available

ABETE-FORNARA G, Bintintan Socaciu P, Fanizzi C, Fiore G, et al
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study.
J Neurooncol. 2023 Dec 18. doi: 10.1007/s11060-023-04533.
PubMed Abstract available

CHEN Q, Wang K, Ren X, Zhao X, et al
Individualized discrimination of tumor progression from treatment-related changes in different types of adult-type diffuse gliomas using [(11)C]methionine PET.
J Neurooncol. 2023 Dec 14. doi: 10.1007/s11060-023-04529.
PubMed Abstract available

CHANG CT, Chen HH, Chuang CC, Chang SH, et al
Ganciclovir as a potential treatment for glioma: a systematic review and meta-analysis.
J Neurooncol. 2023 Dec 8. doi: 10.1007/s11060-023-04503.
PubMed Abstract available

CHEN KT, Huang CY, Pai PC, Yang WC, et al
Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study.
J Neurooncol. 2023 Dec 7. doi: 10.1007/s11060-023-04517.
PubMed Abstract available

MIAO Q, Zheng X, Li L, Zheng X, et al
Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer.
J Neurooncol. 2023;165:517-525.
PubMed Abstract available

WILLEMS YCP, Vaassen F, Zegers CML, Postma AA, et al
Anatomical changes in resection cavity during brain radiotherapy.
J Neurooncol. 2023;165:479-486.
PubMed Abstract available

RAMMELOO E, Schouten JW, Krikour K, Bos EM, et al
Preoperative assessment of eloquence in neurosurgery: a systematic review.
J Neurooncol. 2023;165:413-430.
PubMed Abstract available

SHEN CI, Chiang CL, Huang HC, Tseng YH, et al
Management strategies for intracranial progression in ALK-positive non-small cell lung cancer: a real-world cohort study.
J Neurooncol. 2023;165:459-465.
PubMed Abstract available

WIJAYA JH, Patel UD, Quintero-Consuegra MD, Aguilera-Pena MP, et al
Liquid biopsy in the setting of leptomeningeal metastases: a systematic review and meta-analysis.
J Neurooncol. 2023;165:431-438.
PubMed Abstract available

LYNES J, Khan I, Aguilera C, Rubino S, et al
Development of a "Geo-Tagged" tumor sample registry: intra-operative linkage of sample location to imaging.
J Neurooncol. 2023;165:449-458.
PubMed Abstract available

SELT F, El Damaty A, Schuhmann MU, Sigaud R, et al
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.
J Neurooncol. 2023;165:467-478.
PubMed Abstract available

November 2023

SHEEHAN J, Mantziaris G, Dumont C, Pikis S, et al
Incidental meningiomas: a current and increasingly common challenge.
J Neurooncol. 2023 Nov 30. doi: 10.1007/s11060-023-04525.
PubMed

BAUMGARTEN P, Prange G, Kamp MA, Monden D, et al
Treatment of very elderly glioblastoma patients >/= 75 years of age: whom to treat.
J Neurooncol. 2023 Nov 30. doi: 10.1007/s11060-023-04518.
PubMed Abstract available

ANDREWS CE, Zilberberg J, Perez-Olle R, Exley MA, et al
Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy.
J Neurooncol. 2023 Nov 29. doi: 10.1007/s11060-023-04491.
PubMed Abstract available

KLEINBERG L, Ye X, Supko J, Stevens GHJ, et al
A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM).
J Neurooncol. 2023 Nov 28. doi: 10.1007/s11060-023-04514.
PubMed Abstract available

YAVUZ BB, Kilinc F, Kanyilmaz G, Aktan M, et al
Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients.
J Neurooncol. 2023 Nov 27. doi: 10.1007/s11060-023-04521.
PubMed Abstract available

CHIANG CL, Yang HC, Liao YT, Luo YH, et al
Treatment and survival of patients with small cell lung cancer and brain metastasis.
J Neurooncol. 2023 Nov 20. doi: 10.1007/s11060-023-04512.
PubMed Abstract available

QIU X, Gao J, Hu J, Yang J, et al
Particle beam radiotherapy in the treatment of WHO grade 2 and 3 meningiomas: an early experience from Shanghai Proton and Heavy Ion Center.
J Neurooncol. 2023 Nov 17. doi: 10.1007/s11060-023-04401.
PubMed Abstract available

QIN N, Paisana E, Picard D, Leprivier G, et al
The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.
J Neurooncol. 2023 Nov 17. doi: 10.1007/s11060-023-04508.
PubMed Abstract available

VOGLIS S, Padevit L, van Niftrik CHB, Kalin V, et al
Safety of microneurosurgical interventions for superficial and deep-seated brain metastases: single-center cohort study of 637 consecutive cases.
J Neurooncol. 2023 Nov 10. doi: 10.1007/s11060-023-04478.
PubMed Abstract available

KHAN AB, Dang HQ, Gopakumar S, Lazaro T, et al
Clinical outcomes of stereotactic biopsy on children with pontine diffuse midline glioma.
J Neurooncol. 2023 Nov 9. doi: 10.1007/s11060-023-04475.
PubMed Abstract available

KIM N, Lee J, Nam DH, Lee JI, et al
Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.
J Neurooncol. 2023 Nov 8. doi: 10.1007/s11060-023-04498.
PubMed

NASLUND O, Strand PS, Solheim O, Al Masri M, et al
Incidence, management, and outcome of incidental meningioma: what has happened in 10 years?
J Neurooncol. 2023 Nov 8. doi: 10.1007/s11060-023-04482.
PubMed Abstract available

YAMAMOTO S, Okita Y, Arita H, Sanada T, et al
Qualitative MR features to identify non-enhancing tumors within glioblastoma's T2-FLAIR hyperintense lesions.
J Neurooncol. 2023 Nov 2. doi: 10.1007/s11060-023-04454.
PubMed Abstract available

LIN HT, Lin CM, Wu YY, Chang WH, et al
Predictors for delayed awakening in adult glioma patients receiving awake craniotomy under monitored anesthesia care.
J Neurooncol. 2023 Nov 2. doi: 10.1007/s11060-023-04494.
PubMed Abstract available

CHEN YH, Moore D, Lee CC, Su YH, et al
Focused ultrasound for brain metastases: an update on global clinical trials.
J Neurooncol. 2023 Nov 1. doi: 10.1007/s11060-023-04492.
PubMed Abstract available

HONG Y, Miao Q, Zheng X, Xu Y, et al
Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis.
J Neurooncol. 2023;165:301-312.
PubMed Abstract available

PRICE M, Neff C, Kruchko C, Barnholtz-Sloan JS, et al
Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT.
J Neurooncol. 2023;165:279-290.
PubMed Abstract available

KO MK, Kwak YK, Choi BO, Jeun SS, et al
Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?
J Neurooncol. 2023;165:321-328.
PubMed Abstract available

ZAMARUD A, Marianayagam NJ, Park DJ, Yener U, et al
The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience.
J Neurooncol. 2023;165:373-379.
PubMed Abstract available

October 2023

KRASSNIG S, Leber SL, Orthmann A, Golob-Schwarzl N, et al
Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
J Neurooncol. 2023 Oct 31. doi: 10.1007/s11060-023-04451.
PubMed Abstract available

LEHRER EJ, Khosla AA, Ozair A, Gurewitz J, et al
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients.
J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04413.
PubMed Abstract available

MOHAMMAD AH, Jatana S, Ruiz-Barerra MA, Khalaf R, et al
Metformin use is associated with longer survival in glioblastoma patients with MGMT gene silencing.
J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04485.
PubMed Abstract available

MA S, Lee H, Jo WY, Byun YH, et al
The Warburg effect in patients with brain tumors: a comprehensive analysis of clinical significance.
J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04486.
PubMed Abstract available

CROMPTON D, Koffler D, Fekrmandi F, Lehrer EJ, et al
Preoperative stereotactic radiosurgery as neoadjuvant therapy for resectable brain tumors.
J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04466.
PubMed Abstract available

GROB ST, Miller KR, Sanford B, Donson AM, et al
Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors.
J Neurooncol. 2023 Oct 25. doi: 10.1007/s11060-023-04472.
PubMed Abstract available

ELLIS EM, Drumm MR, Rai SM, Huang J, et al
Long-term antiseizure medication use in patients after meningioma resection: identifying predictors for successful weaning and failures.
J Neurooncol. 2023 Oct 24. doi: 10.1007/s11060-023-04481.
PubMed Abstract available

STROWD R, Ellingson B, Raymond C, Yao J, et al
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma.
J Neurooncol. 2023 Oct 21. doi: 10.1007/s11060-023-04456.
PubMed Abstract available

KIM N, Lee J, Nam DH, Lee JI, et al
Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.
J Neurooncol. 2023 Oct 20. doi: 10.1007/s11060-023-04465.
PubMed Abstract available

YU Y, Chen H, Tian Z, Zhang Q, et al
Improved survival outcome with not-delayed radiotherapy and immediate PD-1/PD-L1 inhibitor for non-small-cell lung cancer patients with brain metastases.
J Neurooncol. 2023 Oct 17. doi: 10.1007/s11060-023-04459.
PubMed Abstract available

NAKAJIMA R, Kinoshita M, Okita H, Nakada M, et al
Glioblastomas at the white matter of temporo-parietal junction cause a poor postoperative independence level.
J Neurooncol. 2023 Oct 17. doi: 10.1007/s11060-023-04479.
PubMed Abstract available

HOU C, Shi S, Gao M, Ji J, et al
Targeting TNFAIP2 induces immunogenic cell death and sensitizes glioblastoma multiforme to anti-PD-1 therapy.
J Neurooncol. 2023 Oct 11. doi: 10.1007/s11060-023-04449.
PubMed Abstract available

DEJONCKHEERE CS, Layer JP, Hamed M, Layer K, et al
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes.
J Neurooncol. 2023 Oct 9. doi: 10.1007/s11060-023-04464.
PubMed Abstract available

BORST GR, Post R
Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis.
J Neurooncol. 2023 Oct 9. doi: 10.1007/s11060-023-04457.
PubMed

PANDYA SHESH B, Walter V, Palsa K, Slagle-Webb B, et al
Sexually dimorphic effect of H-ferritin genetic manipulation on survival and tumor microenvironment in a mouse model of glioblastoma.
J Neurooncol. 2023 Oct 9. doi: 10.1007/s11060-023-04415.
PubMed Abstract available

ERNSTER AE, Body A, Deleyrolle P, St Clair J, et al
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors.
J Neurooncol. 2023 Oct 7. doi: 10.1007/s11060-023-04469.
PubMed Abstract available

KOTCH C, Si SJ, Desai K, Caminada P, et al
The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis.
J Neurooncol. 2023 Oct 7. doi: 10.1007/s11060-023-04468.
PubMed Abstract available

DADEY DYA, Medress ZA, Sharma M, Ugiliweneza B, et al
Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.
J Neurooncol. 2023 Oct 4. doi: 10.1007/s11060-023-04460.
PubMed Abstract available

COVELL MM, Warrier A, Rumalla KC, Dehney CM, et al
RAI-measured frailty predicts non-home discharge following metastatic brain tumor resection: national inpatient sample analysis of 20,185 patients.
J Neurooncol. 2023 Oct 3. doi: 10.1007/s11060-023-04461.
PubMed Abstract available

WELLER J, Zeyen T, Schafer N, Schaub C, et al
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial.
J Neurooncol. 2023 Oct 3. doi: 10.1007/s11060-023-04470.
PubMed Abstract available

VOLLMER J, Ecker J, Hielscher T, Valinciute G, et al
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells.
J Neurooncol. 2023 Oct 3. doi: 10.1007/s11060-023-04445.
PubMed Abstract available

QUE T, Huang G, Tan JE, Zhang P, et al
Supramaximal resection based on en-bloc technique reduces tumor burden and prolongs survival in primary supratentorial lobar glioblastoma.
J Neurooncol. 2023 Oct 2. doi: 10.1007/s11060-023-04399.
PubMed Abstract available

STOCKDILL ML, Mendoza T, Armstrong TS, Miaskowski C, et al
Identification of health-related quality of life profiles among long-term survivors of primary central nervous system tumors.
J Neurooncol. 2023;165:181-190.
PubMed Abstract available

BAI K, Chen X, Qi X, Zhang Y, et al
Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases.
J Neurooncol. 2023;165:149-160.
PubMed Abstract available

ONISHI S, Yamasaki F, Amatya VJ, Takayasu T, et al
Residual diffusion-weighted imaging hyperintense signal in primary central nervous system lymphoma can predict early recurrence.
J Neurooncol. 2023;165:171-179.
PubMed Abstract available

GUTIERREZ-VALENCIA E, Sanchez I, Valles A, Diaz O, et al
Pachymeningeal disease: a systematic review and metanalysis.
J Neurooncol. 2023;165:29-39.
PubMed Abstract available

September 2023

VAN T HEK R, Ortiz-Herrera JL, Salazar-Pigeon A, Ramirez-Loera C, et al
Age and sex disparities in Latin-American adults with gliomas: a systematic review and meta-analysis.
J Neurooncol. 2023 Sep 29. doi: 10.1007/s11060-023-04448.
PubMed Abstract available

KARABACAK M, Jagtiani P, Carrasquilla A, Shrivastava RK, et al
Advancing personalized prognosis in atypical and anaplastic meningiomas through interpretable machine learning models.
J Neurooncol. 2023 Sep 28. doi: 10.1007/s11060-023-04463.
PubMed Abstract available

VAN DER MEER PB, Dirven L, Fiocco M, Vos MJ, et al
Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study.
J Neurooncol. 2023 Sep 27. doi: 10.1007/s11060-023-04450.
PubMed Abstract available

LI L, Shao MY, Zou SC, Xiao ZF, et al
Correction to: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44.
J Neurooncol. 2023 Sep 22. doi: 10.1007/s11060-023-04429.
PubMed

MARWAH R, Xing D, Squire T, Soon YY, et al
Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity.
J Neurooncol. 2023 Sep 21. doi: 10.1007/s11060-023-04441.
PubMed Abstract available

SHEEHAN JP, Trifiletti DM
Comments: neurosurgery and radiation oncology advances have improved visual outcomes for skull base meningioma patients.
J Neurooncol. 2023 Sep 18. doi: 10.1007/s11060-023-04400.
PubMed

KUAN AS, Chiang CL, Wu HM, Yang HC, et al
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses.
J Neurooncol. 2023 Sep 18. doi: 10.1007/s11060-023-04452.
PubMed Abstract available

FURUTA T, Negoto T, Miyoshi H, Moritsubo M, et al
Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas.
J Neurooncol. 2023 Sep 14. doi: 10.1007/s11060-023-04447.
PubMed Abstract available

IGLSEDER S, Iglseder A, Beliveau V, Heugenhauser J, et al
Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
J Neurooncol. 2023 Sep 14. doi: 10.1007/s11060-023-04414.
PubMed Abstract available

KATLOWITZ KA, Athukuri P, Sharma H, Dang H, et al
Seizure outcomes after resection of primary brain tumors in pediatric patients: a systematic review and meta-analysis.
J Neurooncol. 2023 Sep 14. doi: 10.1007/s11060-023-04446.
PubMed Abstract available

JABEHDAR MARALANI P, Stewart J, Hiremath S, Lawrence L, et al
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma.
J Neurooncol. 2023 Sep 14. doi: 10.1007/s11060-023-04440.
PubMed Abstract available

DIMOV D, Brainman D, Berger B, Coras R, et al
The role of cytoreductive surgery in multifocal/multicentric glioblastomas.
J Neurooncol. 2023 Sep 12. doi: 10.1007/s11060-023-04410.
PubMed Abstract available

NINATTI G, Pini C, Bono BC, Gelardi F, et al
The prognostic power of [(11)C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification.
J Neurooncol. 2023 Sep 11. doi: 10.1007/s11060-023-04438.
PubMed Abstract available

ALZATE JD, Mullen R, Mashiach E, Bernstein K, et al
EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptomeningeal disease.
J Neurooncol. 2023 Sep 10. doi: 10.1007/s11060-023-04442.
PubMed Abstract available

SOHN B, Park K, Ahn SS, Park YW, et al
Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype.
J Neurooncol. 2023 Sep 10. doi: 10.1007/s11060-023-04435.
PubMed Abstract available

HOU Z, Hu J, Liu X, Yan Z, et al
Decision system for extent of resection in WHO grade 3 gliomas: a Chinese Glioma Genome Atlas database analysis.
J Neurooncol. 2023 Sep 5. doi: 10.1007/s11060-023-04420.
PubMed Abstract available

WU YY, Chen KT, Chu YC, Yeh CC, et al
Neuropsychological impairment in primary malignant brain tumor patients with awake craniotomy: a hospital-based registration study.
J Neurooncol. 2023 Sep 5. doi: 10.1007/s11060-023-04431.
PubMed Abstract available

MURTHA AN, Zaki PG, Shepard MJ
Letter to the editor: outcome of glioblastoma patients after intensive care unit admission with invasive mechanical ventilation: a multicenter analysis.
J Neurooncol. 2023 Sep 5. doi: 10.1007/s11060-023-04434.
PubMed

LUCKETT PH, Olufawo M, Lamichhane B, Park KY, et al
Predicting survival in glioblastoma with multimodal neuroimaging and machine learning.
J Neurooncol. 2023 Sep 5. doi: 10.1007/s11060-023-04439.
PubMed Abstract available

HUNG JS, Su YH, Chen CJ, Chiang CL, et al
Is it advisable to perform radiosurgery for EGFR-TKI-controlled brain metastases? A retrospective study of the role of radiosurgery in lung cancer treatment.
J Neurooncol. 2023 Sep 1. doi: 10.1007/s11060-023-04425.
PubMed Abstract available

CIFARELLI CP, Vargo JA, Sener U, Cifarelli DT, et al
Intracranial intraoperative radiotherapy (IORT): evaluation of electrocorticography and peri-operative seizure risk.
J Neurooncol. 2023;164:423-430.
PubMed Abstract available

MINNITI G, Paolini S, Antonelli M, Gianno F, et al
Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma.
J Neurooncol. 2023;164:331-339.
PubMed Abstract available

HOU L, Chen X, Qiu G, Qi X, et al
Cerebrospinal fluid exosomal protein alterations via proteomic analysis of NSCLC with leptomeningeal carcinomatosis.
J Neurooncol. 2023;164:367-376.
PubMed Abstract available

FIGUEREDO LF, Shelton WJ, Tagle-Vega U, Sanchez E, et al
The state of art of awake craniotomy in Latin American countries: a scoping review.
J Neurooncol. 2023;164:287-298.
PubMed Abstract available

ID SAID B, Soliman H, Moravan V, Myrehaug S, et al
Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer.
J Neurooncol. 2023;164:437-445.
PubMed Abstract available

ZENG C, Yang Q, Li Z, Wei Z, et al
Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study.
J Neurooncol. 2023;164:643-653.
PubMed Abstract available

ZEYEN T, Paech D, Weller J, Schafer N, et al
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
J Neurooncol. 2023;164:607-616.
PubMed Abstract available

August 2023

PERTZ M, Schlomer S, Seidel C, Hentschel B, et al
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up.
J Neurooncol. 2023 Aug 30. doi: 10.1007/s11060-023-04419.
PubMed Abstract available

JIA W, Zhai X, Jing X, Bao Q, et al
Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases.
J Neurooncol. 2023 Aug 30. doi: 10.1007/s11060-023-04426.
PubMed Abstract available

WAGENER K, Beckhaus J, Boekhoff S, Friedrich C, et al
Publisher Correction to: Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents.
J Neurooncol. 2023 Aug 29. doi: 10.1007/s11060-023-04424.
PubMed

QURESHI HM, Tabor JK, Pickens K, Lei H, et al
Frailty and postoperative outcomes in brain tumor patients: a systematic review subdivided by tumor etiology.
J Neurooncol. 2023 Aug 25. doi: 10.1007/s11060-023-04416.
PubMed Abstract available

DE PIETRO R, Zaccaro L, Marampon F, Tini P, et al
The evolving role of reirradiation in the management of recurrent brain tumors.
J Neurooncol. 2023 Aug 25. doi: 10.1007/s11060-023-04407.
PubMed Abstract available

LEHRER EJ, Trifiletti DM, Sheehan JP
Stereotactic radiosurgery in patients with extensive brain metastases - supporting evidence and knowledge gaps.
J Neurooncol. 2023 Aug 21. doi: 10.1007/s11060-023-04422.
PubMed

EBIKO Y, Tamura K, Hara S, Inaji M, et al
T2-FLAIR mismatch sign correlates with (11)C-methionine uptake in lower-grade diffuse gliomas.
J Neurooncol. 2023 Aug 17. doi: 10.1007/s11060-023-04417.
PubMed Abstract available

GURRIERI L, Mercatali L, Ibrahim T, Fausti V, et al
Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series.
J Neurooncol. 2023 Aug 16. doi: 10.1007/s11060-023-04357.
PubMed Abstract available

LAWSON MCLEAN A
Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib.
J Neurooncol. 2023 Aug 10. doi: 10.1007/s11060-023-04408.
PubMed

MIER-GARCIA JF, Ospina-Santa S, Orozco-Mera J, Ma R, et al
Supramaximal versus gross total resection in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4, effect on overall and progression free survival: systematic review and meta-analysis.
J Neurooncol. 2023 Aug 10. doi: 10.1007/s11060-023-04409.
PubMed Abstract available

JABLONSKA PA, Muniz T, Ribeiro M, Liu ZA, et al
Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis.
J Neurooncol. 2023 Aug 8. doi: 10.1007/s11060-023-04404.
PubMed Abstract available

OTANI R, Ikegami M, Yamada R, Yajima H, et al
PTPN11 variant may be a prognostic indicator of IDH-wildtype glioblastoma in a comprehensive genomic profiling cohort.
J Neurooncol. 2023 Aug 8. doi: 10.1007/s11060-023-04411.
PubMed Abstract available

HOLDAWAY M, Ablyazova F, Huda S, D'Amico RS, et al
First in-human intrathecal delivery of bevacizumab for leptomeningeal spread from recurrent glioblastoma: rationale for a dose escalation trial.
J Neurooncol. 2023 Aug 7. doi: 10.1007/s11060-023-04412.
PubMed Abstract available

LANG A, Jeron RL, Lontzek B, Kiesel B, et al
Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis.
J Neurooncol. 2023 Aug 6. doi: 10.1007/s11060-023-04406.
PubMed Abstract available

NEUMANN B, Onken J, Konig N, Stetefeld H, et al
Outcome of glioblastoma patients after intensive care unit admission with invasive mechanical ventilation: a multicenter analysis.
J Neurooncol. 2023 Aug 2. doi: 10.1007/s11060-023-04403.
PubMed Abstract available

AKINDURO OO, Ghaith AK, El-Hajj VG, Ghanem M, et al
Effect of race, sex, and socioeconomic factors on overall survival following the resection of intramedullary spinal cord tumors.
J Neurooncol. 2023;164:75-85.
PubMed Abstract available

NETH BJ, Webb MJ, White J, Uhm JH, et al
Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience.
J Neurooncol. 2023;164:239-247.
PubMed Abstract available

July 2023

NODA R, Kawashima M, Segawa M, Tsunoda S, et al
Fractionated versus staged gamma knife radiosurgery for mid-to-large brain metastases: a propensity score-matched analysis.
J Neurooncol. 2023 Jul 31. doi: 10.1007/s11060-023-04374.
PubMed Abstract available

HU T, Xuan R, Han E, Cai L, et al
SPOPL induces tumorigenicity and stemness in glioma stem cells by activating Notch signaling.
J Neurooncol. 2023 Jul 31. doi: 10.1007/s11060-023-04394.
PubMed Abstract available

MANTICA M, Drappatz J, Lieberman F, Hadjipanayis CG, et al
Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme.
J Neurooncol. 2023 Jul 29. doi: 10.1007/s11060-023-04398.
PubMed Abstract available

VIOZZI I, Overduin CG, Rijpma A, Rovers MM, et al
MR-guided LITT therapy in patients with primary irresectable glioblastoma: a prospective, controlled pilot study.
J Neurooncol. 2023 Jul 28. doi: 10.1007/s11060-023-04371.
PubMed Abstract available

BALLO MT, Conlon P, Lavy-Shahaf G, Kinzel A, et al
Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis.
J Neurooncol. 2023 Jul 26. doi: 10.1007/s11060-023-04348.
PubMed Abstract available

RAVIN R, Suarez-Meade P, Busse B, Blank PS, et al
Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain.
J Neurooncol. 2023 Jul 25. doi: 10.1007/s11060-023-04349.
PubMed Abstract available

KHATRI VM, Mills MN, Oliver DE, Yu HM, et al
Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases.
J Neurooncol. 2023 Jul 25. doi: 10.1007/s11060-023-04402.
PubMed Abstract available

SPILLE DC, Thomas C, Wagner A, Grauer OM, et al
Molecular predictors for decitabine efficacy in meningiomas - a pilot study.
J Neurooncol. 2023 Jul 21. doi: 10.1007/s11060-023-04379.
PubMed Abstract available

LAYER JP, Hamed M, Potthoff AL, Dejonckheere CS, et al
Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis.
J Neurooncol. 2023 Jul 21. doi: 10.1007/s11060-023-04380.
PubMed Abstract available

BUYUKTEPE M, Kaplan I, Bayatli E, Dogan H, et al
Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay.
J Neurooncol. 2023 Jul 20. doi: 10.1007/s11060-023-04397.
PubMed Abstract available

ZHANG YT, Wang Y, Zhong XD, Chang J, et al
Efficacy of intrathecal methotrexate in children with high-risk medulloblastoma over three years: a retrospective study from a single center.
J Neurooncol. 2023 Jul 20. doi: 10.1007/s11060-023-04388.
PubMed Abstract available

TAORI S, Wei Z, Deng H, Hadjipanayis CG, et al
Stereotactic radiosurgery for patients with brain metastases from gastroesophageal cancers.
J Neurooncol. 2023 Jul 20. doi: 10.1007/s11060-023-04392.
PubMed Abstract available

YANG X, Ji C, Qi Y, Huang J, et al
Signal-transducing adaptor protein 1 (STAP1) in microglia promotes the malignant progression of glioma.
J Neurooncol. 2023 Jul 18. doi: 10.1007/s11060-023-04390.
PubMed Abstract available

CHOJAK R, Fares J, Petrosyan E, Lesniak MS, et al
Cellular senescence in glioma.
J Neurooncol. 2023 Jul 17. doi: 10.1007/s11060-023-04387.
PubMed Abstract available

MALLICK S, Gupta S, Amariyil A, Kunhiparambath H, et al
Hypo-fractionated accelerated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: updated results from phase II HART-GBM trial.
J Neurooncol. 2023 Jul 15. doi: 10.1007/s11060-023-04391.
PubMed Abstract available

ONYIAH C, Shepard MJ
Letter: are there incidences of clinically relevant psychiatric symptoms during glioblastoma treatment?
J Neurooncol. 2023 Jul 13. doi: 10.1007/s11060-023-04376.
PubMed

MATSUI JK, Allen PK, Perlow HK, Johnson JM, et al
Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience.
J Neurooncol. 2023 Jul 13. doi: 10.1007/s11060-023-04386.
PubMed Abstract available

OTANI R, Sadato D, Yamada R, Yajima H, et al
CHD5 gene variant predicts leptomeningeal metastasis after surgical resection of brain metastases of breast cancer.
J Neurooncol. 2023 Jul 13. doi: 10.1007/s11060-023-04381.
PubMed Abstract available

LEI H, Tabor JK, O'Brien J, Qin R, et al
Associations of race and socioeconomic status with outcomes after intracranial meningioma resection: a systematic review and meta-analysis.
J Neurooncol. 2023 Jul 13. doi: 10.1007/s11060-023-04393.
PubMed Abstract available

INDHARTY RS, Japardi I, Irina RS, Tandean S, et al
Comparison of direct cortical stimulation and transcranial magnetic stimulation in brain tumor surgery: systematic review and meta analyses.
J Neurooncol. 2023 Jul 12. doi: 10.1007/s11060-023-04378.
PubMed Abstract available

YADAV N, Babu D, Madigubba S, Panigrahi M, et al
Tyrphostin A9 attenuates glioblastoma growth by suppressing PYK2/EGFR-ERK signaling pathway.
J Neurooncol. 2023 Jul 6. doi: 10.1007/s11060-023-04383.
PubMed Abstract available

MISHRA A, Koffler D, Calugaru E, Rowe N, et al
Let's make size not matter: tumor control and toxicity outcomes of hypofractionated Gamma Knife radiosurgery for large brain metastases.
J Neurooncol. 2023 Jul 6. doi: 10.1007/s11060-023-04365.
PubMed Abstract available

TANRIKULU B, Yasar AH, Canpolat C, Corapcioglu F, et al
Preliminary findings of German-sourced ONC201 treatment in H3K27 altered pediatric pontine diffuse midline gliomas.
J Neurooncol. 2023 Jul 4. doi: 10.1007/s11060-023-04347.
PubMed Abstract available

WAGENER K, Beckhaus J, Boekhoff S, Friedrich C, et al
Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents.
J Neurooncol. 2023 Jul 4. doi: 10.1007/s11060-023-04344.
PubMed Abstract available

LUO M, Tang R, Wang H
Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset.
J Neurooncol. 2023;163:663-674.
PubMed Abstract available

LESKINEN S, Shah HA, Yaffe B, Schneider SJ, et al
Hippocampal avoidance in whole brain radiotherapy and prophylactic cranial irradiation: a systematic review and meta-analysis.
J Neurooncol. 2023;163:515-527.
PubMed Abstract available

June 2023

JONNAKUTI VS, Ji P, Gao Y, Lin A, et al
NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1.
J Neurooncol. 2023 Jun 30. doi: 10.1007/s11060-023-04370.
PubMed Abstract available

MEISSNER AK, Gutsche R, Galldiks N, Kocher M, et al
Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer.
J Neurooncol. 2023 Jun 29. doi: 10.1007/s11060-023-04367.
PubMed Abstract available

MOORE-PALHARES D, Chen H, Keith J, Wang M, et al
Correction to: Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
J Neurooncol. 2023 Jun 28. doi: 10.1007/s11060-023-04364.
PubMed

ADILE AA, Bakhshinyan D, Suk Y, Uehling D, et al
An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastoma.
J Neurooncol. 2023 Jun 24. doi: 10.1007/s11060-023-04372.
PubMed Abstract available

HOLDAWAY M, Starner J, Patel RR, Salama J, et al
Improvement in visual outcomes of patients with base of skull meningioma as a result of evolution in the treatment techniques in the last three decades: a systematic review.
J Neurooncol. 2023 Jun 24. doi: 10.1007/s11060-023-04366.
PubMed Abstract available

CHEN J, Li T, Zhou N, He Y, et al
Engineered Salmonella inhibits GPX4 expression and induces ferroptosis to suppress glioma growth in vitro and in vivo.
J Neurooncol. 2023 Jun 23. doi: 10.1007/s11060-023-04369.
PubMed Abstract available

TOM MC, DiFilippo FP, Jones SE, Suh JH, et al
(18)F-fluciclovine PET/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study.
J Neurooncol. 2023 Jun 21. doi: 10.1007/s11060-023-04377.
PubMed Abstract available

MASSIMINO M, Vennarini S, Buttarelli FR, Antonelli M, et al
Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.
J Neurooncol. 2023 Jun 16. doi: 10.1007/s11060-023-04361.
PubMed Abstract available

KHAN AB, Patel R, McDonald MF, Goethe E, et al
Integrated clinical genomic analysis reveals xenobiotic metabolic genes are downregulated in meningiomas of current smokers.
J Neurooncol. 2023 Jun 15. doi: 10.1007/s11060-023-04359.
PubMed Abstract available

JOST J, Muther M, Brandt R, Altuner U, et al
Conceptual development of an intensive exercise program for glioma patients (ActiNO): summary of clinical experience.
J Neurooncol. 2023 Jun 12. doi: 10.1007/s11060-023-04354.
PubMed Abstract available

MERENZON MA, Levy AS, Bhatia S, Rivera C, et al
Towards the definition of progressive disease in brain metastasis treated with laser ablation: an evidence-based study.
J Neurooncol. 2023 Jun 12. doi: 10.1007/s11060-023-04360.
PubMed Abstract available

CHO NS, Sanvito F, Thakuria S, Wang C, et al
Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas.
J Neurooncol. 2023 Jun 9. doi: 10.1007/s11060-023-04363.
PubMed Abstract available

WELLER J, Katzendobler S, Niedermeyer S, Harter PN, et al
Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status.
J Neurooncol. 2023 Jun 8. doi: 10.1007/s11060-023-04362.
PubMed Abstract available

NAGAI N, Koide Y, Shindo Y, Hashimoto S, et al
Retrospective non-inferiority study of stereotactic radiosurgery for more than ten brain metastases.
J Neurooncol. 2023 Jun 7. doi: 10.1007/s11060-023-04358.
PubMed Abstract available

TOKLU S, Kemerdere R, Kacira T, Gurses MS, et al
Tissue and plasma free amino acid detection by LC-MS/MS method in high grade glioma patients.
J Neurooncol. 2023 Jun 6. doi: 10.1007/s11060-023-04329.
PubMed Abstract available

MA J, Li D, Hong Y, Zhang Y, et al
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas.
J Neurooncol. 2023 Jun 2. doi: 10.1007/s11060-023-04351.
PubMed Abstract available

VAN SCHIE P, Rijksen BLT, Bot M, Wiersma T, et al
Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series.
J Neurooncol. 2023 Jun 2. doi: 10.1007/s11060-023-04343.
PubMed Abstract available

CACCESE M, Desideri I, Padovan M, Bruno F, et al
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study.
J Neurooncol. 2023 Jun 1. doi: 10.1007/s11060-023-04356.
PubMed Abstract available

BISWAS A, Salvucci M, Connor K, Dussmann H, et al
Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
J Neurooncol. 2023;163:327-338.
PubMed Abstract available

May 2023

MOORE-PALHARES D, Chen H, Keith J, Wang M, et al
Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
J Neurooncol. 2023 May 31. doi: 10.1007/s11060-023-04340.
PubMed Abstract available

BANDER ED, Kelly A, Ma X, Christos PJ, et al
Safety and efficacy of Cesium-131 brachytherapy for brain tumors.
J Neurooncol. 2023 May 30. doi: 10.1007/s11060-023-04352.
PubMed Abstract available

MCLAUGHLIN LA, Yildirim O, Rosenblum MK, Imber BS, et al
Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT.
J Neurooncol. 2023 May 29. doi: 10.1007/s11060-023-04355.
PubMed Abstract available

SHEEHAN J, Cifarelli CP, Fadul C
Contemporary care for brain metastasis patients: multidisciplinary approaches and the role of prospective national registries.
J Neurooncol. 2023 May 25. doi: 10.1007/s11060-023-04350.
PubMed

BUSCH N, Wegner RE, Shepard MJ
Letter to the editor: neurocognitive functioning after Gamma Knife and LINAC stereotactic radiosurgery in patients with brain metastases.
J Neurooncol. 2023 May 25. doi: 10.1007/s11060-023-04345.
PubMed

TINI P, Yavoroska M, Mazzei MA, Miracco C, et al
Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status.
J Neurooncol. 2023 May 25. doi: 10.1007/s11060-023-04342.
PubMed Abstract available

JURATLI TA, Jungk C, Miller JJ
Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.
J Neurooncol. 2023 May 22. doi: 10.1007/s11060-023-04317.
PubMed

CROOMS RC, Taylor JW, Jette N, Morgenstern R, et al
Palliative care referral across the disease trajectory in high-grade glioma.
J Neurooncol. 2023 May 20. doi: 10.1007/s11060-023-04338.
PubMed Abstract available

FENG X, Zhu F, Dai L, Liu X, et al
Caspase-3 in glioma indicates an unfavorable prognosis by involving surrounding angiogenesis and tumor cell repopulation.
J Neurooncol. 2023 May 17. doi: 10.1007/s11060-023-04339.
PubMed Abstract available

KNIGHT A, Horsley P, Yuile A, Yim J, et al
Volumetric response and pattern of failure of histone altered high grade glioma in adults following management with radiation therapy.
J Neurooncol. 2023 May 15. doi: 10.1007/s11060-023-04332.
PubMed Abstract available

VALINCIUTE G, Ecker J, Selt F, Hielscher T, et al
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
J Neurooncol. 2023 May 15. doi: 10.1007/s11060-023-04319.
PubMed Abstract available

BONOSI L, Marino S, Benigno UE, Musso S, et al
Sonodynamic therapy and magnetic resonance-guided focused ultrasound: new therapeutic strategy in glioblastoma.
J Neurooncol. 2023 May 14. doi: 10.1007/s11060-023-04333.
PubMed Abstract available

ZILIOLI A, Misirocchi F, Mutti C, Pancaldi B, et al
Volumetric hippocampal changes in glioblastoma: a biomarker for neuroplasticity?
J Neurooncol. 2023 May 13. doi: 10.1007/s11060-023-04315.
PubMed Abstract available

MA Y, Shi F, Sun T, Chen H, et al
Histopathological auxiliary system for brain tumour (HAS-Bt) based on weakly supervised learning using a WHO CNS5-style pipeline.
J Neurooncol. 2023 May 13. doi: 10.1007/s11060-023-04306.
PubMed Abstract available

MERLIN MS, Schmitt E, Mezloy-Destracque M, Dufour C, et al
Neurocognitive and radiological follow-up of children under 5 years of age treated for medulloblastoma according to the HIT-SKK protocol.
J Neurooncol. 2023 May 12. doi: 10.1007/s11060-023-04328.
PubMed Abstract available

PADILLA CS, Ho VKY, Mooijenkind TWAN, Louwman MWJ, et al
Brain metastases in adult patients with melanoma of unknown primary in the Netherlands (2011-2020).
J Neurooncol. 2023 May 12. doi: 10.1007/s11060-023-04335.
PubMed Abstract available

ZABEK T, Szmatola T, Adamczyk-Grochala J, Lewinska A, et al
Knockout of TRDMT1 methyltransferase affects DNA methylome in glioblastoma cells.
J Neurooncol. 2023 May 11. doi: 10.1007/s11060-023-04304.
PubMed Abstract available

KALYVAS A, Gutierrez-Valencia E, Lau R, Ye XY, et al
Anatomical and surgical characteristics correlate with pachymeningeal failure in patients with brain metastases after neurosurgical resection and adjuvant stereotactic radiosurgery.
J Neurooncol. 2023 May 10. doi: 10.1007/s11060-023-04325.
PubMed Abstract available

REGLI LKP, Huijs SMH, Pasmans RCOS, Leue C, et al
Incidence of clinically relevant psychiatric symptoms during glioblastoma treatment: an exploratory study.
J Neurooncol. 2023 May 10. doi: 10.1007/s11060-023-04326.
PubMed Abstract available

SAUNDERS JT, Kumar S, Benavides-Serrato A, Holmes B, et al
Translation of circHGF RNA encodes an HGF protein variant promoting glioblastoma growth through stimulation of c-MET.
J Neurooncol. 2023 May 10. doi: 10.1007/s11060-023-04331.
PubMed Abstract available

LAZZARINI E, Silvestris DA, Benvenuto G, Osti D, et al
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.
J Neurooncol. 2023 May 4. doi: 10.1007/s11060-023-04287.
PubMed Abstract available

ZUO P, Li Y, Wang T, Lin X, et al
A novel CDK4/6 inhibitor combined with irradiation demonstrates potent anti-tumor efficacy in diffuse midline glioma.
J Neurooncol. 2023 May 3. doi: 10.1007/s11060-023-04323.
PubMed Abstract available

FISHMAN H, Monin R, Dor-On E, Kinzel A, et al
Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines.
J Neurooncol. 2023 May 2. doi: 10.1007/s11060-023-04308.
PubMed Abstract available

TRAVERS SS, Fisher CM, Kabos P, Cittelly DM, et al
Breast cancer brain metastases localization and risk of hydrocephalus: a single institution experience.
J Neurooncol. 2023 May 2. doi: 10.1007/s11060-023-04314.
PubMed Abstract available

DE GODOY LL, Chawla S, Brem S, Wang S, et al
Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.
J Neurooncol. 2023 May 2. doi: 10.1007/s11060-023-04324.
PubMed Abstract available

YE L, Wu BS, Xu ZA, Ji XF, et al
Evidence for an intra-tumoral microbiome in pituitary neuroendocrine tumors with different clinical phenotypes.
J Neurooncol. 2023;163:133-142.
PubMed Abstract available

DEWAN MC, Isaacs AM, Cools MJ, Yengo-Kahn A, et al
Treatment of hydrocephalus following posterior fossa tumor resection: a multicenter collaboration from the Hydrocephalus Clinical Research Network.
J Neurooncol. 2023;163:123-132.
PubMed Abstract available

LI Q, Ma Y, Lin Z, Ma J, et al
A prospective cohort study of methotrexate plus idarubicin in newly diagnosed primary CNS lymphoma.
J Neurooncol. 2023;163:39-46.
PubMed Abstract available

April 2023

AMELOT A, Terrier LM, Cognacq G, Jecko V, et al
Correction to: Natural history of spinal cord metastasis from brain glioblastomas.
J Neurooncol. 2023 Apr 26. doi: 10.1007/s11060-023-04320.
PubMed

SENGUPTA S
Integrative neuro-oncology for brain tumor patients.
J Neurooncol. 2023 Apr 25. doi: 10.1007/s11060-023-04309.
PubMed

CHANG WH, Wei KC, Chen PY, Chen YC, et al
The impact of patient factors and tumor characteristics on language neuroplasticity in left hemispheric diffuse gliomas prior to surgical resection.
J Neurooncol. 2023 Apr 24. doi: 10.1007/s11060-023-04311.
PubMed Abstract available

TRACZ JA, Donnelly BM, Ngu S, Vojnic M, et al
The abscopal effect: inducing immunogenicity in the treatment of brain metastases secondary to lung cancer and melanoma.
J Neurooncol. 2023 Apr 22. doi: 10.1007/s11060-023-04312.
PubMed Abstract available

SYED HR, Kilburn L, Fonseca A, Nazarian J, et al
First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound : Technical communication.
J Neurooncol. 2023 Apr 12. doi: 10.1007/s11060-023-04269.
PubMed

DEMETZ M, Krigers A, Moser P, Kerschbaumer J, et al
Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival.
J Neurooncol. 2023 Apr 12. doi: 10.1007/s11060-023-04301.
PubMed Abstract available

ALTIERI R, Certo F, Pacella D, Cammarata G, et al
Metabolic delineation of IDH1 wild-type glioblastoma surgical anatomy: how to plan the tumor extent of resection.
J Neurooncol. 2023 Apr 11. doi: 10.1007/s11060-023-04305.
PubMed Abstract available

VOON NS, Manan HA, Yahya N
Remote assessment of cognition and quality of life following radiotherapy for glioma: deep-learning-based predictive models and MRI correlates.
J Neurooncol. 2023 Apr 4:1-9. doi: 10.1007/s11060-023-04303.
PubMed Abstract available

DINCER A, Morales-Valero SF, Robert SM, Tabor JK, et al
Surgical strategies for intracranial meningioma in the molecular era.
J Neurooncol. 2023 Apr 3. doi: 10.1007/s11060-023-04272.
PubMed Abstract available

YAMASHITA S, Takeshima H, Hata N, Uchida H, et al
Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group.
J Neurooncol. 2023;162:425-433.
PubMed Abstract available

FOO JC, Yaman Bajin I, Marushchak O, McKeown T, et al
Time to dismiss boost? Outcomes of children with localized and metastatic germinoma.
J Neurooncol. 2023;162:443-448.
PubMed Abstract available

ROEHRIG A, Indelicato DJ, Paulino AC, Ermoian R, et al
Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
J Neurooncol. 2023;162:353-362.
PubMed Abstract available

KEARNS K, Shepard MJ, Sheehan JP
Social media and the Journal of Neuro-Oncology.
J Neurooncol. 2023;162:453-454.
PubMed

March 2023

AYMERIC A, Louis-Marie T, Gabrielle C, Vincent J, et al
Natural history of spinal cord metastasis from brain glioblastomas.
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04298.
PubMed Abstract available

QUAN G, Wang T, Ren JL, Xue X, et al
Prognostic and predictive impact of abnormal signal volume evolution early after chemoradiotherapy in glioblastoma.
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04299.
PubMed Abstract available

CHAMPEAUX-DEPOND C, Jecko V, Weller J, Constantinou P, et al
Recurrent high grade glioma surgery with carmustine wafers implantation: a long-term nationwide retrospective study.
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04295.
PubMed Abstract available

OZKARA BB, Federau C, Dagher SA, Pattnaik D, et al
Correlating volumetric and linear measurements of brain metastases on MRI scans using intelligent automation software: a preliminary study.
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04297.
PubMed Abstract available

ZHA B, Yang J, Dang Q, Li P, et al
A phase I clinical trial of sonodynamic therapy combined with temozolomide in the treatment of recurrent glioblastoma.
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04292.
PubMed Abstract available

POPPE JP, Schwartz C
In reply to the letter to the editor by Busch et al. regarding "Surgeon experience in glioblastoma surgery of the elderly-a multicenter, retrospective cohort study".
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04302.
PubMed

KIMURA K, Deguchi S, Mitsuya K, Mamesaya N, et al
Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer center.
J Neurooncol. 2023 Mar 28. doi: 10.1007/s11060-023-04300.
PubMed Abstract available

WAMELINK IJHG, Hempel HL, van de Giessen E, Vries MHM, et al
The patients' experience of neuroimaging of primary brain tumors: a cross-sectional survey study.
J Neurooncol. 2023 Mar 28. doi: 10.1007/s11060-023-04290.
PubMed Abstract available

IUS T, Sabatino G, Panciani PP, Fontanella MM, et al
Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch(R)): a systematic review.
J Neurooncol. 2023 Mar 24. doi: 10.1007/s11060-023-04274.
PubMed Abstract available

PARSONS MW, Sabsevitz DS
Cognitive issues in patients with IDH mutant gliomas: from neuroscience to clinical neuropsychology.
J Neurooncol. 2023 Mar 20. doi: 10.1007/s11060-023-04289.
PubMed Abstract available

LIANG L, Wen L, Qin S, He Z, et al
Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM-IPTW cohort study.
J Neurooncol. 2023 Mar 20. doi: 10.1007/s11060-023-04293.
PubMed Abstract available

SHAH DS, Reddy RV, Dogruel Y, Asfour MZ, et al
Calcified spinal meningiomas: a systematic review of clinical characteristics, treatment strategies, and outcomes.
J Neurooncol. 2023 Mar 17. doi: 10.1007/s11060-023-04291.
PubMed Abstract available

QUACH S, Schwartz C, Aumiller M, Foglar M, et al
Interstitial photodynamic therapy for newly diagnosed glioblastoma.
J Neurooncol. 2023 Mar 16. doi: 10.1007/s11060-023-04284.
PubMed Abstract available

BLEEKER L, Kouwenhoven MCM, de Heer I, Lissenberg-Witte BI, et al
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol.
J Neurooncol. 2023 Mar 15. doi: 10.1007/s11060-023-04285.
PubMed Abstract available

YAN M, Lee M, Myrehaug S, Tseng CL, et al
Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS).
J Neurooncol. 2023 Mar 13. doi: 10.1007/s11060-023-04265.
PubMed Abstract available

DUFFAU H
Occurrence of non-central nervous system cancers during postoperative follow-up of patients who underwent surgery for a WHO grade II glioma: implications for therapeutic management.
J Neurooncol. 2023 Mar 13. doi: 10.1007/s11060-023-04288.
PubMed Abstract available

KING AL, Roche KN, Leeper HE, Vera E, et al
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial.
J Neurooncol. 2023 Mar 8:1-9. doi: 10.1007/s11060-023-04271.
PubMed Abstract available

JUSINO S, Fadul CE, Dillon P
Systematic review of the management of brain metastases from hormone receptor positive breast cancer.
J Neurooncol. 2023 Mar 8. doi: 10.1007/s11060-023-04276.
PubMed Abstract available

TRIFILETTI DM, Akinyelu T, Burri SH, Jeudy A, et al
Glioma inadvertently treated with preoperative stereotactic radiosurgery: focusing on safety.
J Neurooncol. 2023 Mar 6. doi: 10.1007/s11060-023-04278.
PubMed

MARTIN JA, Hart NH, Bradford N, Naumann F, et al
Prevalence and management of sleep disturbance in adults with primary brain tumours and their caregivers: a systematic review.
J Neurooncol. 2023 Mar 2. doi: 10.1007/s11060-023-04270.
PubMed Abstract available

LI C, Guan N, Liu F
T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma.
J Neurooncol. 2023 Mar 1. doi: 10.1007/s11060-023-04257.
PubMed Abstract available

THIERHEIMER M, Cioffi G, Waite KA, Kruchko C, et al
Mortality trends in primary malignant brain and central nervous system tumors vary by histopathology, age, race, and sex.
J Neurooncol. 2023;162:167-177.
PubMed Abstract available

SHARMA M, Do TH, Palzer EF, Huling JD, et al
Comparable safety profile between neuro-oncology procedures involving stereotactic needle biopsy (SNB) followed by laser interstitial thermal therapy (LITT) and LITT alone procedures.
J Neurooncol. 2023;162:147-156.
PubMed Abstract available

WEI Z, Pease M, Tang LW, Deng H, et al
Radiosurgery outcomes in infratentorial juvenile pilocytic astrocytomas.
J Neurooncol. 2023;162:157-165.
PubMed Abstract available

CACCIOTTI C, Chua IS, Cuadra J, Ullrich NJ, et al
Pediatric central nervous system tumor survivor and caregiver experiences with multidisciplinary telehealth.
J Neurooncol. 2023;162:191-198.
PubMed Abstract available

WESSELS PH, Boelens MC, Monkhorst K, Sonke GS, et al
A review on genetic alterations in CNS metastases related to breast cancer treatment. Is there a role for liquid biopsies in CSF?
J Neurooncol. 2023;162:1-13.
PubMed Abstract available

February 2023

TRINGALE KR, Wolden SL, Karajannis M, Haque S, et al
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.
J Neurooncol. 2023 Feb 28. doi: 10.1007/s11060-022-04235.
PubMed Abstract available

MOLITERNO J, Brastianos PK
Journal of Neuro-Oncology, Meningioma issue.
J Neurooncol. 2023 Feb 27. doi: 10.1007/s11060-023-04251.
PubMed

PARK YW, Han K, Kim S, Kwon H, et al
Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalities.
J Neurooncol. 2023 Feb 25. doi: 10.1007/s11060-022-04233.
PubMed Abstract available

WANG JZ, Nassiri F, Landry AP, Patil V, et al
The multiomic landscape of meningiomas: a review and update.
J Neurooncol. 2023 Feb 25. doi: 10.1007/s11060-023-04253.
PubMed Abstract available

PATEL Z, Cho M, Das S
The role of immune checkpoint inhibitors in patients with intracranial metastatic disease.
J Neurooncol. 2023;161:469-478.
PubMed Abstract available

AK M, Lf N, Gm I, Av K, et al
Outcomes following management of relapsed pediatric posterior fossa ependymoma in the molecular era.
J Neurooncol. 2023;161:573-582.
PubMed Abstract available

November 2022

IGLESIAS P, Biagetti B, Araujo-Castro M, Alcazar V, et al
Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma.
J Neurooncol. 2022;160:351-359.
PubMed Abstract available

RAGHIB MF, Salim A, Angez M, Ghazi SM, et al
Prognostic implication of size on outcomes of pituitary macroadenoma: a comparative analysis of giant adenoma with non-giant macroadenoma.
J Neurooncol. 2022;160:491-496.
PubMed Abstract available

SHE L, Deng D, Su L, Liu C, et al
Comparison of surgery with or without adjuvant radiotherapy in treating central neurocytoma: a single-center retrospective real-world study.
J Neurooncol. 2022;160:455-462.
PubMed Abstract available

WEBB M, Johnson DR, Mahajan A, Brown P, et al
Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis.
J Neurooncol. 2022;160:527-534.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum